Ingredion
Annual Report 2014

Plain-text annual report

A Better Mix 2014 Annual Report We are a leading global ingredient company on the move. We are evolving our strategic mix, broadening our emphasis from core ingredients to include higher-value, on-trend specialty ingredients. We are investing in our global infrastructure to support the improved mix, positioning Ingredion to drive global, locally relevant specialty innovation. We are leveraging our strong cash generation, solid balance sheet and culture of continuous improvement to move us forward. A better mix means a better Ingredion—for customers, employees and investors alike. 2019 Objectives Defined1 A specific set of objectives defines the Ingredion we are building: a thriving global industry leader focused on high-value, sustainable, on-trend specialty food ingredients. BY 2019 $8B TOTAL SALES BY 2019 2pts2 1 2014 Base Year BY 2019 $2B IN SPECIALTY SALES BY 2019 10% MARGIN EXPANSION RETURN ON CAPITAL EMPLOYED BY 2019 EPS LOW DOUBLE–DIGIT GROWTH 2 Represents real gross margin absolute dollar growth; actual margins vary due to pass-through of changes in raw material costs INGREDION INCORPORATED 1 A BETTER MIX To Our Shareholders We continued to execute on our strategic blueprint through organic growth, M&A, and investments in innovation and operational excellence. These advancements in our strategy were achieved despite a year made challenging by currency headwinds and economic deceleration. We credit our focus on diversification and disciplined cost control for progressing our agenda and enabling us to continue our long tradition of delivering shareholder value. 2014 marked another year where we made significant progress transforming Ingredion into a global ingredient solutions provider despite a number of challenges. We continued to advance the strategic blueprint and made progress on our 2019 objectives highlighted in this report, even while faced with adverse weather, slowing economies and currency devaluations. Our blueprint guides our future growth opportunities as a leading ingredients company through operational excellence, organic growth, broadening our portfolio and geographic expansion, delivering value for our customers and ultimately creating shareholder value. The foundation of our strategic blueprint is operational excellence. Our commitment to continuous improvement is unrelenting. More than 25 percent of our employees are now Lean Six-Sigma certified, and we are diligent about optimizing performance. We continually seek Our Strategic Blueprint Shareholder Value Creation Organic Growth Broadening Ingredient Portfolio Geographic Scope Operating Excellence to improve every aspect of our operations through efficiency gains, We also continue to broaden our portfolio with a particular including our world-class manufacturing and global supply chain. Our focus on high-value specialty ingredients that address fast-growing, excellent safety metrics continue to improve, and our commitment to sustainable consumer trends, such as “free-from” foods (gluten- quality is evident: 100 percent of our company-owned manufacturing free, non-GMO), authentic ingredients, affordability, and health and facilities are ISO 9001 certified, and more than 95 percent of our facilities wellness. These on-trend solutions help our customers develop the have been certified to the Global Food Safety Initiative standard. wholesome, nutritious products that consumers demand today. In We continue to grow organically through our capabilities in this report, we identify six growth platforms that are aligned with sweeteners and starches. Overall, volumes grew moderately in 2014, consumer trends and strategically selected to accelerate future growth. with higher-value specialty products outpacing our core portfolio. In Finally, the acquisition of Penford Corporation, announced in 2014 fact, specialty ingredients accounted for 24 percent of our net sales. and completed in March, increases our capabilities and enhances our We expect strong cash flow generated by our existing portfolio to specialty products portfolio. It is a privilege to welcome our Penford drive investments in innovation and ultimately, future growth. colleagues to the Ingredion family. 2 INGREDION INCORPORATEDOur geographic footprint provides another avenue for growth. strategic alliances. Ingredion has completed several very successful With employees in more than 40 countries and 24 Ingredion Idea transactions under John’s direction. I appreciate his dedication, insight, LabsTM innovation centers around the world, we have a global network and leadership. that fosters innovation and collaboration with customers in more than Additionally, I would like to recognize two board members who 100 countries. And our regional operating model allows us to tailor retired during 2014. For more than a decade, we were extremely global innovations to local markets based on consumer trends and fortunate to have the guidance and critical support of Richard Almeida customer needs. and James Ringler. I also want to thank our board of directors for its As a result of our focus on our strategic blueprint over the past counsel and support, and our extraordinary employees around the five years, we have significantly outpaced the S&P 500 in share price world who work diligently to make Ingredion even better. Because appreciation and total shareholder return. We expect to continue on of their efforts, we once again have been recognized by FORTUNE that path with improving margins from growth in specialty products magazine as a Most Admired Company in the Food Production category and generating strong cash flow. We are making significant investments and named for the second year in a row as one of the World’s Most in our manufacturing facilities and enhancing our R&D capabilities to Ethical Companies by The Ethisphere Institute. deliver value for our shareholders today and into the future. Finally, we would like to thank our shareholders for your continued Our commitment to maintaining a strong balance sheet enables support and investment in Ingredion. us to deploy capital strategically. We continue to explore M&A opportunities to further grow our portfolio and expand globally. Attractive dividends and significant share repurchases also demonstrate Sincerely, our ongoing commitment to shareholders. With our strong financial profile and innovation-driven outlook for growth, we expect to create even more value for shareholders in the future. In closing, I want to thank John Saucier, Ingredion’s senior vice Ilene S. Gordon president, corporate strategy and global business development, for Chairman, President and Chief Executive Officer his service. He will be retiring this year. Over the past nine years, John April 7, 2015 has led our efforts to grow and expand through acquisitions and other 3 INGREDION INCORPORATEDA BETTER MIX Global Scale, Local Innovation Our global presence places us where our customers need us; our strategically located Ingredion Idea Labs™ innovation centers keep us in front of regional consumer trends. 55% 2014 net sales North America Established presence with strong sales and cash generation. Growth opportunities in health and wellness sectors in the region. 21% 2014 net sales South America Strong regional presence and long-term growth potential in core and specialty products. Global Headquarters Manufacturing Locations Ingredion Idea LabsTM Innovation Center Headquarters Regional Ingredion Idea LabsTM R&D Centers Penford Acquisition sites Ingredion Incorporated is a leading global ingredients solutions provider. With customers in more than 100 countries, the Company serves over 60 diverse market sectors in food, beverage, brewing, pharmaceutical, biomaterials and other industries. Our innovative ingredient solutions are a part of everyday products and emerging, on-trend consumer goods. Our starches, sweeteners, texturants and nutritionals are used by our customers to provide everything from sweetness, taste and texture to immune system support, fat replacement and adhesive strength. Headquartered in Westchester, Illinois, Ingredion has manufacturing, R&D and sales offices in more than 40 countries and employs more than 11,000 people worldwide. $100MM NEW INVESTMENT IN SPECIALTY INGREDIENT EXPANSION $37MM ANNUAL R&D INVESTMENT GLOBALLY 350 INGREDIENT SCIENTISTS WORLDWIDE 70% OF SALES OUTSIDE THE U.S. 4 INGREDION INCORPORATED A BETTER MIX 14% 2014 net sales Asia Pacific Developing economies and rising incomes expected to fuel robust growth in packaged and convenience foods. INGREDION INCORPORATED 5 10% 2014 net sales Europe, Middle East, Africa Increasing demand for clean-label products in Europe expect to drive growth in high-margin specialty starches. Regional R&D translates local innovation into global growth. Ingredion Idea Labs™ innovation centers offer science-based ideas, innovations and solutions that support our customers’ success and profitability. With four key areas: consumer insights, applied research, applications knowhow and process technology, we work collaboratively with our customers to speed on-trend product innovations to market though a robust, data-driven approach. And our network of 24 facilities around the world, enables us to tailor innovations to support regional preferences and tastes. A BETTER MIX Higher Value, Trend-aligned Our six innovation platforms focus our specialty ingredients and align with key consumer trends. This focus enables us to offer our customers higher differentiated value so they can compete and grow in evolving consumer markets. WHOLESOME Starches and flours for natural origin, clean-label products TEXTURE Solutions that are designed to optimize consumer acceptance and build back texture NUTRITION Fiber and carbohydrates with digestive health and energy management benefits Consumers drive our product development. Whether we are reducing fat in a sauce or adding texture to a nutritious soup, our R&D efforts are focused on key consumer trends and sustainable growth areas that we call innovation platforms: wholesome, texture, nutrition, sweetness, delivery systems and green solutions. By concentrating our innovation, we are able to offer our customers targeted and relevant solutions to cutting-edge consumer trends wherever they do business and with greater potential for success in the marketplace. Ingredion acquires PENFORD A specialty ingredient leader joins Ingredion. Ingredion acquired Penford Corporation in March 2015. The acquisition expands our portfolio of high-value specialty products by enhancing our green solutions, hydrocolloid and specialty potato starch offerings. These products enable us to provide more diverse solutions to growing consumer trends in gluten-free, non-GMO, texture and sustainability while supporting the Company’s strategy of growth. 6 INGREDION INCORPORATEDA BETTER MIX SWEETNESS Sweetening systems that provide natural origin, reduced-calorie and sugar-free solutions DELIVERY SYSTEMS Systems designed to provide superior emulsification and flavor/ ingredient protection GREEN SOLUTIONS Expertise in personal care, glass fiber, home care and bio-plastic applications ALIGNED WITH KEY CONSUMER TRENDS All over the world, consumer preferences are evolving. Ingredion is there. HEALTH AND WELLNESS CONVENIENCE FOOD PROTECTION INDULGENCE CLEAN LABEL COST REDUCTION AND AFFORDABILITY SUSTAINABLE SOURCING 7 INGREDION INCORPORATEDFinancial Highlights Dollars in millions, except per share amounts; years ended December 31 Income Statement Data Net sales Operating income Diluted earnings per share Balance Sheet and Other Data Cash and cash equivalents Total assets Total debt Total equity (including redeemable equity) Annual dividends paid per common share Net debt to capitalization percentage1 Net debt to adjusted EBITDA2 ratio1 Cash provided by operations Depreciation and amortization Capital expenditures 2014 % Change 2013 % Change 2012 $5,668 581 4.74 580 5,091 1,827 2,229 1.68 33.5 % 1.5 731 195 276 (10) (5) (6) $ 6,328 613 5.05 574 5,360 1,810 2,453 1.40 31.7 % 1.5 619 194 298 (3) (8) (8) $6,532 668 5.47 609 5,592 1,800 2,478 0.86 30.8 % 1.3 732 211 313 SALES (BASED ON 2014 NET SALES) COMPOUND ANNUAL GROWTH RATES 51% 13% 13% 9% 7% FOOD BEVERAGE +15% 10-YEAR DILUTED EARNINGS PER SHARE ANIMAL NUTRITION PAPER AND CORRUGATING +16% 10-YEAR CASH FROM OPERATION BREWING 7% OTHER +10% 10-YEAR NET SALES NET SALES (in millions) OPERATING INCOME (in millions) REPORTED DILUTED EARNINGS PER SHARE (in dollars) ’14 ’13 ’12 ’11 ’10 $5,668 $6,328 $6,532 $6,219 $4,367 ’14 ’13 ’12 ’11 ’10 $581 $613 $668 $671 ’14 ’13 ’12 ’11 ’10 $2.20 $339 $4.74 $5.05 $5.47 $5.32 ADJUSTED DILUTED EARNINGS PER SHARE 3 (in dollars) RETURN ON CAPITAL EMPLOYED 1 (percentage) MARKET CAPITALIZATION (in millions at year end) ’14 ’13 ’12 ’11 ’10 $5.20 $5.05 $5.57 $4.68 $3.24 ’14 ’13 ’12 ’11 ’10 10.6% 11.3% 12.2% 11.6% 12.3% ’14 ’13 ’12 ’11 ’10 $6,051 $5,087 $4,963 $3,991 $3,497 1 See Financial Performance Metrics beginning on page 70 of this Annual Report for a reconciliation of these metrics that are not calculated in accordance with Generally Accepted Accounting Principles (GAAP) to the most comparable GAAP measures. 2 Earnings before interest, taxes, depreciation and amortization. 3 See page 69 of this Annual Report for a reconciliation of this metric, which is not calculated in accordance with GAAP to the reported diluted earnings per share. 8 INGREDION INCORPORATED UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13397 INGREDION INCORPORATED (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 22-3514823 (I.R.S. Employer Identification No.) 5 Westbrook Corporate Center, Westchester, Illinois 60154 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code (708) 551-2600 Securities registered pursuant to Section 12(b) of the Act: Title of Each Class Common Stock, $.01 par value per share Name of Each Exchange on Which Registered New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [X] No [ ] Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X] Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections. Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes [X] No [ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ] Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act. (Check one) Large accelerated filer [X] Accelerated filer [ ] Non-accelerated filer [ ] (Do not check if a smaller reporting company) Smaller reporting company [ ] Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X] The aggregate market value of the Registrant’s voting stock held by non-affiliates of the Registrant (based upon the per share closing price of $75.04 on June 30, 2014, and, for the purpose of this calculation only, the assumption that all of the Registrant’s directors and executive officers are affiliates) was approximately $5,319,000,000. The number of shares outstanding of the Registrant’s Common Stock, par value $.01 per share, as of February 19, 2015, was 71,505,000. Documents Incorporated by Reference: Information required by Part III (Items 10, 11, 12, 13 and 14) of this document is incorporated by reference to certain portions of the Registrant’s definitive Proxy Statement (the “Proxy Statement”) to be distributed in connection with its 2015 Annual Meeting of Stockholders which will be filed with the Securities and Exchange Commission within 120 days after December 31, 2014. Table of Contents to Form 10-K Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Part I Item 1. 1 Item 1A. Risk Factors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Item 1B. Unresolved Staff Comments. . . . . . . . . . . . . . . . . . . . . . . . 12 Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Item 2. Item 3. Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Item 4. Mine Safety Disclosures . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Part II Item 5. Market for Registrant’s Common Equity, Item 6. Item 7. Related Stockholder Matters and Issuer Purchases of Equity Securities . . . . . . . . . . . . . . . . 14 Selected Financial Data. . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Management’s Discussion and Analysis of Financial Condition and Results of Operations . . . . . . . . 15 Item 7A. Quantitative and Qualitative Disclosures Item 8. Item 9. About Market Risk. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Financial Statements and Supplementary Data . . . . . . . 32 Changes In and Disagreements With Accountants on Accounting and Financial Disclosure . . . . . . . . . . . . . 61 Item 9A. Controls and Procedures. . . . . . . . . . . . . . . . . . . . . . . . . . . 61 Item 9B. Other Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61 Part III Item 10. Directors, Executive Officers Item 11. Item 12. Item 13. Item 14. and Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . 62 Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . 62 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters . . . 62 Certain Relationships and Related Transactions, and Director Independence . . . . . . . . . . . . . . . . . . . . . . . . 62 Principal Accountant Fees and Services. . . . . . . . . . . . . . 62 Part IV Item 15. Exhibits and Financial Statement Schedules . . . . . . . . . . 62 Signatures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 Part I Item 1. Business The Company Ingredion Incorporated (“Ingredion”) is a leading global manufac- turer and supplier of starch and sweetener ingredients to a range of industries, including packaged food, beverage, brewing, industrial, pharmaceutical and personal care customers. Ingredion was incorpo- rated as a Delaware corporation in 1997 and its common stock is traded on the New York Stock Exchange. On October 1, 2010, we acquired National Starch, a global developer and manufacturer of specialty and modified starches for a cash purchase price of $1.369 billion. The acquisition provided Ingredion with a broader portfolio of products, enhanced geographic reach, and the ability to offer customers a broad range of value added ingredient solutions for a variety of their evolving needs. On October 14, 2014, we entered into a definitive agreement to acquire Penford Corporation (“Penford”), a US-based leader in specialty ingredients for food and non-food applications. The acquisition has been approved by the boards of directors of both companies and by the shareholders of Penford. It is subject to approval by regulators as well as to other customary closing conditions. The purchase price is approximately $340 million, including the assumption of debt. Penford, headquartered in Centennial, Colorado had net sales of $444 million in fiscal year 2014. Penford employs approximately 443 people and operates six plants in the United States, all of which manufacture specialty starches. The acquisition will provide Ingredion with an enhanced portfolio of specialty and industrial products and further improve our ability to offer customers a broad range of value added ingredient solutions for a variety of their evolving needs. The acquisition is expected to close in the first quarter of 2015 pending regulatory approval. For purposes of this report, unless the context otherwise requires, all references herein to the “Company,” “Ingredion,” “we,” “us,” and “our” shall mean Ingredion Incorporated and its subsidiaries. Ingredion supplies a broad range of customers in many diverse industries around the world, including the food, beverage, brewing, pharmaceutical, paper and corrugated products, textile and personal care industries, as well as the global animal feed and corn oil markets. Our product line includes starches and sweeteners, animal feed products and edible corn oil. Our starch-based products include both food-grade and industrial starches. Our sweetener products include glucose syrups, high maltose syrups, high fructose corn syrup (“HFCS”), caramel color, dextrose, polyols, maltodextrins and glucose and syrup solids. Our products are derived primarily from the processing of corn and other starch-based materials, such as tapioca, potato and rice. Our manufacturing process is based on a capital-intensive, two-step process that involves the wet milling and processing of starch-based materials, primarily corn. During the front-end process, corn is steeped in a water-based solution and separated into starch and co-products such as animal feed and corn oil. The starch is then either dried for sale or further processed to make sweeteners, starches and other ingredients that serve the particular needs of various industries. We believe our approach to production and service, which focuses on local management and production improvements of our worldwide operations, provides us with a unique understanding of the cultures and product requirements in each of the geographic markets in which we operate, bringing added value to our customers through innovative solutions. Our consolidated net sales were $5.67 billion in 2014. Approxi- mately 55 percent of our 2014 net sales were provided from our North American operations. Our South American operations provided 21 percent of net sales, while our Asia Pacific and EMEA (Europe, Middle East and Africa) operations contributed approximately 14 percent and 10 percent, respectively. Products Sweetener Products Our sweetener products represented approxi- mately 39 percent, 42 percent and 44 percent of our net sales for 2014, 2013 and 2012, respectively. Glucose Syrups Glucose syrups are fundamental ingredients widely used in food products, such as baked goods, snack foods, beverages, canned fruits, condiments, candy and other sweets, dairy products, ice cream, jams and jellies, prepared mixes and table syrups. Glucose syrups offer functionality in addition to sweetness to processed foods. They add body and viscosity; help control freezing points, crystalliza- tion and browning; add humectancy (ability to add moisture) and flavor; and act as binders. High Maltose Syrup This special type of glucose syrup is primarily used as a fermentable sugar in brewing beers. High maltose syrups are also used in the production of confections, canning and some other food processing applications. Our high maltose syrups speed the fermentation process, allowing brewers to increase capacity without adding capital. High Fructose Corn Syrup High fructose corn syrup is used in a variety of consumer products including soft drinks, fruit-flavored beverages, baked goods, dairy products, confections and other food and beverage products. In addition to sweetness and ease of use, high fructose corn syrup provides body; humectancy; and aids in browning, freezing point and crystallization control. Dextrose Dextrose has a wide range of applications in the food and confection industries, in solutions for intravenous and other pharma- ceutical applications, and numerous industrial applications like wallboard, biodegradable surface agents and moisture control agents. Dextrose functionality in foods, beverages and confectionary includes sweetness control; body and viscosity; acting as a bulking, drying and 1 INGREDION INCORPORATEDanti-caking agent; serving as a carrier; providing freezing point and crystallization control; and aiding in fermentation. Dextrose is also a fermentation agent in the production of light beer. In pharmaceutical applications dextrose is used in IV solutions as well as an excipient suitable for direct compression in tableting. Polyols These products are sugar-free, reduced calorie sweeteners primarily derived from starch or sugar for the food, beverage, confectionery, industrial, personal and oral care, and nutritional supplement markets. In addition to sweetness, polyols inhibit crystallization; provide binding, humectancy and plasticity; add texture; extend shelf life; prevent moisture migration; and are an excipient suitable for tableting. Maltodextrins and Glucose Syrup Solids These products have a multitude of food applications, including formulations where liquid syrups cannot be used. Maltodextrins are resistant to browning, provide excellent solubility, have a low hydroscopicity (do not retain moisture), and are ideal for their carrier/bulking properties. Glucose syrup solids have a bland flavor, remain clear in solution, are easy to handle and provide bulking properties. Starch Products Our starch products represented approximately 43 percent, 41 percent and 37 percent of our net sales for 2014, 2013 and 2012, respectively. Starches are an important component in a wide range of processed foods, where they are used for adhesion, clouding, dusting, expansion, fat replacement, freshness, gelling, glazing, mouth feel, stabilization and texture. Cornstarch is sold to cornstarch packers for sale to consumers. Starches are also used in paper production to create a smooth surface for printed communications and to improve strength in recycled papers. Specialty starches are used for enhanced drainage, fiber retention, oil and grease resistance, improved printability and biochemical oxygen demand control. In the corrugating industry, starches and specialty starches are used to produce high quality adhesives for the production of shipping containers, display board and other corrugated applications. The textile industry uses starches and specialty starches for sizing (abrasion resistance) to provide size and finishes for manufactured products. Industrial starches are used in the production of construction materials, textiles, adhesives, pharmaceuti- cals and cosmetics, as well as in mining, water filtration and oil and gas drilling. Specialty starches are used for biomaterial applications including biodegradable plastics, fabric softeners and detergents, hair and skin care applications, dusting powders for surgical gloves and in the production of glass fiber and insulation. Specialty Ingredients We consider certain of our starch and sweetener products to be specialty ingredients. Specialty ingredients comprised approximately 24 percent of our net sales for 2014, up from 21 percent in 2013. Our specialty ingredients are aligned with growing market and consumer trends such as health and wellness, clean-label, affordability, indulgence and sustainability. We plan to drive growth for our specialty ingredients portfolio by leveraging the following six platforms (or springboards): Wholesome, Texture, Nutrition, Sweetness, Delivery Systems and Green Solutions. Wholesome Clean-label solutions that enable front-of-pack claims Texture Precise texture solutions designed to optimize consumer acceptance and build back texture Nutrition Nutritional carbohydrates with benefits of digestive health and energy management Sweetness Sweetening systems that provide affordability, natural, reduced calorie, and sugar-free solutions Delivery Systems Functional ingredients designed to deliver superior emulsification and protection of flavors and other active ingredients Green Solutions Nature-based materials for replacement of synthet ics in non-food applications Wholesome: Specialty ingredients that provide clean-label solutions enabling front-of-pack claims for our customers. Products include Novation clean label functional starches, value added pulse-based ingredients and Gluten Free offerings. Texture: Specialty ingredients that provide food texture solutions for consumer acceptance and build back texture. Include starch systems that replace more expensive ingredients and are designed to optimize customer formulation costs, texturizers that create rich, creamy mouth feel, and products that enhance texture in healthier offerings. Nutrition: Specialty ingredients that provide nutritional carbohydrates with benefits of digestive health and energy management. Our fibers and complimentary nutritional ingredients address the leading health and wellness concerns of consumers, including digestive health, infant nutrition, weight and energy management, aging and immunity. Sweetness: Specialty ingredients that provide affordability, natural, reduced calorie and sugar-free sweetener solutions for our customers. We have a broad portfolio of nutritive and non-nutritive sweeteners, including high potency sweeteners and our naturally based stevia sweetener. Delivery Systems: Functional ingredients that are designed to deliver superior emulsification and protection of flavors and other active ingredients. Products include starches to help emulsify or mix natural colors in beverages and specialty starches that encapsulate and protect flavors and vitamins in pharmaceuticals and spray-dried food ingredients. Green Solutions: Bio-based solutions that help manufacturers become more sustainable by replacing synthetic materials with nature-based ingredients in personal care, home care and other industrial segments. Each springboard addresses multiple consumer trends. For instance, specialty texture solutions are leveraged to address consumer health and wellness, affordability and indulgence demands while wholesome solutions can address clean-label, indulgence and health and wellness consumer demands. Specialty ingredients that provide nutrition solutions for health and wellness can also address food indulgence and convenience desires of consumers. Specialty ingredients that provide sweetness solutions for health and wellness demands can also deliver affordability and food indulgence solutions. 2 INGREDION INCORPORATEDCo-Products and others Co-products and others accounted for 18 percent, 17 percent and 19 percent of our net sales for 2014, 2013 and 2012, respectively. Refined corn oil (from germ) is sold to packers of cooking oil and to producers of margarine, salad dressings, shorten- ing, mayonnaise and other foods. Corn gluten feed is sold as animal feed. Corn gluten meal is sold as high-protein feed for chickens, pet food and aquaculture. Additionally, we utilize a network of tolling manufacturers in various regions in the production cycle of certain specialty starches. In general, these tolling manufacturers produce certain basic starches for us, and we in turn complete the manufacturing process of the specialty starches through our finishing channels. We utilize our global network of manufacturing facilities to support key global product lines. Geographic Scope and Operations We are principally engaged in the production and sale of sweeteners and starches for a wide range of industries, and we manage our business on a geographic regional basis. Our operations are classified into four reportable business segments: North America, South America, Asia Pacific and EMEA. In 2014, approximately 55 percent of our net sales were derived from operations in North America, while net sales from operations in South America represented 21 percent. Net sales from operations in Asia Pacific and EMEA represented approximately 14 percent and 10 percent, respectively, of our 2014 net sales. See Note 12 of the notes to the consolidated financial statements entitled “Segment Information” for additional financial information with respect to our reportable business segments. In general, demand for our products is balanced throughout the year. However, demand for sweeteners in South America is greater in the first and fourth quarters (its summer season) while demand for sweeteners in North America is greater in the second and third quarters. Due to the offsetting impact of these demand trends, we do not experience material seasonal fluctuations in our net sales. Our North America segment consists of operations in the US, Canada and Mexico. The region’s facilities include 13 plants producing a wide range of both sweeteners and starches. We are the largest manufacturer of corn-based starches and sweeteners in South America, with sales in Brazil, Colombia and Ecuador and the Southern Cone of South America, which includes Argentina, Chile, Peru and Uruguay. Our South America segment includes 11 plants that produce regular, modified, waxy and tapioca starches, high fructose and high maltose syrups and syrup solids, dextrins and maltodextrins, dextrose, specialty starches, caramel color, sorbitol and vegetable adhesives. Our Asia Pacific segment manufactures corn-based products in South Korea, Australia and China. Also, we manufacture tapioca-based products in Thailand, which supplies not only our Asia Pacific segment but the rest of our global network. The region’s facilities include 7 plants that produce modified, specialty, regular, waxy and tapioca starches, dextrins, glucose, high maltose syrup, dextrose, HFCS and caramel color. Our EMEA segment includes 5 plants that produce modified and specialty starches, glucose and dextrose in England, Germany and Pakistan. Competition The starch and sweetener industry is highly competitive. Many of our products are viewed as basic ingredients that compete with virtually identical products and derivatives manufactured by other companies in the industry. The US is a highly competitive market where there are other starch processors, several of which are divisions of larger enterprises. Some of these competitors, unlike us, have vertically integrated their starch processing and other operations. Competitors include ADM Corn Processing Division (“ADM”) (a division of Archer- Daniels-Midland Company), Cargill, Inc., Tate & Lyle Ingredients Americas, Inc., and several others. Our operations in Mexico and Canada face competition from US imports and local producers including ALMEX, a Mexican joint venture between ADM and Tate & Lyle Ingredients Americas, Inc. In South America, Cargill has starch processing operations in Brazil and Argentina. Many smaller local corn and tapioca refiners also operate in many of our markets. Competition within our markets is largely based on price, quality and product availability. Several of our products also compete with products made from raw materials other than corn. HFCS and monohydrate dextrose compete principally with cane and beet sugar products. Co-products such as corn oil and gluten meal compete with products of the corn dry milling industry and with soybean oil, soybean meal and other products. Fluctuations in prices of these competing products may affect prices of, and profits derived from, our products. Customers We supply a broad range of customers in over 60 industries world- wide. The following table provides the percentage of total net sales by industry for each of our segments for 2014: Industries Served Food Beverage Animal Nutrition Paper and Corrugating Brewing Other Total Total Company North America South America APAC EMEA 51% 13% 13% 9% 7% 7% 100% 48% 17% 14% 9% 7% 5% 100% 43% 10% 17% 9% 14% 7% 100% 65% 7% 6% 14% 3% 5% 100% 63% 1% 9% 3% 0% 24% 100% No customer accounted for 10 percent or more of our net sales in 2014, 2013 or 2012. 3 INGREDION INCORPORATEDRaw Materials Corn (primarily yellow dent) is the primary basic raw material we use to produce starches and sweeteners. The supply of corn in the United States has been, and is anticipated to continue to be, adequate for our domestic needs. The price of corn, which is determined by reference to prices on the Chicago Board of Trade, fluctuates as a result of various factors including: farmers’ planting decisions, climate, and government policies (including those related to the production of ethanol), livestock feeding, shortages or surpluses of world grain supplies, and domestic and foreign government policies and trade agreements. We also use tapioca, potato, rice and sugar as raw material. Corn is also grown in other areas of the world, including Canada, Mexico, Europe, South Africa, Argentina, Australia, Brazil, China and Pakistan. Our affiliates outside the United States utilize both local supplies of corn and corn imported from other geographic areas, including the United States. The supply of corn for these affiliates is also generally expected to be adequate for our needs. Corn prices for our non-US affiliates generally fluctuate as a result of the same factors that affect US corn prices. We also utilize specialty grains such as waxy and high amylose corn in our operations. In general, the planning cycle for our specialty grain sourcing begins three years in advance of the anticipated delivery of the specialty corn since the necessary seed must be grown in the season prior to grain contracting. In order to secure these specialty grains at the time of our anticipated needs, we contract with certain farmers to grow the specialty corn approximately two years in advance of delivery. These specialty grains are higher cost due to their more limited supply and require longer planning cycles to mitigate the risk of supply shortages. Due to the competitive nature of our industry and the availability of substitute products not produced from corn, such as sugar from cane or beets, end product prices may not necessarily fluctuate in a manner that correlates to raw material costs of corn. We follow a policy of hedging our exposure to commodity fluctuations with commodities futures and options contracts primarily for certain of our North American corn purchases. We use derivative hedging contracts to protect the gross margin of our firm-priced business in North America. Other business may or may not be hedged at any given time based on management’s judgment as to the need to fix the costs of our raw materials to protect our profitability. Outside of North America, we generally enter into short-term commercial sales contracts and adjust our selling prices based upon the local raw material costs. See Item 7A, Quantitative and Qualitative Disclosures about Market Risk, in the section entitled “Commodity Costs” for additional information. Research and Development We have global research and development capabilities concentrated in Bridgewater, New Jersey. Activities at Bridgewater include plant science and physical, chemical and biochemical modifications to food formulations, food sensory evaluation, as well as development of non-food applications, such as starch-based biopolymers. In 2013, we expanded our Bridgewater facility with the addition of a lab and sensory evaluation space dedicated to our sweeteners portfolio. In addition, we have product application technology centers that direct our product development teams worldwide to create product application solutions to better serve the ingredient needs of our customers. Product development activity is focused on developing product applications for identified customer and market needs. Through this approach, we have developed value-added products for use by customers in various industries. We usually collaborate with customers to develop the desired product application either in the customers’ facilities, our technical service laboratories or on a contract basis. These efforts are supported by our marketing, product technology and technology support staff. Research and development expense for 2014 was approximately $37 million. Sales and Distribution Our salaried sales personnel, who are generally dedicated to custom- ers in a geographic region, sell our products directly to manufacturers and distributors. In addition, we have a staff that provides technical support to our sales personnel on an industry basis. We generally contract with trucking companies to deliver our bulk products to customer destinations. In North America, we generally use trucks to ship to nearby customers. For those customers located considerable distances from our plants, we use either rail or a combination of railcars and trucks to deliver our products. We generally lease railcars for terms of three to ten years. Patents, Trademarks and Technical License Agreements We own approximately 900 patents and patents pending which relate to a variety of products and processes, and a number of established trademarks under which we market our products. We also have the right to use other patents and trademarks pursuant to patent and trademark licenses. We do not believe that any individual patent or trademark is material to our business. There is no currently pending challenge to the use or registration of any of our significant patents or trademarks that would have a material adverse impact on us or our results of operations if decided against us. Employees As of December 31, 2014 we had approximately 11,400 employees, of which approximately 1,900 were located in the United States. Approximately 36 percent of US and 48 percent of our non-US employees are unionized. Of our total, we have approximately 1,100 temporary employees. 4 INGREDION INCORPORATEDGovernment Regulation and Environmental Matters As a manufacturer and marketer of food items and items for use in the pharmaceutical industry, our operations and the use of many of our products are subject to various federal, state, foreign and local statutes and regulations, including the Federal Food, Drug and Cosmetic Act and the Occupational Safety and Health Act. We and many of our products are also subject to regulation by various government agencies, including the United States Food and Drug Administration. Among other things, applicable regulations prescribe requirements and establish standards for product quality, purity and labeling. Failure to comply with one or more regulatory requirements can result in a variety of sanctions, including monetary fines. No such fines of a material nature were imposed on us in 2014. We may also be required to comply with federal, state, foreign and local laws regulat- ing food handling and storage. We believe these laws and regulations have not negatively affected our competitive position. Our operations are also subject to various federal, state, foreign and local laws and regulations with respect to environmental matters, including air and water quality and underground fuel storage tanks, and other regulations intended to protect public health and the environment. We operate industrial boilers that fire natural gas, coal, or biofuels to operate our manufacturing facilities and they are our primary source of greenhouse gas emissions. In Argentina, we are in discussions with local regulators associated with conducting studies of possible environmental remediation programs at our Chacabuco plant. We are unable to predict the outcome of these discussions; however, we do not believe that the ultimate cost of remediation will be material. Based on current laws and regulations and the enforce- ment and interpretations thereof, we do not expect that the costs of future environmental compliance will be a material expense, although there can be no assurance that we will remain in compliance or that the costs of remaining in compliance will not have a material adverse effect on our future financial condition and results of operations. During 2014, we spent approximately $9 million for environmental control and wastewater treatment equipment to be incorporated into existing facilities and in planned construction projects. We currently anticipate that we will spend approximately $8 million for environmen- tal facilities and programs in both 2015 and 2016. Other Our Internet address is www.ingredion.com. We make available, free of charge through our Internet website, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended. These reports are made available as soon as reasonably practicable after they are electronically filed with or furnished to the Securities and Exchange Commission. Our corporate governance guidelines, board committee charters and code of ethics are posted on our website, the address of which is www.ingredion.com, and each is available in print to any shareholder upon request in writing to Ingredion Incorporated, 5 Westbrook Corporate Center, Westchester, Illinois 60154 Attention: Corporate Secretary. The contents of our website are not incorporated by reference into this report. Executive Officers of the Registrant Set forth below are the names and ages of all of our executive officers, indicating their positions and offices with the Company and other business experience. Our executive officers are elected annually by the Board to serve until the next annual election of officers and until their respective successors have been elected and have qualified unless removed by the Board. Ilene S. Gordon – 61 Chairman of the Board, President and Chief Executive Officer of the Company since May 4, 2009. Ms. Gordon was President and Chief Executive Officer of Rio Tinto’s Alcan Packaging, a multinational business unit engaged in flexible and specialty packaging, from October 2007 until she took office as Chairman of the Board, President and Chief Executive Officer of the Company. From December 2006 to October 2007, Ms. Gordon was a Senior Vice President of Alcan Inc. and President and Chief Executive Officer of Alcan Packaging. Alcan Packaging was acquired by Rio Tinto in October 2007. From 2004 until December 2006, Ms. Gordon served as President of Alcan Food Packaging Americas, a division of Alcan Inc. From 1999 until Alcan’s December 2003 acquisition of Pechiney Group, Ms. Gordon was a Senior Vice President of Pechiney Group and President of Pechiney Plastic Packaging, Inc., a global flexible packaging business. Prior to joining Pechiney in June 1999, Ms. Gordon spent 17 years with Tenneco Inc., where she most recently served as Vice President and General Manager, heading up Tenneco’s folding carton business. Ms. Gordon also serves as a director of International Paper Company, a global paper and packaging company. She served as a director of Arthur J. Gallagher & Co., an international insurance brokerage and risk management business, from 1999 to May 15, 2013 and as a director of United Stationers Inc., a wholesale distributor of business products and a provider of marketing and logistics services to resellers, from January 2000 until May 2009. Ms. Gordon also serves as a director of Northwestern Memorial Hospital, The Executives’ Club of Chicago, the Economic Club of Chicago, The Chicago Council on Global Affairs and World Business Chicago. She is also a trustee of The MIT Corpora- tion and The Conference Board. Ms. Gordon holds a Bachelor’s degree in mathematics from the Massachusetts Institute of Technology (MIT) and a Master’s degree in management from MIT’s Sloan School of Management. 5 INGREDION INCORPORATEDChristine M. Castellano – 49 Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer since April 1, 2013. Prior to that Ms. Castel- lano served as Senior Vice President, General Counsel and Corporate Secretary from October 1, 2012 to March 31, 2013. Ms. Castellano previously served as Vice President International Law and Deputy General Counsel from April 28, 2011 to September 30, 2012, Associate General Counsel, South America and Europe from January 1, 2011 to April 27, 2011, and as Associate General International Counsel from 2004 to December 31, 2010. Prior to that, Ms. Castellano served as Counsel US and Canada from 2002 to 2004. Ms. Castellano joined CPC International, Inc. now Unilever Bestfoods (“CPC”) as Operations Attorney in September 1996 and held that position until 2002. CPC was a worldwide group of businesses, principally engaged in three major industry segments: consumer foods, baking and corn refining. Ingredion commenced operations as a spin-off of CPC’s corn refining business. Prior to joining CPC, Ms. Castellano was an income partner in the law firm McDermott Will & Emery from January 1, 1996 and had served as an associate in that firm from 1991 to December 31, 1996. She also serves as a trustee of the John Marshall Law School and the Peggy Notebaert Nature Museum. Ms. Castellano holds a Bachelor degree in political science from the University of Colorado and a Juris Doctor degree from the University of Michigan School of Law. Ricardo de Abreu Souza – 64 Senior Vice President and President, South America Ingredient Solutions since January 1, 2014. Prior to that Mr. de Abreu Souza served as President and General Manager of the Company’s Mexican subsidiary, from February 1, 2010 to December 31, 2013. Mr. de Abreu Souza previously served as Commercial Director of the Company’s Mexican subsidiary from 2006 to January 31, 2010. Prior thereto he served in positions of increasing responsibility since joining the Company in 1977. Mr. de Abreu Souza holds a Bachelor degree in chemical engineering from MacKenzie University in Sao Paulo, Brazil and a Master degree in business administration from IPADE Business School of Universidad Panamericana in Mexico. Anthony P. DeLio – 59 Senior Vice President and Chief Innovation Officer since January 1, 2014. Prior to that Mr. DeLio served as Vice President, Global Innova- tion from November 4, 2010 to December 31, 2013, and he served as Vice President, Global Innovation for National Starch from January 1, 2009 to November 3, 2010. Mr. DeLio served as Vice President and General Manager, North America, of National Starch from February 26, 2006 to December 31, 2008. Prior to that he served as Associate Vice Chancellor of Research at the University of Illinois at Urbana-Champaign from August 2004 to February 2006. Previously, Mr. DeLio served as Corporate Vice President of Marketing and External Relations of Archer Daniels Midland Company (“ADM”), one of the world’s largest processors of oilseeds, corn, wheat, cocoa and other agricultural commodities and a leading manufacturer of protein meal, vegetable oil, corn sweeteners, flour, biodiesel, ethanol and other value-added food and feed ingredients, from October 2002 to October 2003. Prior to that Mr. DeLio was President of the Protein Specialties and Nutraceutical Divisions of ADM from September 2000 to October 2002 and President of the Nutraceutical Division of ADM from June 1999 to September 2001. He held various senior product development positions with Mars, Inc. from 1980 to May 1999. Mr. DeLio holds a Bachelor of Science degree in chemical engineering from Rensselaer Polytechnic Institute. Jack C. Fortnum – 58 Executive Vice President and Chief Financial Officer since January 6, 2014. Prior to that Mr. Fortnum served as Executive Vice President and President, North America from February 1, 2012 to January 5, 2014. Mr. Fortnum previously served as Executive Vice President and President, Global Beverage, Industrial and North America Sweetener Solutions from October 1, 2010 to January 31, 2012. Prior thereto, Mr. Fortnum served as Vice President from 1999 to September 30, 2010 and President of the North America Division from May 2004 to September 30, 2010. Mr. Fortnum joined CPC in 1984 and held positions of increasing responsibility including serving as President, US/Canadian Region of the Company from July 2003 to May 2004. Mr. Fortnum is a former Chairman of the Board of the Corn Refiners Association. Mr. Fortnum holds a Bachelor degree in economics from the University of Toronto and completed the Senior Business Administration Course offered by McGill University. Diane J. Frisch – 60 Senior Vice President, Human Resources since October 1, 2010. Ms. Frisch previously served as Vice President, Human Resources, from May 1, 2010 to September 30, 2010. Prior to that, Ms. Frisch served as Vice President of Human Resources and Communications for the Food Americas and Global Pharmaceutical Packaging busi- nesses of Rio Tinto’s Alcan Packaging, a multinational company engaged in flexible and specialty packaging, from January 2004 to March 30, 2010. Prior to being acquired by Alcan Packaging, Ms. Frisch served as Vice President of Human Resources for the flexible packaging business of Pechiney, S.A., an aluminum and packaging company with headquarters in Paris and Chicago, from January 2001 to January 2004. Previously, she served as Vice President of Human Resources for Culligan International Company and Vice President and Director of Human Resources for Alumax Mill Products, Inc., a division of Alumax Inc. Ms. Frisch holds a Bachelor of Arts degree in psychology from Ithaca College, Ithaca, NY, and a Master of Science degree in industrial relations from the University of Wisconsin in Madison. 6 INGREDION INCORPORATEDMatthew R. Galvanoni – 42 Vice President and Corporate Controller since August 15, 2012. Mr. Galvanoni previously served as Vice President, Corporate Accounting from June 18, 2012, when he joined Ingredion, to August 14, 2012. Mr. Galvanoni was previously employed by Exelon Corporation for 10 years. He served as Principal Accounting Officer of Exelon Generation and Vice President and Assistant Corporate Controller of Exelon Corporation from July 2009 until the merger of Exelon Corporation with Constellation Energy Group, Inc. in March 2012, at which time, Mr. Galvanoni became the Vice President, Financial Systems Integration until May 2012. Mr. Galvanoni previously served as Vice President and Controller of Commonwealth Edison Company and PECO Energy Company from January 2007 to July 2009. He served in various roles at the Director level of the Controllership organization of Exelon Corporation from November 2002 to December 2006. Mr. Galvanoni holds a Bachelor of Science degree in accounting from the University of Illinois, Urbana-Champaign and a Master of Business Administration degree from Northwestern University. He is a certified public accountant in the State of Illinois. Jorgen Kokke – 46 Senior Vice President and President, Asia Pacific since September 16, 2014. Mr. Kokke previously served as Vice President and General Manager, Asia Pacific from January 6, 2014 to September 15, 2014. Prior to that, Mr. Kokke served as Vice President and General Manager, EMEA since joining National Starch on March 1, 2009. Prior to that, he served as a Vice President of CSM NV, a global food ingredients supplier, where he had responsibility for the global Purac Food & Nutrition business from 2006 to 2009. Prior thereto, Mr. Kokke was Director of Strategy and Business Development at CSM NV. Prior to that he held a variety of roles of increasing responsibility in sales, business development, marketing and general management in Unilever’s Loders Crocklaan Group. Mr. Kokke holds a Master degree in economics from the University of Amsterdam. John F. Saucier – 61 Senior Vice President, Corporate Strategy and Global Business Development since October 1, 2010. Mr. Saucier previously served as Vice President and President Asia/Africa Division and Global Business Development from November 2007 to September 30, 2010. Mr. Saucier previously served as Vice President, Global Business and Product Development, Sales and Marketing from April 2006 to November 2007. Prior to that, Mr. Saucier was President, Integrated Nylon Division of Solutia Inc., a specialty chemical manufacturer from May 2004 to March 2005, and Vice President of Solutia and General Manager of its Integrated Nylon Division from September 2001 to May 2004. Solutia Inc. and 14 of its US subsidiaries filed voluntary petitions under the bankruptcy laws in December 2003. Mr. Saucier holds Bachelor and Master degrees in mechanical engineering from the University of Missouri and a Master degree in Business Administra- tion from Washington University in St. Louis. Robert J. Stefansic – 53 Senior Vice President, Operational Excellence, Sustainability and Chief Supply Chain Officer since May 28, 2014. From January 1, 2014 to May 27, 2014, Mr. Stefansic served as Senior Vice President, Operational Excellence and Environmental, Health, Safety & Sustainability. Prior to that, Mr. Stefansic served as Vice President, Operational Excellence and Environmental, Health, Safety and Sustainability from August 1, 2011 to December 31, 2013. He previously served as Vice President, Global Manufacturing Network Optimization and Environmental, Health, Safety and Sustainability of National Starch, from November 1, 2010 to July 31, 2011. Prior to that, he served as Vice President, Global Operations of National Starch from November 1, 2006 to October 31, 2010. Prior to that, he served as Vice President, Naorth America Manufacturing of National Starch from December 13, 2004 to October 31, 2006. Prior to joining National Starch he held positions of increasing responsibility with The Valspar Corporation, General Chemical Corporation and Allied Signal Corporation. Mr. Stefansic holds a Bachelor degree in chemical engineering and a Master degree in business administration from the University of South Carolina. James P. Zallie – 53 Executive Vice President, Global Specialties and President North America and EMEA since January 6, 2014. Prior to that Mr. Zallie served as Executive Vice President, Global Specialties and President, EMEA and Asia Pacific from February 1, 2012 to January 5, 2014. Mr. Zallie previously served as Executive Vice President and President, Global Ingredient Solutions from October 1, 2010 to January 31, 2012. Mr. Zallie previously served as President and Chief Executive Officer of the National Starch business from January 2007 to September 30, 2010. Mr. Zallie worked for National Starch for more than 27 years in various positions of increasing responsibility, first in technical, then marketing and then international business management positions. Mr. Zallie also serves as a director of Innophos Holdings, Inc., a leading international producer of performance-critical and nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceu- tical, oral care and industrial end markets. He holds Masters degrees in food science and business administration from Rutgers University and a Bachelor of Science degree in food science from Pennsylvania State University. 7 INGREDION INCORPORATEDItem 1A. Risk Factors Our business and assets are subject to varying degrees of risk and uncertainty. The following are factors that we believe could cause our actual results to differ materially from expected and historical results. Additional risks that are currently unknown to us may also impair our business or adversely affect our financial condition or results of operations. In addition, forward-looking statements within the meaning of the federal securities laws that are contained in this Form 10-K or in our other filings or statements may be subject to the risks described below as well as other risks and uncertainties. Please read the cautionary notice regarding forward-looking statements in Item 7 below. Current economic conditions may adversely impact demand for our products, reduce access to credit and cause our customers and others with whom we do business to suffer financial hardship, all of which could adversely impact our business, results of operations, financial condition and cash flows. Economic conditions in the South America, the European Union and many other countries and regions in which we do business have experienced various levels of weakness over the last few years, and may remain challenging for the foreseeable future. General business and economic conditions that could affect us include the strength of the economies in which we operate, unemployment, inflation and fluctuations in debt markets. While currently these conditions have not impaired our ability to access credit markets and finance our operations, there can be no assurance that there will not be a further deterioration in the financial markets. There could be a number of other effects from these economic developments on our business, including reduced consumer demand for products; pressure to extend our customers’ payment terms; insolvency of our customers, resulting in increased provisions for credit losses; decreased customer demand, including order delays or cancellations, and counterparty failures negatively impacting our operations. In connection with our defined benefit pension plans, adverse changes in investment returns earned on pension assets and discount rates used to calculate pension and related liabilities or changes in required pension funding levels may have an unfavorable impact on future pension expense and cash flow. In addition, the volatile worldwide economic conditions and market instability may make it difficult for us, our customers and our suppliers to accurately forecast future product demand trends, which could cause us to produce excess products that can increase our inventory carrying costs. Alternatively, this forecasting difficulty could cause a shortage of products that could result in an inability to satisfy demand for our products. We operate a multinational business subject to the economic, politi- cal and other risks inherent in operating in foreign countries and with foreign currencies. We have operated in foreign countries and with foreign currencies for many years. Our results are subject to foreign currency exchange fluctuations. Our operations are subject to political, economic and other risks. There has been and continues to be significant political uncertainty in some countries in which we operate. Economic changes, terrorist activity and political unrest may result in business interruption or decreased demand for our products. Protectionist trade measures and import and export licensing requirements could also adversely affect our results of operations. Our success will depend in part on our ability to manage continued global political and/or economic uncertainty. We primarily sell world commodities. Historically, local prices have adjusted relatively quickly to offset the effect of local currency devaluations, although we cannot guarantee this in the future. Due to pricing controls on many consumer products instituted by the Argentina government, it has taken longer than in the past to achieve pricing improvement in that country. Also, the recent strength in the US dollar may provide some challenges to our sales prices as it could take an extended period of time to fully recapture the impact of foreign currency devaluation. We may hedge transactions that are denominated in a currency other than the currency of the operating unit entering into the underlying transaction. We are subject to the risks normally attendant to such hedging activities. Raw material and energy price fluctuations, and supply interruptions and shortages could adversely affect our results of operations. Our finished products are made primarily from corn. Purchased corn and other raw material costs account for between 40 percent and 65 percent of finished product costs. Some of our products are based upon specific varieties of corn that are produced in significantly less volumes than yellow dent corn. These specialty grains are higher-cost due to their more limited supply and require planning cycles of up to three years in order for us to receive our desired amount of specialty corn. Also, we utilize tapioca in the manufacturing of starch products in Thailand. If our raw materials are not available in sufficient quantities or quality, our results of operations could be negatively impacted. Energy costs represent approximately 11 percent of our finished product costs. We use energy primarily to create steam in our production process and to dry product. We consume coal, natural gas, electricity, wood and fuel oil to generate energy. In Pakistan, the overall economy has been slowed by severe energy shortages which both negatively impact our ability to produce sweeteners and starches, and also negatively impact the demand from our customers due to their inability to produce their end products because of the shortage of reliable energy. 8 INGREDION INCORPORATEDThe market prices for our raw materials may vary considerably depending on supply and demand, world economies and other factors. We purchase these commodities based on our anticipated usage and future outlook for these costs. We cannot assure that we will be able to purchase these commodities at prices that we can adequately pass on to customers to sustain or increase profitability. In North America, we sell a large portion of our finished products at firm prices established in supply contracts typically lasting for periods of up to one year. In order to minimize the effect of volatility in the cost of corn related to these firm-priced supply contracts, we enter into corn futures and options contracts, or take other hedging positions in the corn futures market. We are unable to directly hedge price risk related to co-product sales; however, we occasionally enter into hedges of soybean oil (a competing product to our animal feed and corn oil) in order to mitigate the price risk of animal feed and corn oil sales. These derivative contracts typically mature within one year. At expiration, we settle the derivative contracts at a net amount equal to the difference between the then-current price of corn (or soybean oil) and the derivative contract price. These hedging instruments are subject to fluctuations in value; however, changes in the value of the underlying exposures we are hedging generally offset such fluctuations. The fluctuations in the fair value of these hedging instruments may affect our cash flow. We fund any unrealized losses or receive cash for any unrealized gains on futures contracts on a daily basis. While the corn futures contracts or hedging positions are intended to minimize the effect of volatility of corn costs on operating profits, the hedging activity can result in losses, some of which may be material. Outside of North America, sales of finished products under long-term, firm-priced supply contracts are not material. We also use over-the-counter natural gas swaps to hedge portions of our natural gas costs, primarily in our North American operations. Due to market volatility, we cannot assure that we can adequately pass potential increases in the cost of corn and other raw materials on to customers through product price increases or purchase quantities of corn and other raw materials at prices sufficient to sustain or increase our profitability. Our corn and raw material costs account for 40 percent to 65 percent of our product costs. The price and availability of corn and other raw materials is influenced by economic and industry conditions, including supply and demand factors such as crop disease and severe weather conditions such as drought, floods or frost that are difficult to anticipate and which we cannot control. Our profitability may be affected by other factors beyond our control. Our operating income and ability to increase profitability depend to a large extent upon our ability to price finished products at a level that will cover manufacturing and raw material costs and provide an acceptable profit margin. Our ability to maintain appropriate price levels is determined by a number of factors largely beyond our control, such as aggregate industry supply and market demand, which may vary from time to time, and the economic conditions of the geographic regions where we conduct our operations. We operate in a highly competitive environment and it may be difficult to preserve operating margins and maintain market share. We operate in a highly competitive environment. Many of our products compete with virtually identical or similar products manufactured by other companies in the starch and sweetener industry. In the United States, there are competitors, several of which are divisions of larger enterprises that have greater financial resources than we do. Some of these competitors, unlike us, have vertically integrated their corn refining and other operations. Many of our products also compete with products made from raw materials other than corn, including cane and beet sugar. Fluctuation in prices of these competing products may affect prices of, and profits derived from, our products. In addition, govern- ment programs supporting sugar prices indirectly impact the price of corn sweeteners, especially HFCS. Competition in markets in which we compete is largely based on price, quality and product availability. Changes in consumer preferences and perceptions may lessen the demand for our products, which could reduce our sales and profitability and harm our business. Food products are often affected by changes in consumer tastes, national, regional and local economic conditions and demographic trends. For instance, changes in prevailing health or dietary prefer- ences causing consumers to avoid food products containing sweetener products, including HFCS, in favor of foods that are perceived as being more healthy, could reduce our sales and profitability, and such reductions could be material. Increasing concern among consumers, public health professionals and government agencies about the potential health concerns associated with obesity and inactive lifestyles represent a significant challenge to some of our customers, including those engaged in the food and soft drink industries. The uncertainty of acceptance of products developed through biotech- nology could affect our profitability. The commercial success of agricultural products developed through biotechnology, including genetically modified corn, depends in part on public acceptance of their development, cultivation, distribution and consumption. Public attitudes can be influenced by claims that genetically modified products are unsafe for consumption or that they pose unknown risks to the environment even if such claims are not based on scientific studies. These public attitudes can influence regulatory and legislative decisions about biotechnology. The sale 9 INGREDION INCORPORATEDof the Company’s products which may contain genetically modified corn could be delayed or impaired because of adverse public perception regarding the safety of the Company’s products and the potential effects of these products on animals, human health and the environment. Our information technology systems, processes, and sites may suffer interruptions or failures which may affect our ability to conduct our business. Our information technology systems, some of which are dependent on services provided by third parties, provide critical data connectivity, information and services for internal and external users. These interactions include, but are not limited to, ordering and managing materials from suppliers, converting raw materials to finished products, inventory management, shipping products to customers, processing transactions, summarizing and reporting results of operations, human resources benefits and payroll management, complying with regulatory, legal or tax requirements, and other processes necessary to manage our business. We have put in place security measures to protect ourselves against cyber-based attacks and disaster recovery plans for our critical systems. However, if our information technology systems are breached, damaged, or cease to function properly due to any number of causes, such as catastrophic events, power outages, security breaches, or cyber-based attacks, and our disaster recovery plans do not effectively mitigate on a timely basis, we may encounter disruptions that could interrupt our ability to manage our operations and suffer damage to our reputation, which may adversely impact our revenues, operating results and financial condition. Our profitability could be negatively impacted if we fail to maintain satisfactory labor relations. Approximately 36 percent of our US and 48 percent of our non-US employees are members of unions. Strikes, lockouts or other work stoppages or slow downs involving our unionized employees could have a material adverse effect on us. Our reliance on certain industries for a significant portion of our sales could have a material adverse effect on our business. Approximately 51 percent of our 2014 sales were made to companies engaged in the food industry and approximately 13 percent were made to companies in both the beverage and animal nutrition markets. Additionally, sales to the paper and corrugating industry and the brewing industry represented approximately 9 percent and 7 percent of our 2014 net sales, respectively. If our food customers, beverage customers, brewing industry customers, paper and corrugating customers or animal feed customers were to substantially decrease their purchases, our business might be materially adversely affected. Natural disasters, war, acts and threats of terrorism, pandemic and other significant events could negatively impact our business. If the economies of any countries where we sell or manufacture products are affected by natural disasters; such as earthquakes, floods or severe weather; war, acts of war or terrorism; or the outbreak of a pandemic; it could result in asset write-offs, decreased sales and overall reduced cash flows. Government policies and regulations in general, and specifically affecting agriculture-related businesses, could adversely affect our operating results. Our operating results could be affected by changes in trade, monetary and fiscal policies, laws and regulations, and other activities of United States and foreign governments, agencies, and similar organizations. These conditions include but are not limited to changes in a country’s or region’s economic or political conditions, trade regulations affecting production, pricing and marketing of products, local labor conditions and regulations, reduced protection of intellectual property rights, changes in the regulatory or legal environment, restrictions on currency exchange activities, currency exchange rate fluctuations, burdensome taxes and tariffs, and other trade barriers. International risks and uncertainties, including changing social and economic conditions as well as terrorism, political hostilities, and war, could limit our ability to transact business in these markets and could adversely affect our revenues and operating results. Due to cross-border disputes, our operations could be adversely affected by actions taken by the governments of countries where we conduct business. The recognition of impairment charges on goodwill or long-lived assets could adversely impact our future financial position and results of operations. We perform an annual impairment assessment for goodwill and our indefinite-lived intangible assets, and as necessary, for other long-lived assets. If the results of such assessments were to show that the fair value of these assets were less than the carrying values, we could be required to recognize a charge for impairment of goodwill and/or long-lived assets and the amount of the impairment charge could be material. The results of our impairment testing in the fourth quarter of 2014 indicated that the estimated fair value of our Southern Cone of South America reporting unit was less than its carrying amount primarily due to the impacts on its fair value of the elongation of unfavorable financial trends, such as the impact of higher production costs and our inability to increase selling prices to a level sufficient to recover the impacts of inflation and currency devaluation. Also, the political and economic volatility in the region and continued uncertainty in Argentina negatively impacted our earnings forecasts in the near term. Therefore, we recorded a non-cash 10 INGREDION INCORPORATEDimpairment charge of $33 million in the fourth quarter of 2014 to write-off the remaining balance of goodwill for this reporting unit. Additionally, based on the results of the annual assessment, we concluded that as of October 1, 2014, it was more likely than not that the fair value of all other reporting units was greater than their carrying value (although the $32 million of goodwill at our Brazil reporting unit continues to be closely monitored due to recent trends experienced in this reporting unit, such as continued economic headwinds and heightened competition). Even though it was determined that there was no additional long-lived asset impairment as of October 1, 2014, the future occurrence of a potential indicator of impairment, such as a significant adverse change in the business climate that would require a change in our assumptions or strategic decisions made in response to economic or competitive conditions, could require us to perform an assessment prior to the next required assessment date of October 1, 2015. Changes in our tax rates or exposure to additional income tax liabilities could impact our profitability. We are subject to income taxes in the United States and in various other foreign jurisdictions. Our effective tax rates could be adversely affected by changes in the mix of earnings by jurisdiction, changes in tax laws or tax rates including potential tax reform in the US to broaden the tax base and reduce deductions or credits, changes in the valuation of deferred tax assets and liabilities, and material adjustments from tax audits. The carrying values of deferred tax assets, which are predominantly in the US, United Kingdom, Mexico and Korea, are dependent upon our ability to generate future taxable income in these jurisdictions. In addition, the amount of income taxes we pay is subject to ongoing audits in various jurisdictions and a material assessment by a governing tax authority could affect our profitability. Operating difficulties at our manufacturing plants could adversely affect our operating results. Producing starches and sweeteners through corn refining is a capital intensive industry. We have 36 plants and have preventive maintenance and de-bottlenecking programs designed to maintain and improve grind capacity and facility reliability. If we encounter operating difficulties at a plant for an extended period of time or start-up problems with any capital improvement projects, we may not be able to meet a portion of sales order commitments and could incur significantly higher operating expenses, both of which could adversely affect our operating results. We also use boilers to generate steam required in our manufacturing processes. An event that impaired the operation of a boiler for an extended period of time could have a significant adverse effect on the operations of any plant where such event occurred. Also, we are subject to risks related to such matters as product quality or contamination; compliance with environmental, health and safety regulations; and customer product liability claims. The liabilities that could result from these risks may not always be covered by, or could exceed the limits of our insurance coverage related to product liability and food safety matters. In addition, negative publicity caused by product liability and food safety matters may damage our reputa- tion. The occurrence of any of the matters described above could adversely affect our revenues and operating results. We may not have access to the funds required for future growth and expansion. We may need additional funds to grow and expand our operations. We expect to fund our capital expenditures from operating cash flow to the extent we are able to do so. If our operating cash flow is insufficient to fund our capital expenditures, we may either reduce our capital expenditures or utilize our general credit facilities. For further strategic growth through mergers or acquisitions, we may also seek to generate additional liquidity through the sale of debt or equity securities in private or public markets or through the sale of non-productive assets. We cannot provide any assurance that our cash flows from operations will be sufficient to fund anticipated capital expenditures or that we will be able to obtain additional funds from financial markets or from the sale of assets at terms favorable to us. If we are unable to generate sufficient cash flows or raise sufficient additional funds to cover our capital expenditures or other strategic growth opportunities, we may not be able to achieve our desired operating efficiencies and expansion plans, which may adversely impact our competitiveness and, therefore, our results of operations. Our working capital requirements, including margin requirements on open positions on futures exchanges, are directly affected by the price of corn and other agricultural commodities, which may fluctuate significantly and change quickly. We may not successfully identify and complete acquisitions or strategic alliances on favorable terms or achieve anticipated synergies relating to any acquisitions or alliances, and such acquisitions could result in unforeseen operating difficulties and expenditures and require significant management resources. We regularly review potential acquisitions of complementary businesses, technologies, services or products, as well as potential strategic alliances. We may be unable to find suitable acquisition candidates or appropriate partners with which to form partnerships or strategic alliances. Even if we identify appropriate acquisition or alliance candidates, we may be unable to complete such acquisitions or alliances on favorable terms, if at all. In addition, the process of integrating an acquired business (such as Penford), technology, service or product into our existing business and operations may 11 INGREDION INCORPORATEDresult in unforeseen operating difficulties and expenditures. Integra- tion of an acquired company also may require significant management resources that otherwise would be available for ongoing development of our business. Moreover, we may not realize the anticipated benefits of any acquisition or strategic alliance, and such transactions may not generate anticipated financial results. Future acquisitions could also require us to issue equity securities, incur debt, assume contingent liabilities or amortize expenses related to intangible assets, any of which could harm our business. An inability to contain costs could adversely affect our future profitabil- ity and growth. Our future profitability and growth depends on our ability to contain operating costs and per-unit product costs and to maintain and/or implement effective cost control programs, while at the same time maintaining competitive pricing and superior quality products, customer service and support. Our ability to maintain a competitive cost structure depends on continued containment of manufacturing, delivery and administrative costs, as well as the implementation of cost-effective purchasing programs for raw materials, energy and related manufacturing requirements. If we are unable to contain our operating costs and maintain the productivity and reliability of our production facilities, our profitability and growth could be adversely affected. Volatility in the stock market, fluctuations in quarterly operating results and other factors could adversely affect the market price of our common stock. The market price for our common stock may be significantly affected by factors such as our announcement of new products or services or such announcements by our competitors; technological innovation by us, our competitors or other vendors; quarterly variations in our operating results or the operating results of our competitors; general conditions in our or our customers’ markets; and changes in the earnings estimates by analysts or reported results that vary materially from such estimates. In addition, the stock market has experienced significant price fluctuations that have affected the market prices of equity securities of many companies that have been unrelated to the operating performance of any individual company. No assurance can be given that we will continue to pay dividends. The payment of dividends is at the discretion of our Board of Directors and will be subject to our financial results and the availability of surplus funds to pay dividends. Item 1B. Unresolved Staff Comments None 12 Item 2. Properties We operate, directly and through our consolidated subsidiaries, 36 manufacturing facilities, all of which are owned. In addition, we lease our corporate headquarters in Westchester, Illinois and our research and development facility in Bridgewater, New Jersey. The following list details the locations of our manufacturing facilities within each of our four reportable business segments: North America Cardinal, Ontario, Canada London, Ontario, Canada Port Colborne, Ontario, Canada San Juan del Rio, Queretaro, Mexico Guadalajara, Jalisco, Mexico Mexico City, Edo, Mexico Stockton, California, U.S. Bedford Park, Illinois, U.S. Mapleton, Illinois, U.S. Indianapolis, Indiana, U.S. North Kansas City, Missouri, U.S. Winston-Salem, North Carolina, U.S. Charleston, South Carolina, U.S. South America Baradero, Argentina Chacabuco, Argentina Balsa Nova, Brazil Cabo, Brazil Conchal, Brazil Mogi-Guacu, Brazil Rio de Janeiro, Brazil Trombudo, Brazil Barranquilla, Colombia Cali, Colombia Lima, Peru Asia Pacific Lane Cove, Australia Shanghai, China Ichon, South Korea Inchon, South Korea Ban Kao Dien, Thailand Kalasin, Thailand Sikhiu, Thailand EMEA Cornwala, Pakistan Faisalabad, Pakistan Mehran, Pakistan Hamburg, Germany Goole, United Kingdom INGREDION INCORPORATEDWe believe our manufacturing facilities are sufficient to meet our current production needs. We have preventive maintenance and de-bottlenecking programs designed to further improve grind capacity and facility reliability. We have electricity co-generation facilities at all of our US and Canadian plants with the exception of Indianapolis, North Kansas City, Stockton, Charleston and Mapleton, as well as at our plants in San Juan del Rio, Mexico; Mexico City, Mexico; Baradero, Argentina; Cali, Colombia; and Balsa Nova and Mogi-Guacu, Brazil, that provide electricity at a lower cost than is available from third parties. We generally own and operate these co-generation facilities, except for the facilities at our Cardinal, Ontario; and Balsa Nova and Mogi-Guacu, Brazil locations, which are owned by, and operated pursuant to co-generation agreements with third parties. In recent years, we have made significant capital expenditures to update, expand and improve our facilities, spending $276 million in 2014. We believe these capital expenditures will allow us to operate efficient facilities for the foreseeable future. We currently anticipate that capital expenditures for 2015 will approximate $300 million. Item 3. Legal Proceedings As previously reported, on April 22, 2011, Western Sugar and two other sugar companies filed a complaint in the U.S. District Court for the Central District of California against the Corn Refiners Association (“CRA”) and certain of its member companies, including us, alleging false and/or misleading statements relating to high fructose corn syrup in violation of the Lanham Act and California’s unfair competition law. The complaint seeks injunctive relief and unspecified damages. On May 23, 2011, the plaintiffs amended the complaint to add additional plaintiffs, among other reasons. On July 1, 2011, the CRA and the member companies in the case filed a motion to dismiss the first amended complaint on multiple grounds. On October 21, 2011, the U.S. District Court for the Central District of California dismissed all Federal and state claims against us and the other members of the CRA, with leave for the plaintiffs to amend their complaint, and also dismissed all state law claims against the CRA. The state law claims against the CRA were dismissed pursuant to a California law known as the anti-SLAPP (Strategic Lawsuit Against Public Participation) statute, which, according to the court’s opinion, allows early dismissal of meritless first amendment cases aimed at chilling expression through costly, time-consuming litigation. The court held that the CRA’s statements were protected speech made in a public forum in connection with an issue of public interest (high fructose corn syrup). Under the anti-SLAPP statute, the CRA is entitled to recover its attorney’s fees and costs from the plaintiffs. On November 18, 2011, the plaintiffs filed a second amended complaint against certain of the CRA member companies, including us, seeking to reinstate the federal law claims, but not the state law claims, against certain of the CRA member companies, including us. On December 16, 2011, the CRA member companies filed a motion to dismiss the second amended complaint on multiple grounds. On July 31, 2012, the U.S. District Court for the Central District of California denied the motion to dismiss for all CRA member companies other than Roquette America, Inc. On September 4, 2012, we and the other CRA member companies that remain defendants in the case filed an answer to the plaintiffs’ second amended complaint that, among other things, added a counterclaim against the Sugar Association. The counterclaim alleges that the Sugar Association has made false and misleading statements that processed sugar differs from high fructose corn syrup in ways that are beneficial to consumers’ health (i.e., that consumers will be healthier if they consume foods and beverages containing processed sugar instead of high fructose corn syrup). The counterclaim, which was filed in the U.S. District Court for the Central District of California, seeks injunctive relief and unspecified damages. Although the counterclaim was initially only filed against the Sugar Association, the Company and the other CRA member companies that remain defendants in the Western Sugar case have reserved the right to add other plaintiffs to the counterclaim in the future. On October 29, 2012, the Sugar Association and the other plaintiffs filed a motion to dismiss the counterclaim and certain related portions of the defendants’ answer, each on multiple grounds. On December 10, 2012, the remaining member companies which are defendants in the case responded to the motion to dismiss the counterclaim. On January 14, 2013, the plaintiffs filed a reply to the defendants’ response to the motion to dismiss. On September 16, 2013, the U.S. District Court for the Central District of California denied the motion to dismiss the counterclaim, which entitles the Company and the other CRA member companies to continue to pursue the counterclaim against the Sugar Association and the other plaintiffs. On May 23, 2014, the defendants asked the court for leave to amend their counterclaim to add the individual sugar companies as counterclaim defendants. The motion for leave to amend was denied by the court on August 4, 2014 and this decision is in the process of being appealed by the defendants. On August 26, 2014, each of the Company and Tate & Lyle filed motions to disqualify the plaintiffs’ lead counsel, Squire Patton Boggs, due to a conflict of interest arising from Squire Sanders’ merger with Patton Boggs, a firm which represents each of the Company and Tate & Lyle. In addition, on August 26, 2014, the defendants filed two separate motions for summary judgment, one on the issue of liability and the other on the issue of damages, and the plaintiffs filed a motion for summary judgment with respect to the defendants’ counterclaim. The motion to disqualify the plaintiff’s attorneys was argued before the court on both November 13 and November 25, 2014. On February 13, 2015, the court granted the Company’s and Tate & Lyle’s motions to dismiss Squire Patton Boggs due to a conflict of interest. The schedule for arguing the summary judgment motions and the pre-trial conference have been delayed until May 5, 2015 while the plaintiffs seek replacement counsel in the case. 13 INGREDION INCORPORATEDWe continue to believe that the second amended complaint is without merit and intend to vigorously defend this case. In addition, we intend to vigorously pursue our rights in connection with the counterclaim. We are also party to a large number of labor claims relating to our Brazilian operations. We have reserved an aggregate of approximately $5 million as of December 31, 2014 in respect of these claims. These labor claims primarily relate to dismissals, severance, health and safety, work schedules and salary adjustments. We are currently subject to various other claims and suits arising in the ordinary course of business, including certain environmental proceedings and other commercial claims. We do not believe that the results of such legal proceedings, even if unfavorable to us, will be material to us. There can be no assurance, however, that such claims or suits or those arising in the future, whether taken individually or in the aggregate, will not have a material adverse effect on our financial condition or results of operations. Item 4. Mine Safety Disclosures Not applicable. Part II Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Shares of our common stock are traded on the New York Stock Exchange (“NYSE”) under the ticker symbol “INGR.” The number of holders of record of our common stock was 5,078 at January 31, 2015. We have a history of paying quarterly dividends. The amount and timing of the dividend payment, if any, is based on a number of factors including estimated earnings, financial position and cash flow. The payment of a dividend is solely at the discretion of our Board of Directors. Future dividend payments will be subject to our financial results and the availability of funds and statutory surplus to pay dividends. The quarterly high and low sales prices for our common stock and cash dividends declared per common share for 2013 and 2014 are shown below. 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr 2014 Market prices High Low Per share dividends declared 2013 Market prices High Low Per share dividends declared $70.00 58.28 $÷0.42 $77.92 65.25 $÷0.42 $80.54 73.10 $÷0.42 $87.20 69.94 $÷0.42 $72.58 62.44 $÷0.38 $74.31 62.65 $÷0.38 $72.19 60.62 $÷0.38 $70.48 63.49 $÷0.42 Issuer Purchases of Equity Securities: The following table summarizes information with respect to our purchases of our common stock during the fourth quarter of 2014. (shares in thousands) Oct. 1 – Oct. 31, 2014 Nov. 1 – Nov. 30, 2014 Dec. 1 – Dec. 31, 2014 Total Total Number of Shares Purchased – – 672 672 Average Price Paid per Share – – 78.45 78.45 Maximum Number (or Approximate Dollar Value) of Shares that may yet be Purchased Under the Plans or Programs at end of period 847 shares 847 shares 5,176 shares* Total Number of Shares Purchased as part of Publicly Announced Plans or Programs – – 672 672 * On December 12, 2014, the Board of Directors authorized a new stock repurchase program permitting the Company to purchase up to 5 million of its outstanding common shares from January 1, 2015 through December 31, 2019. The Company’s previously authorized stock repurchase program permitting the purchase of up to 4 million shares has been almost fully utilized with 176 thousand shares available to be repurchased as of December 31, 2014. 14 INGREDION INCORPORATEDItem 6. Selected Financial Data Selected financial data is provided below. (in millions, except per share amounts) 2014 2013 2012 2011 2010(a) Summary of operations: Net sales Net income attributable to Ingredion Net earnings per common share of Ingredion: Basic Diluted Cash dividends declared per common share of Ingredion Balance sheet data: Working capital Property, plant and equipment-net Total assets Long-term debt Total debt Total equity (f) Shares outstanding, year end $5,668 $6,328 $6,532 $6,219 $4,367 355(b) 396 428(c) 416(d) 169(e) $÷4.82(b) $÷5.14 $÷4.74(b) $÷5.05 $÷5.59(c) $÷5.44(d) $÷2.24(e) $÷5.47(c) $÷5.32(d) $÷2.20(e) $÷1.68 $÷1.56 $÷0.92 $÷0.66 $÷0.56 $1,423 $1,394 $1,427 $1,176 $÷«881 2,073 5,091 1,804 1,827 $2,207 2,156 5,360 1,717 1,810 $2,429 2,193 5,592 1,724 1,800 $2,459 2,156 5,317 1,801 1,949 $2,133 2,156 5,040 1,681 1,769 $2,001 71.3 74.3 77.0 75.9 76.0 Additional data: Depreciation and amortization $÷«195 276 Capital expenditures $÷«194 298 $÷«211 313 $÷«211 263 $÷«155 159 (a) (b) (c) (d) (e) Includes National Starch from October 1, 2010 forward. Includes a $33 million impairment charge ($0.44 per diluted common share) to write-off goodwill at our Southern Cone of South America reporting unit and after-tax costs of $1 million ($0.02 per diluted common share) related to the pending Penford acquisition. Includes a $13 million benefit from the reversal of a valuation allowance that had been recorded against net deferred tax assets of our Korean subsidiary ($0.16 per diluted common share), after-tax charges for impaired assets and restructuring costs of $23 million ($0.29 per diluted common share), an after-tax gain from a change in a North American benefit plan of $3 million ($0.04 per diluted common share), after-tax costs of $3 million ($0.03 per diluted common share) relating to the integration of National Starch and an after-tax gain from the sale of land of $2 million ($0.02 per diluted common share). See Notes 4 and 8 of the notes to the consolidated financial statements included in this Annual Report on Form 10-K for additional information. Includes a $58 million NAFTA award ($0.75 per diluted common share) received from the Government of the United Mexican States, an after-tax gain of $18 million ($0.23 per diluted common share) pertaining to a change in a postretirement plan, after-tax charges of $7 million for restructuring costs ($0.08 per diluted common share) and after-tax costs of $21 million ($0.26 per diluted common share) relating to the integration of National Starch. Includes $14 million of after-tax charges for bridge loan and other financing costs ($0.18 per diluted common share), after-tax costs related to the National Starch acquisition of $26 million ($0.34 per diluted common share), after-tax charges of $22 million ($0.29 per diluted common share) for impaired assets and other costs primarily associated with our operations in Chile and after-tax charges of $18 million ($0.23 per diluted common share) relating to the sale of National Starch inventory that was adjusted to fair value at the acquisition date in accordance with business combination accounting rules. (f) Includes non-controlling interests. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Overview We are a major supplier of high-quality food and industrial ingredients to customers around the world. We have 36 manufacturing plants located in North America, South America, Asia Pacific and Europe, the Middle East and Africa (“EMEA”), and we manage and operate our businesses at a regional level. We believe this approach provides us with a unique understanding of the cultures and product requirements in each of the geographic markets in which we operate, bringing added value to our customers. Our ingredients are used by customers in the food, beverage, animal feed, paper and corrugating, and brewing industries, among others. Our Strategic Blueprint continues to guide our decision-making and strategic choices with an emphasis on value-added ingredients for our customers. The foundation of our Strategic Blueprint is operational excellence, which includes our focus on safety, quality and continuous improvement. We see growth opportunities in three areas. First is organic growth as we work to expand our current business. Second, we are focused on broadening our ingredient portfolio of on-trend products through internal and external business development. Finally, we look for growth from geographic expansion as we pursue extension of our reach to new locations. The ultimate goal of these strategies and actions is to deliver increased shareholder value. Critical success factors in our business include managing our significant manufacturing costs, including costs for corn, other raw materials and utilities. In addition, due to our global operations we are exposed to fluctuations in foreign currency exchange rates. We use derivative financial instruments, when appropriate, for the purpose of minimizing the risks and/or costs associated with fluctuations in certain raw material and energy costs, foreign exchange rates and interest rates. Also, the capital intensive nature of our business requires that we generate significant cash flow over time in order to selectively reinvest in our operations and grow organically, as well as through strategic acquisitions and alliances. We utilize certain key financial metrics relating to working capital, debt and return on capital employed to monitor our progress toward achieving our strategic business objectives (see section entitled “Key Financial Performance Metrics”). Our net income per diluted common share for 2014 declined 6 percent from 2013 due to the recording of a non-cash impairment charge of $33 million to write-off goodwill at our Southern Cone of South America business unit and $2 million of costs related to our pending acquisition of Penford Corporation. Without these items, our diluted earnings per common share would have increased 3 percent from 2013. Our operating income, excluding the impairment charge and acquisition costs, was up slightly from a year ago as growth in EMEA, Asia Pacific and reduced corporate expenses were substantially 15 INGREDION INCORPORATEDoffset by weaker results in North America and South America. In North America, our largest segment, operating income declined 6 percent primarily reflecting the unfavorable impact of harsh winter weather conditions on our business in the first quarter of 2014. South America operating income fell 7 percent driven by the impact of difficult economic conditions in the Southern Cone of South America and unfavorable currency translation driven by the stronger US dollar. Operating income grew in both Asia Pacific and EMEA reflecting volume and gross margin growth. Given that both Asia Pacific and EMEA possess strong specialty product portfolios, we remain confident regarding future growth in these segments. Our operating cash flow of $731 million for 2014 grew 18 percent from 2013. We continue to use our operating cash flow to invest in our business and reward shareholders. Our acquisition of Penford Corporation (see below) is expected to close in the first quarter of 2015 pending regulatory approval. It should be immediately accretive to earnings and will enhance our specialty ingredient product portfolio. Additionally, we continue to make strategic investments in research and development and capital for our specialty product portfolio. During 2014 we repurchased 3.8 million of our common shares and our board of directors recently authorized the repurchase of an additional five million shares over the next five years. We also continued to pay quarterly cash dividends to our shareholders. Our balance sheet is strong and positions us well for future strategic initiatives. Looking ahead, we anticipate that our operating income and net income will grow in 2015 compared to 2014. In North America, we expect operating income to increase as we do not expect a repetition of the adverse weather effect that we experienced in the first quarter of 2014 and to benefit from anticipated improvement in price/product price mix. In South America, we expect modest operating income growth driven primarily by good cost management. We anticipate slow economic growth and continued foreign exchange headwinds in that segment for 2015. In Argentina, the political and economic environment remains volatile, challenging and uncertain, and we currently believe that our full year 2015 operating income in that country will be flat relative to 2014. Operating income in both Asia Pacific and EMEA should continue to grow in 2015, despite currency headwinds associ- ated with a stronger US dollar. We anticipate that this growth will be driven primarily by improved price/product mix from our specialty ingredient product portfolio and effective cost control. On October 14, 2014, we entered into a definitive agreement to acquire Penford Corporation (“Penford”), a US-based leader in specialty ingredients for food and non-food applications. The acquisition has been approved by the boards of directors of both companies and by the shareholders of Penford. It is subject to approval by regulators as well as to other customary closing conditions. The purchase price is estimated to be $340 million, including the assumption of debt. We expect to fund the acquisition of Penford with available cash and proceeds from borrowings under our revolving credit agreement. Penford, headquartered in Centennial, Colorado had net sales of $444 million in fiscal year 2014. Penford employs approximately 443 people and operates six plants in the United States, all of which manufacture specialty starches. See Note 3 of the notes to the consolidated financial statements for additional information. We currently expect that our available cash balances, future cash flow from operations and borrowing capacity under our credit facilities will provide us with sufficient liquidity to fund our anticipated capital expenditures, dividends and other investing and/or financing activities for the foreseeable future. Results of Operations We have significant operations in North America, South America, Asia Pacific and EMEA. For most of our foreign subsidiaries, the local foreign currency is the functional currency. Accordingly, revenues and expenses denominated in the functional currencies of these subsidiaries are translated into US dollars (“USD”) at the applicable average exchange rates for the period. Fluctuations in foreign currency exchange rates affect the US dollar amounts of our foreign subsidiaries’ revenues and expenses. The impact of foreign currency exchange rate changes, where significant, is provided below. 2014 Compared to 2013 Net Income Attributable to Ingredion Net income attributable to Ingredion for 2014 decreased to $355 million, or $4.74 per diluted common share, from $396 million, or $5.05 per diluted common share in 2013. Our results for 2014 include an impairment charge of $33 million ($0.44 per diluted common share) to write-off goodwill at our Southern Cone of South America reporting unit (see Note 4 of the notes to the consolidated financial statements for additional information) and after-tax costs of $2 million ($0.02 per diluted common share) related to our pending acquisition of Penford. Without the impairment charge and acquisition costs, our net income would have declined 2 percent from 2013, while our diluted earnings per share would have grown by 3 percent. This improvement in our diluted earnings per common share was driven by the favorable impact of our share repurchases. Net Sales Net sales for 2014 decreased to $5.67 billion from $6.33 billion in 2013, primarily reflecting reduced net sales in North America driven by lower raw material costs (primarily corn) that were reflected in our product pricing. A summary of net sales by reportable business segment is shown below: (in millions) North America South America Asia Pacific EMEA Total 2014 2013 Increase (Decrease) % Change $3,093 1,203 794 578 $5,668 $3,647 1,334 805 542 $6,328 $(554) (131) (11) 36 $(660) (15) (10) (1) 7∞ (10) 16 INGREDION INCORPORATED∞ ∞ ∞ ∞ The decrease in net sales was driven by an 8 percent price/product mix decline primarily attributable to lower raw material costs and unfavorable currency translation of 4 percent due to the stronger US dollar. A 2 percent volume increase partially offset the unfavorable impacts of the reduced selling prices and currency translation. Net sales in North America decreased 15 percent, primarily reflecting a 16 percent price/product mix decline driven principally by lower raw material costs. A 2 percent volume improvement more than offset unfavorable currency translation of 1 percent in Canada. Net sales in South America decreased 10 percent, as a 16 percent decline attributable to weaker foreign currencies more than offset price/product mix improvement of 6 percent. Volume in the segment was flat. Asia Pacific net sales declined 1 percent, as a 5 percent price/ product mix decline and unfavorable currency translation of 2 percent, more than offset volume growth of 6 percent. EMEA net sales grew 7 percent reflecting price/product mix improvement of 3 percent, 3 percent volume growth and favorable currency translation of 1 percent primarily attributable to a stronger British Pound Sterling. Cost of Sales Cost of sales for 2014 decreased 12 percent to $4.55 bil- lion from $5.20 billion in 2013. This reduction primarily reflects lower raw material costs and the effects of currency translation. Gross corn costs per ton for 2014 decreased approximately 24 percent from 2013, driven by lower market prices for corn. Currency translation caused cost of sales for 2014 to decrease approximately 4 percent from 2013, reflecting the impact of weaker foreign currencies, particularly in South America. Our gross profit margin for 2014 was 20 percent, compared to 18 percent in 2013. Despite reduced selling prices driven by lower corn costs, we have generally maintained per unit gross profit dollar levels, resulting in the improved gross profit margin percentages. Selling, General and Administrative Expenses Selling, general and administrative (“SG&A”) expenses for 2014 declined to $525 million from $534 million in 2013. The decrease was driven principally by foreign currency weakness which more than offset slightly higher compensation-related costs. Currency translation caused SG&A expenses for 2014 to decrease approximately 4 percent from 2013. SG&A expenses represented 47 percent of gross profit in 2014, consistent with 2013. Other Income – Net Other income-net of $24 million for 2014 increased from other income-net of $16 million in 2013. This increase primarily reflects $7 million of income associated with a tax indemnifi- cation agreement relating to a subsidiary acquired from Akzo Nobel N.V. (“Akzo”) in 2010 and a $3 million gain from the sale of our idled plant in Kenya. In the third quarter of 2014, we recognized a charge to our income tax provision for an unfavorable income tax audit result at the former Akzo subsidiary related to a pre-acquisition period for which we are indemnified by Akzo. The costs incurred by the acquired subsidiary are recorded in our provision for income taxes while the reimbursement from Akzo under the indemnification agreement is recorded as other income. The impact on our net income is zero. Operating Income A summary of operating income is shown below: (in millions) North America South America Asia Pacific EMEA Corporate expenses Write-off of impaired assets Acquisition costs Operating income 2014 $375 108 103 95 (65) (33) (2) $581 2013 $401 116 97 74 (75) – – $613 Favorable (Unfavorable) Variance Favorable (Unfavorable) % Change $(26) (8) 6 21 10 (33) (2) $(32) (6) (7) 6∞ 28∞ 13∞ NM NM (5) Operating income for 2014 decreased to $581 million from $613 mil- lion in 2013. Operating income for 2014 includes a $33 million charge to write-off impaired goodwill at our Southern Cone of South America reporting unit and $2 million of costs associated with our pending acquisition of Penford. Without the impairment charge and acquisition costs, operating income for 2014 would have been essentially flat with 2013. Our operating income primarily reflects earnings growth in EMEA and Asia Pacific along with reduced corporate expenses, which basically offset lower earnings in North America and South America. Unfavorable currency translation attributable to a stronger US dollar reduced operating income by approximately $28 million from 2013. North America operating income decreased 6 percent to $375 mil- lion from $401 million in 2013. The decline primarily reflects our weak first quarter 2014 results that were negatively impacted by harsh winter weather conditions that caused higher energy, transportation and production costs. Additionally, currency translation associated with a weaker Canadian dollar caused operating income to decrease by approximately $7 million in North America. We are pursuing insurance recoveries for the property and business interruption loss that was caused by the harsh winter weather. South America operating income decreased 7 percent to $108 million from $116 million in 2013. The decrease was driven by weaker results in the Southern Cone of South America, which more than offset earnings growth in Brazil. The operating income decline in the Southern Cone of South America primarily reflects the impact of higher production costs and our inability to increase selling prices to a level sufficient to recover the impacts of inflation and currency devaluation. Translation effects associated with weaker South American currencies (particularly the Argentine Peso and Brazilian Real) caused operating income to decrease by approximately $18 million. We currently anticipate that our business in South America will continue to be challenged by difficult economic conditions in 2015. Asia Pacific operating income grew 6 percent to $103 million from $97 million in 2013. This increase was driven principally by volume growth in our Asian business and lower corn costs in South Korea. 17 INGREDION INCORPORATED∞ ∞ ∞ Unfavorable translation effects associated with weaker Asian currencies caused Asia Pacific operating income to decrease by approximately $3 million. EMEA operating income rose 28 percent to $95 million from $74 million in 2013. The improved earnings primarily reflect improved selling prices, volume growth and manufacturing efficiencies resulting from capital investments, particularly in Europe, and lower energy costs in Pakistan. Financing Costs – Net Financing costs-net decreased to $61 million in 2014 from $66 million in 2013. The decline reflects a decrease in interest expense, an increase in interest income and a reduction in foreign currency transaction losses. The reduction in interest expense reflects lower average interest rates driven by the effect of our interest rate swaps, which more than offset the impact of higher average borrowings. The increase in interest income was driven principally by higher interest rates on our cash investments. Provision for Income Taxes Our effective tax rate was 30.2 percent in 2014, as compared to 26.3 percent in 2013. In the fourth quarter of 2014 we impaired goodwill in our Southern Cone subsidiaries and recorded a charge of $33 million without a tax benefit, which increased the effective tax rate by 1.8 percentage points. We use the US dollar as the functional currency for our subsidiaries in Mexico. Because of the decline in the value of the Mexican peso versus the US dollar, primarily late in 2014, the Mexican tax provision includes an unfavorable impact of approximately $7 million, or 1.3 percentage points in our effective tax rate, primarily associated with foreign currency transaction gains for local income tax purposes on net US dollar monetary assets held in Mexico for which there is no corresponding gain in our pre-tax income. The tax provision also includes approximately $7 million for an unfavorable audit result at a National Starch subsidiary related to a pre-acquisition period for which we are indemnified by Akzo. Addition- ally, the 2014 tax provision includes $12 million of net favorable reversals of previously unrecognized tax benefits due to the lapsing of the statute of limitations. We have significant operations in Canada, Mexico and Thailand where the statutory tax rates are 25 percent, 30 percent and 20 percent, respectively. In addition, our subsidiary in Brazil has a lower effective tax rate of 26 percent including local tax incentives. Our effective tax rate for 2013 includes approximately $2 million of tax benefits related to the January 2, 2013 enactment of the US American Taxpayer Relief Act of 2012. We also received a favorable tax determina- tion from the Canadian courts during 2013 that resulted in approximately $4 million of tax benefits related to prior years, and an additional $2 million related to 2013. In addition, in 2013, we recognized approxi- mately $11 million of tax benefits related to net changes in previously unrecognized tax benefits and global provision to return adjustments. Without the impact of the items described above, our effective tax rates for 2014 and 2013 would have been approximately 28 percent and 30 percent, respectively. See Note 8 of the notes to the consoli- dated financial statements for additional information. Net Income Attributable to Non-controlling Interests Net income attributable to non-controlling interests was $8 million in 2014, up from $7 million in 2013. The increase primarily reflects improved net income at our non-wholly-owned operation in Pakistan. Comprehensive Income We recorded comprehensive income of $156 million in 2014, as compared with $288 million in 2013. The decrease in comprehensive income primarily reflects a $75 million unfavorable variance relating mainly to the reduced funded status of our pension and postretirement benefit plans associated with lower discount rates and a revised mortality table, a $58 million unfavorable variance in the cumulative translation adjustment and our lower net income of $40 million, partially offset by a $44 million favorable variance associated with our cash-flow hedging activity. The unfavor- able variance in the cumulative translation adjustment reflects a greater weakening in end of period foreign currencies relative to the US dollar, as compared to a year ago. 2013 Compared to 2012 Net Income Attributable to Ingredion Net income attributable to Ingredion for 2013 decreased to $396 million, or $5.05 per diluted common share, from 2012 net income of $428 million, or $5.47 per diluted common share. Our results for 2012 included after-tax charges of $16 million ($0.20 per diluted common share) for impaired assets and restructuring costs in Kenya, China and Colombia (see Note 4 of the notes to the consolidated financial statements for additional information), after-tax restructuring charges of $7 million ($0.09 per diluted common share) relating to our manufacturing optimization plan in North America, and after-tax costs of $3 million ($0.03 per diluted common share) associated with our integration of National Starch. Additionally, our 2012 results included the reversal of a $13 million valuation allowance that had been recorded against net deferred tax assets of our Korean subsidiary ($0.16 per diluted common share), an after-tax gain from a change in a benefit plan of $3 million ($0.04 per diluted common share) and an after-tax gain from the sale of land of $2 million ($0.02 per diluted common share). Without the impairment/restructuring charges, the reversal of the Korean deferred tax asset valuation allowance, the gain from the benefit plan change, the gain from the land sale and the integration costs in 2012, net income and diluted earnings per common share for 2013 would have declined 9 percent from 2012. This decline in net income primarily reflects lower operating income driven principally by significantly reduced operating income in South America. 18 INGREDION INCORPORATEDNet Sales Net sales for 2013 decreased to $6.33 billion from $6.53 bil- lion in 2012, primarily reflecting reduced sales in South America and North America. A summary of net sales by reportable business segment is shown below: (in millions) North America South America Asia Pacific EMEA Total 2013 2012 Increase (Decrease) % Change $3,647 1,334 805 542 $6,328 $3,741 1,462 816 513 $6,532 $÷(94) (128) (11) 29 $(204) (3) (9) (1) 6∞ (3) The decrease in net sales primarily reflects a 3 percent volume reduction and unfavorable currency translation of 3 percent attributable to weaker foreign currencies relative to the US dollar, which more than offset improved price/product mix of 3 percent. Net sales in North America decreased 3 percent, as a 4 percent volume decline and slightly unfavorable currency translation attribut- able to a weaker Canadian dollar more than offset improved price/ product mix of 2 percent. Increased selling prices helped to offset higher corn costs. Net sales in South America decreased 9 percent, as a 10 percent decline attributable to weaker foreign currencies and a 2 percent volume reduction more than offset a 3 percent price/product mix improvement. The volume reduction primarily reflects weaker economic conditions, particularly in the Southern Cone of South America and in Brazil, and reduced sales to the brewing industry where excess industry capacity resulted in weaker brewery demand for high maltose in Brazil. Asia Pacific net sales declined 1 percent, as a volume decline of 2 percent and slightly unfavorable currency translation effects more than offset a 1 percent price/product mix improvement. The volume reduction reflects the effect of the fourth quarter 2012 sale of our investment in our Chinese non-wholly-owned consolidated subsidiary, Shouguang Golden Far East Modified Starch Co., Ltd. (“GFEMS”). Without net sales of $23 million from GFEMS in 2012, Asia Pacific net sales for 2013 would have increased 2 percent and volume would have grown 1 percent from a year ago. EMEA net sales grew 6 percent reflecting price/product mix improvement of 8 percent and 1 percent volume growth, which more than offset unfavorable currency translation of 3 percent. Without an $11 million sales reduction attributable to the closure of our plant in Kenya, EMEA net sales for 2013 would have increased approximately 8 percent and volume would have grown approximately 3 percent from 2012. Cost of Sales Cost of sales for 2013 decreased 2 percent to $5.20 billion from $5.29 billion in 2012. Higher raw material costs were more than offset by reduced volume, the effects of currency translation and the impacts of continued cost savings focus. Pricing actions by us limited the unfavorable impact of higher raw material costs on our operating income. Currency translation caused cost of sales for 2013 to decrease approximately 3 percent from 2012, reflecting the impact of weaker foreign currencies, particularly in South America. Gross corn costs per ton for 2013 increased approximately 1 percent from 2012, driven by higher market prices for corn. Additionally, energy costs increased approximately 2 percent from 2012, primarily reflecting higher costs in Korea and Pakistan. Our gross profit margin for 2013 was 18 percent, compared to 19 percent in 2012, primarily reflecting lower gross profits in South America. Selling, General and Administrative Expenses SG&A expenses for 2013 declined to $534 million from $556 million in 2012. The decrease was driven principally by foreign currency weakness and cost savings initiatives. Currency translation caused SG&A expenses for 2013 to decrease approximately 3 percent from 2012. SG&A expenses represent- ed approximately 8 percent of net sales in 2013, consistent with 2012. Other Income – Net Other income-net of $16 million for 2013 decreased from other income-net of $22 million in 2012. This decrease primarily reflects the effects of a $5 million gain from a change in a North America benefit plan and a $2 million gain from a land sale, both of which were recorded in the fourth quarter of 2012. Operating Income. A summary of operating income is shown below: (in millions) North America South America Asia Pacific EMEA Corporate expenses Restructuring/ impairment charges Gain from change in benefit plans Integration costs Gain from sale of land Operating income 2013 $401 116 97 74 (75) – – – – $613 2012 $408 198 95 78 (78) (36) 5 (4) 2 $668 Favorable (Unfavorable) Variance Favorable (Unfavorable) % Change $÷(7) (82) 2 (4) 3 36 (5) 4 (2) $(55) (2) (41) 2∞ (6) 4∞ NM NM NM NM (8) Operating income for 2013 declined to $613 million from $668 mil- lion in 2012. Operating income for 2012 included $20 million of charges for impaired assets and restructuring costs in Kenya, $11 million of restructuring charges to reduce the carrying value of certain equipment associated with our manufacturing optimization plan in North America, $5 million of charges for impaired assets in China and Colombia, and $4 million of costs pertaining to the integration of National Starch. 19 INGREDION INCORPORATED∞ ∞ ∞ ∞ ∞ ∞ ∞ ∞ Additionally, operating income for 2012 included the $5 million gain from the benefit plan change in North America and the $2 million gain from the sale of land. Without the impairment/restructuring charges, integration costs, the gain from the benefit plan change and the gain from the land sale, operating income for 2013 would have decreased 13 percent, primarily reflecting reduced operating income in South America. Unfavorable currency translation associated with weaker foreign currencies caused operating income to decline by approxi- mately $21 million from 2012. North America operating income decreased 2 percent to $401 million from $408 million in 2012. Lower volumes due to reduced customer demand drove the operating income decline. Improved product selling prices and manufacturing cost saving initiatives limited the unfavorable impact of the reduced sales volume. Currency translation associated with a weaker Canadian dollar caused operating income to decrease by approximately $3 million in North America. South America operating income decreased 41 percent to $116 million from $198 million in 2012. The decrease was driven by significantly weaker results in the Southern Cone of South America and in Brazil. Our inability to increase selling prices to a level sufficient to recover higher corn, energy and labor costs, primarily in Argentina, and the reduced absorption of fixed manufactur- ing costs as a result of lower sales volumes due to soft demand from a weaker economy, drove the earnings decline. Translation effects associated with weaker South American currencies (particularly the Argentine Peso and Brazilian Real) caused operating income to decrease by approximately $14 million. Asia Pacific operating income rose 2 percent to $97 million from $95 million in 2012. This increase primarily reflects organic volume growth and slightly higher product selling prices, which more than offset higher local production costs and the impact of weaker foreign currencies. Unfavorable translation effects associated with weaker foreign currencies caused Asia Pacific operating income to decrease by approximately $1 million. EMEA operating income decreased 6 percent to $74 million from $78 million in 2012. The decrease primarily reflects the impacts of weaker foreign currencies and higher local production and energy costs, which more than offset improved product price/mix and volume growth. Translation effects associated with weaker foreign currencies (particularly the Pakistan Rupee) caused EMEA operating income to decrease by approximately $3 million. Financing Costs – Net Financing costs-net decreased slightly to $66 million in 2013 from $67 million in 2012. The decrease primarily reflects reduced interest expense driven by lower average borrowings and interest rates and an increase in interest income attributable to our higher cash balances, partially offset by an increase in foreign currency transaction losses. Provision for Income Taxes Our effective tax rate was 26.3 percent in 2013, as compared to 27.8 percent in 2012. Our effective tax rate for 2013 includes approximately $2 million of tax benefits related to the January 2, 2013 enactment of the US American Taxpayer Relief Act of 2012. The Company also received a favorable tax determination from the Canadian courts during 2013 that resulted in approximately $4 million of tax benefits related to prior years, and an additional $2 million related to the current year. In addition, the Company recognized approximately $11 million of tax favorability related to net changes in previously unrecognized tax benefits and global provision to return adjustments. Our effective income tax rate for 2012 includes the effects of the discrete reversal of a $13 million valuation allowance that had been recorded against net deferred tax assets of our Korean subsidiary, the recognition of an income tax benefit of $8 million related to our $20 million restructuring charge in Kenya and the associated tax write-off of the investment. Additionally, in 2012 we recorded a $4 million pre-tax charge related to the disposition of GFEMS, which is not expected to produce a realizable tax benefit. Without the impact of the items described above, our effective tax rates for 2013 and 2012 would have been approximately 30 percent in both periods. See Note 8 of the notes to the consolidated financial statements for additional information. Net Income Attributable to Non-controlling Interests Net income attributable to non-controlling interests was $7 million in 2013, up from $6 million in 2012. The increase reflects the impact of our 2012 sale of GFEMS and improved net income at our non-wholly-owned operation in Pakistan. Comprehensive Income We recorded comprehensive income of $288 million in 2013, as compared with $366 million in 2012. The decrease in comprehensive income primarily reflects a $125 million unfavorable variance in the cumulative translation adjustment, a $41 million unfavorable variance associated with our cash-flow hedging activity and our lower net income of $31 million, partially offset by a $119 million favorable variance relating mainly to the improved funded status of our pension and postretirement benefit plans. The unfavorable variance in the cumulative translation adjustment reflects a greater weakening in end of period foreign currencies relative to the US dollar, as compared to a year ago. Liquidity and Capital Resources At December 31, 2014, our total assets were $5.09 billion, down from $5.36 billion at December 31, 2013. This decrease primarily reflects translation effects associated with weaker end of period foreign currencies relative to the US dollar. Total equity decreased to $2.21 bil- lion at December 31, 2014, from $2.43 billion at December 31, 2013. This decrease primarily reflects our share repurchases, dividends on our common stock and an increase in our accumulated other comprehen- sive loss driven principally by unfavorable foreign currency translation. These declines more than offset the favorable impact of our 2014 net income on total equity. 20 INGREDION INCORPORATEDWe have a senior, unsecured, $1 billion revolving credit agreement (the “Revolving Credit Agreement”) that matures on October 22, 2017. Subject to certain terms and conditions, we may increase the amount of the revolving credit facility under the Revolving Credit Agreement by up to $250 million in the aggregate. All committed pro rata borrowings under the revolving credit facility will bear interest at a variable annual rate based on the LIBOR or prime rate, at our election, subject to the terms and conditions thereof, plus, in each case, an applicable margin based on our leverage ratio (as reported in the financial statements delivered pursuant to the Revolving Credit Agreement). The Revolving Credit Agreement contains customary representa- tions, warranties, covenants, events of default, terms and conditions, including limitations on liens, incurrence of debt, mergers and significant asset dispositions. We must also comply with a leverage ratio and an interest coverage ratio covenant. The occurrence of an event of default under the Revolving Credit Agreement could result in all loans and other obligations under the agreement being declared due and payable and the revolving credit facility being terminated. We met all covenant requirements as of December 31, 2014. At December 31, 2014, we had $87 million of borrowings outstand- ing under our Revolving Credit Agreement. In addition, we have a number of short-term credit facilities consisting of operating lines of credit. At December 31, 2014, we had total debt outstanding of $1.83 billion, compared to $1.81 billion at December 31, 2013. In addition to the borrowings outstanding under the Revolving Credit Agreement, our total debt includes $350 million of 3.2 percent notes due November 1, 2015, $300 million (principal amount) of 1.8 percent senior notes due 2017, $200 million of 6.0 percent senior notes due 2017, $200 million of 5.62 percent senior notes due 2020, $400 million (principal amount) of 4.625 percent notes due 2020, $250 million (principal amount) of 6.625 percent senior notes due 2037 and $23 million of consolidated subsidiary debt consisting of local country short-term borrowings. Ingredion Incorporated, as the parent company, guarantees certain obligations of its consolidated subsidiaries. At December 31, 2014, such guarantees aggregated $214 million. Manage- ment believes that such consolidated subsidiaries will meet their financial obligations as they become due. Historically, the principal source of our liquidity has been our internally generated cash flow, which we supplement as necessary with our ability to borrow on our bank lines and to raise funds in the capital markets. In addition to borrowing availability under our Revolving Credit Agreement, we also have approximately $485 million of unused operating lines of credit in the various foreign countries in which we operate. The weighted average interest rate on our total indebtedness was approximately 4.1 percent and 4.4 percent for 2014 and 2013, respectively. Net Cash Flows A summary of operating cash flows is shown below: (in millions) Net income Depreciation and amortization Write-off of impaired assets Deferred income taxes Changes in working capital Other Cash provided by operations 2014 $363 195 33 (11) 84 67 $731 2013 $403 194 – 30 (57) 49 $619 Cash provided by operations was $731 million in 2014, as compared with $619 million in 2013. The increase in operating cash flow for 2014 primarily reflects improved cash flow associated with working capital activities. An increase in accounts payable and accrued liabilities associated with the timing of payments and a decrease in our margin accounts relating to commodity hedging contracts were the primary sources of our 2014 cash inflow from reduced working capital. We had cash inflows of $39 million in 2014 from our margin account activity relating to commodity hedging contracts. To manage price risk related to corn purchases in North America, we use derivative instruments (corn futures and options contracts) to lock in our corn costs associated with firm-priced customer sales contracts. We are unable to directly hedge price risk related to co-product sales; however, we enter into hedges of soybean oil (a competing product to our animal feed and corn oil) in order to mitigate the price risk of animal feed and corn oil sales. As the market price of corn fluctuates, our derivative instruments change in value and we fund any unreal- ized losses or receive cash for any unrealized gains related to outstanding corn futures and option contracts. We plan to continue to use corn futures and option contracts to hedge the price risk associ- ated with firm-priced customer sales contracts in our North American business and, accordingly, we will be required to make cash deposits to or be entitled to receive cash from our margin accounts depending on the movement in the market price for corn. Listed below are our primary investing and financing activities for 2014: (in millions) Capital expenditures Payments on debt Proceeds from borrowings Dividends paid (including to non-controlling interests) Repurchases of common stock Sources (Uses) of Cash $(276) (213) 231 (128) (304) On December 12, 2014, our board of directors declared a quarterly cash dividend of $0.42 per share of common stock. This dividend was paid on January 26, 2015 to stockholders of record at the close of business on December 31, 2014. 21 INGREDION INCORPORATEDAs part of our stock repurchase program, we entered into an accelerated share repurchase agreement (“ASR”) on July 30, 2014 with an investment bank under which we repurchased $300 million of our common stock. We paid the $300 million on August 1, 2014 and received an initial delivery of shares from the investment bank of 3,152,502 shares, representing approximately 80 percent of the shares anticipated to be repurchased based on current market prices at that time. The initial delivery of shares resulted in an immediate reduction in the number of shares used to calculate the weighted average common shares outstanding for basic and diluted net earnings per share from the effective date of the ASR. On December 29, 2014, the ASR was completed and we received 671,823 additional shares of our common stock bringing the total amount of repurchases to 3,824,325 shares, based upon the volume-weighted average price of $78.45 per share over the term of the share repurchase agreement. The ASR was funded through a combination of cash on hand and utilization of the Revolving Credit Agreement. On October 14, 2014, we entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among Penford Corporation, a Washington corporation (“Penford”), Prospect Sub, Inc., a Washington corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), and the Company. The Merger Agreement and the consumma- tion of the transactions contemplated by the Merger Agreement were unanimously approved by our board of directors. The Merger Agree- ment provides for the merger of Merger Sub with and into Penford, on the terms and subject to the conditions set forth in the Merger Agreement (the “Merger”), with Penford continuing as the surviving corporation in the Merger. As a result of the Merger, Penford will become a wholly-owned subsidiary of the Company. Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share (a “Share”) of common stock of Penford (“Penford Common Stock”) issued and outstanding immediately prior to the Effective Time, other than (a) Shares owned by the Company or Merger Sub, or by any subsidiary of the Company or Merger Sub, immediately prior to the Effective Time and (b) Shares outstanding immediately prior to the Effective Time and held by a holder who is entitled to exercise dissenters’ rights and properly exercises dissenters’ rights under Washington law with respect to such Shares, will be converted into the right to receive $19.00 in cash per Share, without interest and subject to and reduced by the amount of any tax withholding. As of the date of the Merger Agreement, Penford had 12,735,038 outstanding Shares and 1,429,000 Shares underlying outstanding options. Outstanding borrowings under Penford’s revolving credit agreement will become due as a result of the Merger. The purchase price is estimated to be $340 million, including the assumption of debt. We expect to fund the acquisition of Penford with available cash and proceeds from borrowings under our revolving credit agreement. The acquisition is expected to close in the first quarter of 2015 pending regulatory approval. See Note 3 of the notes to the consolidated financial statements for additional information. We currently anticipate that capital expenditures for 2015 will approximate $300 million. We currently expect that our available cash balances, future cash flow from operations and borrowing capacity under our credit facilities will provide us with sufficient liquidity to fund our anticipated capital expenditures, dividends, and other investing and/or financing activities for the foreseeable future. We have not provided federal and state income taxes on accumu- lated undistributed earnings of certain foreign subsidiaries because these earnings are considered to be permanently reinvested. It is not practicable to determine the amount of the unrecognized deferred tax liability related to the undistributed earnings. We do not anticipate the need to repatriate funds to the United States to satisfy domestic liquidity needs arising in the ordinary course of business, including liquidity needs associated with our domestic debt service require- ments or planned acquisition of Penford. Approximately $604 million of our total cash and cash equivalents and short-term investments of $614 million at December 31, 2014, was held by our operations outside of the United States. We anticipate that such cash and short-term investments will be used to fund growth opportunities outside of the United States, including capital expenditures and acquisitions. We expect that available cash balances and credit facilities in the United States, along with cash generated from operations, will be sufficient to meet our operating and other cash needs for the foreseeable future. Hedging We are exposed to market risk stemming from changes in commodity prices, foreign currency exchange rates and interest rates. In the normal course of business, we actively manage our exposure to these market risks by entering into various hedging transactions, authorized under established policies that place clear controls on these activities. These transactions utilize exchange-traded derivatives or over-the- counter derivatives with investment grade counterparties. Our hedging transactions may include, but are not limited to, a variety of derivative financial instruments such as commodity futures, options and swap contracts, forward currency contracts and options, interest rate swap agreements and treasury lock agreements. See Note 5 of the notes to the consolidated financial statements for additional information. Commodity Price Risk Our principal use of derivative financial instruments is to manage commodity price risk in North America relating to anticipated purchases of corn and natural gas to be used in the manufacturing process. We periodically enter into futures, options and swap contracts for a portion of our anticipated corn and natural gas usage, generally over the following twelve to twenty-four months, in order to hedge price risk associated with fluctuations in market 22 INGREDION INCORPORATEDprices. These derivative instruments are recognized at fair value and have effectively reduced our exposure to changes in market prices for these commodities. We are unable to directly hedge price risk related to co-product sales; however, we enter into hedges of soybean oil (a competing product to our corn oil) in order to mitigate the price risk of corn oil sales. Unrealized gains and losses associated with marking our commodities-based derivative instruments to market are recorded as a component of other comprehensive income (“OCI”). At December 31, 2014, our accumulated other comprehensive loss account (“AOCI”) included $13 million of losses, net of tax of $6 million, related to these derivative instruments. It is anticipated that these losses will be reclassified into earnings during the next twelve months. We expect the losses to be offset by changes in the underlying commodities cost. Foreign Currency Exchange Risk Due to our global operations, including many emerging markets, we are exposed to fluctuations in foreign currency exchange rates. As a result, we have exposure to translational foreign exchange risk when our foreign operation results are translated to USD and to transactional foreign exchange risk when transactions not denominated in the functional currency of the operating unit are revalued. We primarily use derivative financial instruments such as foreign currency forward contracts, swaps and options to manage our foreign currency transactional exchange risk. At December 31, 2014, we had foreign currency forward sales contracts with an aggregate notional amount of $150 million and foreign currency forward purchase contracts with an aggregate notional amount of $70 million that hedged transactional exposures. The fair value of these derivative instruments is an asset of $1 million at December 31, 2014. We also have foreign currency derivative instruments that hedge certain foreign currency transactional exposures and are designated as cash-flow hedges. The amount included in AOCI relating to these hedges at December 31, 2014 was not significant. We have significant operations in Argentina. We utilize the official exchange rate published by the Argentine government for re-measurement purposes. Due to exchange controls put in place by the Argentine government, a parallel market exists for exchanging Argentine pesos to US dollars at rates less favorable than the official rate. Argentina and other emerging markets experienced increased devaluation and volatility in 2014 and we anticipate that this trend will continue in 2015. Interest Rate Risk We occasionally use interest rate swaps and Treasury Lock agreements (“T-Locks”) to hedge our exposure to interest rate changes, to reduce the volatility of our financing costs, or to achieve a desired proportion of fixed versus floating rate debt, based on current and projected market conditions. We did not have any T-Locks outstanding at December 31, 2014 or 2013. In September 2014, we entered into interest rate swap agreements that effectively convert the interest rates on our 6.0 percent $200 mil- lion senior notes due April 15, 2017, our 1.8 percent $300 million senior notes due September 25, 2017 and on $200 million of our $400 million 4.625 percent senior notes due November 1, 2020, to variable rates. Additionally, we have interest rate swap agreements that effectively convert the interest rate on our 3.2 percent $350 million senior notes due November 1, 2015 to a variable rate. These swap agreements call for us to receive interest at the fixed coupon rate of the respective notes and to pay interest at a variable rate based on the six-month US dollar LIBOR rate plus a spread. We have designated these interest rate swap agreements as hedges of the changes in fair value of the underlying debt obligations attributable to changes in interest rates and account for them as fair-value hedges. The fair value of these interest rate swap agreements was $13 million at both December 31, 2014 and December 31, 2013, and is reflected in the Consolidated Balance Sheets within other assets, with an offsetting amount recorded in long-term debt to adjust the carrying amount of the hedged debt obligations. At December 31, 2014, our accumulated other comprehensive loss account included $7 million of losses (net of tax of $4 million) related to settled Treasury Lock agreements. These deferred losses are being amortized to financing costs over the terms of the senior notes with which they are associated. It is anticipated that $2 million of these losses (net of tax of $1 million) will be reclassified into earnings during the next twelve months. Contractual Obligations and Off Balance Sheet Arrangements The table below summarizes our significant contractual obligations as of December 31, 2014. Information included in the table is cross- referenced to the notes to the consolidated financial statements elsewhere in this report, as applicable. (in millions) Contractual Obligations Note reference Less than 1 year Total 2 – 3 years 4 – 5 years More than 5 years Payments due by period Long-term debt (a) Interest on long-term debt Operating lease obligations Pension and other postretirement obligations Purchase obligations (b) Total (c) 6 6 7 9 $1,787 $350 $÷«587 $÷÷– $÷«850 607 174 76 41 124 64 93 41 314 28 113 1,404 $4,085 6 344 6 324 $817 $1,105 6 242 95 494 $382 $1,781 (a) Long-term debt at December 31, 2014 includes $350 million of 3.2 percent senior notes that mature November 1, 2015. These borrowings are included in long-term debt as we have the ability and intent to refinance the notes on a long-term basis prior to the maturity date. (b) The purchase obligations relate principally to power supply and raw material sourcing agreements, including take or pay contracts, which help to provide us with adequate power and raw material supply at certain of our facilities. (c) The above table does not reflect unrecognized income tax benefits of $23 million, the timing of which is uncertain. See Note 8 of the notes to the consolidated financial statements for additional information with respect to unrecognized income tax benefits. 23 INGREDION INCORPORATEDWe currently anticipate that in 2015 we will make cash contribu- tions of $1 million and $2 million to our US and non-US pension plans, respectively. See Note 9 of the notes to the consolidated financial statements for further information with respect to our pension and postretirement benefit plans. Key Financial Performance Metrics We use certain key financial metrics to monitor our progress towards achieving our long-term strategic business objectives. These metrics relate to our return on capital employed, our financial leverage, and our management of working capital, each of which is tracked on an ongoing basis. We assess whether we are achieving an adequate return on invested capital by measuring our “Return on Capital Employed” (“ROCE”) against our cost of capital. We monitor our financial leverage by regularly reviewing our ratio of net debt to adjusted earnings before interest, taxes, depreciation and amortization (“Net Debt to Adjusted EBITDA”) and our “Net Debt to Capitalization” percentage to assure that we are properly financed. We assess our level of working capital investment by evaluating our “Operating Working Capital as a percent- age of Net Sales.” We believe these metrics provide valuable manage- rial information to help us run our business and are useful to investors. The metrics below include certain information (including Capital Employed, Adjusted Operating Income, Adjusted EBITDA, Net Debt, Adjusted Current Assets, Adjusted Current Liabilities and Operating Working Capital) that is not calculated in accordance with Generally Accepted Accounting Principles (“GAAP”). Management uses non-GAAP financial measures internally for strategic decision-making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide a more meaningful, consistent comparison of our operating results and trends for the periods presented. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. These non-GAAP measures should be consid- ered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with generally accepted accounting principles. Non-GAAP financial measures are not prepared in accordance with GAAP; therefore, the information is not necessarily comparable to other companies. A reconciliation of non-GAAP historical financial measures to the most comparable GAAP measure is provided in the tables below. Our calculations of these key financial metrics for 2014 with comparisons to the prior year are as follows: Return on Capital Employed (dollars in millions) Total equity * Add: Cumulative translation adjustment * Share-based payments subject to redemption * Total debt * Less: Cash and cash equivalents * Capital employed * (a) Operating income Adjusted for: Impairment charge Acquisition costs Adjusted operating income Income taxes (at effective tax rates of 28.3% in 2014 and 26.3% in 2013) ** Adjusted operating income, net of tax (b) Return on Capital Employed (b÷a) 2014 2013 $2,429 $2,459 489 24 1,810 (574) $4,178 $÷«581 33 2 335 19 1,800 (609) $4,004 $÷«613 – – $÷«616 $÷«613 (174) $÷«442 10.6% (161) $÷«452 11.3% * Balance sheet amounts used in computing capital employed represent beginning of period balances. ** The effective income tax rate for 2014 excludes the impacts of an impairment charge and acquisition costs. Including these items, the Company’s effective income tax rate for 2014 was 30.2 percent. Listed below is a schedule that reconciles our effective income tax rate under US GAAP to the adjusted income tax rate. (dollars in millions) As reported Add back: Impairment charge Acquisition costs Adjusted–non–GAAP Income before Income Taxes (a) 2013 2014 Provision for Income Taxes (b) 2013 2014 Effective Income Tax Rate (b÷a) 2013 2014 $520 $547 $157 $144 30.2% 26.3% 33 2 $555 – – $547 – – $157 – – $144 28.3% 26.3% Net Debt to Adjusted EBITDA ratio (dollars in millions) Short-term debt Long-term debt Less: Cash and cash equivalents Short-term investments Total net debt (a) Net income attributable to Ingredion Add back: Impairment charge Acquisition costs Net income attributable to non-controlling interest Provision for income taxes Financing costs, net of interest income of $13 and $11, respectively Depreciation and amortization Adjusted EBITDA (b) Net Debt to Adjusted EBITDA ratio (a ÷ b) 2014 2013 $÷÷«23 1,804 (580) (34) $1,213 $÷«355 33 2 8 157 61 195 $÷«811 1.5 $÷÷«93 1,717 (574) – $1,236 $÷«396 – – 7 144 66 194 $÷«807 1.5 24 INGREDION INCORPORATED Net Debt to Capitalization Percentage (dollars in millions) Short-term debt Long-term debt Less: Cash and cash equivalents Short-term investments Total net debt (a) Deferred income tax liabilities Share-based payments subject to redemption Total equity Total capital Total net debt and capital (b) Net Debt to Capitalization percentage (a÷b) 2014 2013 $÷÷«23 1,804 (580) (34) $1,213 $÷«180 22 2,207 $2,409 $3,622 33.5% $÷÷«93 1,717 (574) – $1,236 $÷«207 24 2,429 $2,660 $3,896 31.7% Operating Working Capital as a Percentage of Net Sales (dollars in millions) 2014 2013 Current assets Less: Cash and cash equivalents Short-term investments Deferred income tax assets Adjusted current assets Current liabilities Less: Short-term debt Adjusted current liabilities Operating working capital (a) Net sales (b) Operating Working Capital as a  percentage of Net Sales (a÷b) $2,144 (580) (34) (48) $1,482 $÷«721 (23) $÷«698 $÷«784 $5,668 $2,214 (574) – (68) $1,572 $÷«820 (93) $÷«727 $÷«845 $6,328 13.8% 13.4% Commentary on Key Financial Performance Metrics: In accordance with our long-term objectives, we set certain goals relating to these key financial performance metrics that we strive to meet. At December 31, 2014, we had achieved our established targets. However, no assurance can be given that we will continue to meet our financial performance metric targets. See Item 1A “Risk Factors” and Item 7A “Quantitative and Qualitative Disclosures About Market Risk.” The objectives set out below reflect our current aspirations in light of our present plans and existing circumstances. We may change these objectives from time to time in the future to address new opportuni- ties or changing circumstances as appropriate to meet our long-term needs and those of our shareholders. ROCE Our long-term goal is to achieve a ROCE in excess of 10.0 per- cent. In determining this performance metric, the negative cumulative translation adjustment is added back to total equity to calculate returns based on the Company’s original investment costs. While our ROCE for 2014 declined to 10.6 percent from 11.3 percent in 2013, it still remains above our target of 10.0 percent. The decline in our ROCE for 2014 primarily reflects an increased beginning of the year capital employed base and a higher effective income tax rate. Net Debt to Adjusted EBITDA Ratio Our long-term objective is to maintain a ratio of net debt to adjusted EBITDA of less than 2.25. This ratio was 1.5 at December 31, 2014, consistent with the prior year. Net Debt to Capitalization Percentage Our long-term goal is to maintain a Net Debt to Capitalization percentage in the range of 32 to 35 percent. At December 31, 2014, our Net Debt to Capitalization per- centage was 33.5 percent, up from 31.7 percent a year ago, primarily reflecting a lower capital base driven by our share repurchases, dividends on our common stock and an increase in our accumulated other comprehensive loss driven principally by unfavorable foreign currency translation, which more than offset the impact of our 2014 net income. Operating Working Capital as a Percentage of Net Sales Our long-term goal is to maintain operating working capital in a range of 12 to 14 percent of our net sales. At December 31, 2014, the metric was 13.8 percent, up from the 13.4 percent of a year ago. The increase in the metric primarily reflects the impact of our lower net sales. Critical Accounting Policies and Estimates Our consolidated financial statements have been prepared in accor- dance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results may differ from these estimates under different assumptions and conditions. We have identified below the most critical accounting policies upon which the financial statements are based and that involve our most complex and subjective decisions and assessments. Our senior management has discussed the development, selection and disclosure of these policies with members of the Audit Committee of our Board of Directors. These accounting policies are provided in the notes to the consolidated financial statements. The discussion that follows should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. Long-lived Assets We have substantial investments in property, plant and equipment and definite-lived intangible assets. For property, plant and equipment, we recognize the cost of depreciable assets in operations over the estimated useful life of the assets and evaluate the recoverability of these assets whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. For definite-lived intangible assets, we recognize the cost of these amortizable assets in operations over their estimated 25 INGREDION INCORPORATED useful life and evaluate the recoverability of the assets whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. The carrying value of property, plant and equipment and definite-lived intangible assets at Decem- ber 31, 2014 was $2.1 billion and $158 million, respectively. In assessing the recoverability of the carrying value of property, plant and equipment and definite-lived intangible assets, we may have to make projections regarding future cash flows. In developing these projections, we make a variety of important assumptions and estimates that have a significant impact on our assessments of whether the carrying values of property, plant and equipment and definite-lived intangible assets should be adjusted to reflect impair- ment. Among these are assumptions and estimates about the future growth and profitability of the related business unit or asset group, anticipated future economic, regulatory and political conditions in the business unit’s or asset group’s market and estimates of terminal or disposal values. No impairment charges for property, plant and equipment or definite-lived intangible assets were recorded in 2014 or 2013. In 2012, we decided to restructure our business operations in Kenya and close our manufacturing plant in the country. As part of that decision, we recorded a $20 million restructuring charge, which included fixed asset impairment charges of $6 million to write down the carrying amount of certain assets to their estimated fair values. As part of our ongoing strategic optimization, in 2012 we decided to exit our investment in GFEMS, a non-wholly-owned consolidated subsidiary in China. In conjunction with that decision, we recorded a $4 million impairment charge to reduce the carrying value of GFEMS to its estimated net realizable value. We also recorded a $1 million charge for impaired assets in Colombia in 2012. In addition, as part of a manufacturing optimization program developed in conjunction with the acquisition of National Starch to improve profitability, we completed a plan in 2012 that optimized our production capabilities at certain of our North American facilities. As a result, we recorded restructuring charges to write-off certain equipment by the plan completion date. We recorded charges of $11 million in 2012, of which $10 million represented accelerated depreciation on the equipment.  Through our continual assessment to optimize our operations, we address whether there is a need for additional consolidation of manufacturing facilities or to redeploy assets to areas where we can expect to achieve a higher return on our investment. This review may result in the closing or selling of certain of our manufacturing facilities. The closing or selling of any of the facilities could have a significant negative impact on the results of operations in the year that the closing or selling of a facility occurs. Even though it was determined that there was no additional long-lived asset impairment as of December 31, 2014, the future occurrence of a potential indicator of impairment, such as a significant adverse change in the business climate that would require a change in our assumptions or strategic decisions made in response to economic or competitive conditions, could require us to perform tests of recoverabil- ity in the future. We continue to closely monitor certain assets in our South America business due to the continued sluggish economy there. Goodwill and Indefinite-Lived Intangible Assets Our methodology for allocating the purchase price of acquisitions is based on established valuation techniques that reflect the consideration of a number of factors, including valuations performed by third-party appraisers when appropriate. Goodwill is measured as the excess of the cost of an acquired entity over the fair value assigned to identifiable assets acquired and liabilities assumed. We have identified several reporting units for which cash flows are determinable and to which goodwill may be allocated. Goodwill is either assigned to a specific reporting unit or allocated between reporting units based on the relative excess fair value of each reporting unit. In addition, we have certain indefinite- lived intangible assets in the form of trade names and trademarks. The carrying value of goodwill and indefinite-lived intangible assets at December 31, 2014 was $478 million and $132 million, respectively. We perform our goodwill and indefinite-lived intangible asset impairment tests annually as of October 1, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. In testing goodwill for impairment, we first assesses qualitative factors in determining whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. After assessing the qualitative factors, if we determine that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount then we do not perform the two-step impairment test. If we conclude otherwise, then we perform the first step of the two-step impairment test as described in ASC Topic 350. In the first step, the fair value of the reporting unit is compared to its carrying value. If the fair value of the reporting unit exceeds the carrying value of its net assets, goodwill is not considered impaired and no further testing is required. If the carrying value of the net assets exceeds the fair value of the reporting unit, a second step of the impairment assessment is performed in order to determine the implied fair value of a reporting unit’s goodwill. In performing our impairment tests for goodwill, management makes certain estimates and judgments. These estimates and judgments include the identification of reporting units and the determination of fair values of reporting units, which management estimates using both discounted cash flow analyses and an analysis of market multiples. Significant assumptions used in the determination of fair value for reporting units include estimates for discount and long-term net sales growth rates, in addition to operating and capital expenditure requirements. We considered significant changes in discount rates for the reporting units based on current market interest rates and specific risk factors within each geographic region. 26 INGREDION INCORPORATEDWe also evaluated qualitative factors, such as legal, regulatory, or competitive forces, in estimating the impact to the fair value of the reporting units noting no significant changes that would result in any reporting unit failing the impairment test. Changes in assumptions concerning projected results or other underlying assumptions could have a significant impact on the fair value of the reporting units in the future. The results of our impairment testing in the fourth quarter of 2014 indicated that the estimated fair value of our Southern Cone of South America reporting unit was less than its carrying amount primarily due to the impacts on its fair value of the elongation of unfavorable financial trends, such as the impact of higher production costs and our inability to increase selling prices to a level sufficient to recover the impacts of inflation and currency devaluation. Also, the political and economic volatility in the region and continued uncertainty in Argentina negatively impacted our earnings forecasts in the near term. Therefore, we recorded a non-cash impairment charge of $33 million to write-off the remaining balance of goodwill for this reporting unit. Additionally, based on the results of the annual assessment, we concluded that as of October 1, 2014, it was more likely than not that the fair value of all other reporting units was greater than their carrying value (although the $32 million of goodwill at our Brazil reporting unit continues to be closely monitored due to recent trends experienced in this reporting unit, such as continued economic headwinds and heightened competition). In performing the qualitative annual impairment assessment for other indefinite-lived intangible assets, we considered various factors in determining if it was more likely than not that the fair value of these indefinite-lived intangible assets was greater than their carrying value. We evaluated net sales attributable to these intangible assets as compared to original projections and evaluated future projections of net sales related to these assets. In addition, we considered market and industry conditions in the reporting units in which these intangible assets reside noting no significant changes that would result in a failed Step One impairment test as described in ASC Topic 350. Based on the results of this qualitative assessment as of October 1, 2014, we concluded that it was more likely than not that the fair value of these indefinite-lived intangible assets was greater than their carrying value. Income Taxes We recognize the expected future tax consequences of temporary differences between book and tax bases of assets and liabilities and provide a valuation allowance when deferred tax assets are not more likely than not to be realized. We have considered forecasted earnings, future taxable income, the mix of earnings in the jurisdictions in which we operate and prudent and feasible tax planning strategies in determining the need for a valuation allowance. In the event we were to determine that we would not be able to realize all or part of our deferred tax assets in the future, we would increase the valuation allowance and make a corresponding charge to earnings in the period in which we make such determination. Likewise, if we later determine that we are more likely than not to realize the deferred tax assets, we would reverse the applicable portion of the previously provided valuation allowance. We had a valuation allowance of $3 million at both December 31, 2014 and 2013. We are regularly audited by various taxing authorities, and sometimes these audits result in proposed assessments where the ultimate resolution may result in us owing additional taxes. We establish reserves when, despite our belief that our tax return positions are appropriate and supportable under local tax law, we believe there is uncertainty with respect to certain positions and we may not succeed in realizing the tax benefit. We evaluate these unrecognized tax benefits and related reserves each quarter and adjust the reserves and the related interest and penalties in light of changing facts and circum- stances regarding the probability of realizing tax benefits, such as the settlement of a tax audit or the expiration of a statute of limitations. We believe the estimates and assumptions used to support our evaluation of tax benefit realization are reasonable. However, final determinations of prior-year tax liabilities, either by settlement with tax authorities or expiration of statutes of limitations, could be materially different than estimates reflected in assets and liabilities and historical income tax provisions. The outcome of these final determinations could have a material effect on our income tax provision, net income, or cash flows in the period in which that determination is made. We believe our tax positions comply with applicable tax law and that we have adequately provided for any known tax contingencies. Our liability for unrecog- nized tax benefits, excluding interest and penalties at December 31, 2014 and 2013 was $23 million and $34 million, respectively. No taxes have been provided on approximately $2.172 billion of undistributed foreign earnings that are planned to be indefinitely reinvested. If future events, including changes in tax law, material changes in estimates of cash, working capital and long-term invest- ment requirements, necessitate that these earnings be distributed, an additional provision for income and withholding taxes may apply, which could materially affect our future effective tax rate. Retirement Benefits We sponsor non-contributory defined benefit plans covering substantially all employees in the United States and Canada, and certain employees in other foreign countries. We also provide healthcare and life insurance benefits for retired employees in the United States, Canada and Brazil. In order to measure the expense and obligations associated with these benefits, our manage- ment must make a variety of estimates and assumptions including discount rates, expected long-term rates of return, rate of compensa- tion increases, employee turnover rates, retirement rates, mortality rates and other factors. We review our actuarial assumptions on an annual basis as of December 31 (or more frequently if a significant event requiring remeasurement occurs) and modify our assumptions based on current rates and trends when it is appropriate to do so. The effects of modifications are recognized immediately on the balance 27 INGREDION INCORPORATEDsheet, but are generally amortized into operating earnings over future periods, with the deferred amount recorded in accumulated other comprehensive income. We believe the assumptions utilized in recording our obligations under our plans, which are based on our experience, market conditions, and input from our actuaries, are reasonable. We use third-party specialists to assist management in evaluating our assumptions and estimates, as well as to appropriately measure the costs and obligations associated with our retirement benefit plans. Had we used different estimates and assumptions with respect to these plans, our retirement benefit obligations and related expense could vary from the actual amounts recorded, and such differences could be material. Additionally, adverse changes in investment returns earned on pension assets and discount rates used to calculate pension and postretirement benefit related liabilities or changes in required funding levels may have an unfavorable impact on future expense and cash flow. Net periodic pension and postretirement benefit cost for all of our plans was $16 million in 2014 and $25 million in 2013. We determine our assumption for the discount rate used to measure year-end pension and postretirement obligations based on high-quality fixed-income investments that match the duration of the expected benefit payments, which has been benchmarked using a long-term, high-quality AA corporate bond index. The weighted average discount rate used to determine our obligations under US pension plans for December 31, 2014 and 2013 was 4.00 percent and 4.60 percent, respectively. The weighted average discount rate used to determine our obligations under non-US pension plans for December 31, 2014 and 2013 was 4.47 percent and 5.60 percent, respectively. The weighted average discount rate used to determine our obligations under our postretirement plans for December 31, 2014 and 2013 was 5.70 percent and 6.47 percent, respectively. A one-percentage point decrease in the discount rates at Decem- ber 31, 2014 would have increased the accumulated benefit obligation and projected benefit obligation by the following amounts: In millions US Pension Plans Accumulated benefit obligation Projected benefit obligation Non-US Pension Plans Accumulated benefit obligation Projected benefit obligation Postretirement Plans Accumulated benefit obligation $36 $34 $40 $32 $÷6 The Company’s investment policy for its pension plans is to balance risk and return through diversified portfolios of passively-managed equity index instruments, fixed income index securities, and short- term investments. Maturities for fixed income securities are managed such that sufficient liquidity exists to meet near-term benefit payment obligations. The asset allocation is reviewed regularly and portfolio investments are rebalanced to the targeted allocation when considered appropriate. For 2014, we have assumed an expected long-term rate of return on assets, which is based on the fair value of plan assets, of 7.25 percent for US plans and 6.45 percent for Canadian plans. In developing the expected long-term rate of return assumption on plan assets, which consist mainly of US and Canadian equity and debt securities, management evaluated historical rates of return achieved on plan assets and the asset allocation of the plans, input from our independent actuaries and investment consultants, and historical trends in long-term inflation rates. Projected return estimates made by such consultants are based upon broad equity and bond indices. We also maintain several funded pension plans in other international locations. The expected returns on plan assets are determined based on each plan’s investment approach and asset allocations. A hypotheti- cal 25 basis point decrease in the expected long-term rate of return assumption for 2015 would increase net periodic pension cost for the US and Canada plans by less than $1 million each. Healthcare cost trend rates are used in valuing our postretirement benefit obligations and are established based upon actual health care cost trends and consultation with actuaries and benefit providers. At December 31, 2014, the health care cost trend rate assumptions for the next year for the US, Canada and Brazil plans were 6.70 percent, 7.05 percent and 8.66 percent, respectively. The sensitivities of service cost and interest cost and year-end benefit obligations to changes in healthcare cost trend rates (both initial and ultimate rates) for the postretirement benefit plans as of December 31, 2014 are as follows: One-percentage point increase in trend rates: Increase in service cost and interest cost components Increase in year-end benefit obligations One-percentage point decrease in trend rates: Decrease in service cost and interest cost components Decrease in year-end benefit obligations 2014 $1 million $4 million $1 million $3 million See Note 9 of the notes to the consolidated financial statements for more information related to our benefit plans. New Accounting Standards In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) that introduces a new five-step revenue recognition model in which an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. 28 INGREDION INCORPORATEDThis ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recog- nized from the costs to obtain or fulfill a contract. This standard is effective for fiscal years beginning after December 15, 2016, including interim periods within that reporting period. The standard will allow various transition approaches upon adoption. We are assessing the impacts of this new standard; however the adoption of the guidance in this Update is not expected to have a material impact on our Consolidated Financial Statements. Forward-Looking Statements This Form 10-K contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends these forward-looking statements to be covered by the safe harbor provisions for such statements. Forward-looking statements include, among other things, any statements regarding the Company’s prospects or future financial condition, earnings, revenues, tax rates, capital expenditures, expenses or other financial items, any statements concerning the Company’s prospects or future operations, including management’s plans or strategies and objectives therefor and any assumptions, expectations or beliefs underlying the foregoing. These statements can sometimes be identified by the use of forward looking words such as “may,” “will,” “should,” “anticipate,” “assume”, “believe,” “plan,” “project,” “estimate,” “expect,” “intend,” “continue,” “pro forma,” “forecast,” “outlook” or other similar expressions or the negative thereof. All statements other than statements of historical facts in this report or referred to in or incorporated by reference into this report are “forward-looking statements.” These statements are based on current circumstances or expecta- tions, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and are beyond our control. Although we believe our expectations reflected in these forward-looking state- ments are based on reasonable assumptions, stockholders are cautioned that no assurance can be given that our expectations will prove correct. Actual results and developments may differ materially from the expectations expressed in or implied by these statements, based on various factors, including the effects of global economic conditions, including, particularly, continuation or worsening of the current economic, currency and political conditions in South America and economic conditions in Europe, and their impact on our sales volumes and pricing of our products, our ability to collect our receivables from customers and our ability to raise funds at reasonable rates; fluctua- tions in worldwide markets for corn and other commodities, and the associated risks of hedging against such fluctuations; fluctuations in the markets and prices for our co-products, particularly corn oil; fluctuations in aggregate industry supply and market demand; the behavior of financial markets, including foreign currency fluctuations and fluctuations in interest and exchange rates; volatility and turmoil in the capital markets; the commercial and consumer credit environ- ment; general political, economic, business, market and weather conditions in the various geographic regions and countries in which we buy our raw materials or manufacture or sell our products; future financial performance of major industries which we serve, including, without limitation, the food and beverage, pharmaceuticals, paper, corrugated, textile and brewing industries; energy costs and availabil- ity, freight and shipping costs, and changes in regulatory controls regarding quotas, tariffs, duties, taxes and income tax rates; operating difficulties; availability of raw materials, including tapioca and the specific varieties of corn upon which our products are based; energy issues in Pakistan; boiler reliability; our ability to effectively integrate and operate acquired businesses; our ability to achieve budgets and to realize expected synergies; our ability to complete planned maintenance and investment projects successfully and on budget; labor disputes; genetic and biotechnology issues; changing consump- tion preferences including those relating to high fructose corn syrup; increased competitive and/or customer pressure in the starch processing industry; and the outbreak or continuation of serious communicable disease or hostilities including acts of terrorism. Factors relating to the pending acquisition of Penford Corporation that could cause actual results and developments to differ from expectations include: required regulatory approvals may not be obtained in a timely manner, if at all; the pending acquisition may not be consummated in a timely manner or at all; the anticipated benefits of the pending acquisition, including synergies, may not be realized; and the integration of Penford’s operations with those of Ingredion may be materially delayed or may be more costly or difficult than expected. Our forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see Item 1A-Risk Factors above and subsequent reports on Forms 10-Q or 8-K. 29 INGREDION INCORPORATEDItem 7A. Quantitative and Qualitative Disclosures About Market Risk Interest Rate Exposure We are exposed to interest rate risk on our variable-rate debt and price risk on our fixed-rate debt. As of Decem- ber 31, 2014, approximately 36 percent or $650 million of our borrowings are fixed rate debt and 64 percent or approximately $1.16 billion of our debt is subject to changes in short-term rates, which could affect our interest costs. We assess market risk based on changes in interest rates utilizing a sensitivity analysis that measures the potential change in earnings, fair values and cash flows based on a hypothetical 1 percent- age point change in interest rates at December 31, 2014. A hypothetical increase of 1 percentage point in the weighted average floating interest rate would increase our annual interest expense by approximately $12 million. See Note 6 of the notes to the consolidated financial statements entitled “Financing Arrangements” for further information. At December 31, 2014 and 2013, the carrying and fair values of long-term debt were as follows: (in millions) 4.625% senior notes, due November 1, 2020 3.2% senior notes, due November 1, 2015 1.8% senior notes, due September 25, 2017 6.625% senior notes, due April 15, 2037 6.0% senior notes, due April 15, 2017 5.62% senior notes, due March 25, 2020 U.S. revolving credit facility due October 22, 2017 Fair value adjustment related to hedged fixed rate debt instrument Total long-term debt Carrying Amount 2014 Fair Value Carrying Amount 2013 Fair Value $÷«399 $÷«427 $÷«399 $÷«420 350 299 256 200 200 87 356 302 312 220 222 87 350 298 257 200 200 – 363 296 281 219 221 – 13 $1,804 13 $1,939 13 $1,717 13 $1,813 A hypothetical change of 1 percentage point in interest rates would change the fair value of our fixed rate debt at December 31, 2014 by approximately $87 million. Since we have no current plans to repurchase our outstanding fixed-rate instruments before their maturities, the impact of market interest rate fluctuations on our long-term debt is not expected to have a significant effect on our consolidated financial statements. In September 2014, we entered into interest rate swap agreements that effectively convert the interest rates on our 6.0 percent $200 mil- lion senior notes due April 15, 2017, our 1.8 percent $300 million senior notes due September 25, 2017 and on $200 million of our $400 million 4.625 percent senior notes due November 1, 2020, to variable rates. Additionally, we have interest rate swap agreements that effectively convert the interest rate on our 3.2 percent $350 million senior notes due November 1, 2015 to a variable rate. These swap agreements call for us to receive interest at the fixed coupon rate of the respective notes and to pay interest at a variable rate based on the six-month US dollar LIBOR rate plus a spread. We have designated these interest rate swap agreements as hedges of the changes in fair value of the underlying debt obligations attributable to changes in interest rates and account for them as fair-value hedges. The fair value of these interest rate swap agreements approximated $13 million at Decem- ber 31, 2014 and is reflected in the Consolidated Balance Sheets within other assets, with an offsetting amount recorded in long-term debt to adjust the carrying amount of the hedged debt obligations. Raw Material and Energy Costs Our finished products are made primarily from corn. In North America, we sell a large portion of finished products at firm prices established in supply contracts typically lasting for periods of up to one year. In order to minimize the effect of volatility in the cost of corn related to these firm-priced supply contracts, we enter into corn futures contracts or take other hedging positions in the corn futures market. These contracts typically mature within one year. At expiration, we settle the derivative contracts at a net amount equal to the difference between the then-current price of corn and the futures contract price. While these hedging instruments are subject to fluctuations in value, changes in the value of the underlying exposures we are hedging generally offset such fluctuations. While the corn futures contracts or other hedging positions are intended to minimize the volatility of corn costs on operating profits, occasionally the hedging activity can result in losses, some of which may be material. Outside of North America, sales of finished products under long-term, firm-priced supply contracts are not material. Energy costs represent approximately 11 percent of our operating costs. The primary use of energy is to create steam in the production process and to dry product. We consume coal, natural gas, electricity, wood and fuel oil to generate energy. The market prices for these commodities vary depending on supply and demand, world economies and other factors. We purchase these commodities based on our anticipated usage and the future outlook for these costs. We cannot assure that we will be able to purchase these commodities at prices that we can adequately pass on to customers to sustain or increase profitability. We use derivative financial instruments, such as over-the- counter natural gas swaps, to hedge portions of our natural gas costs generally over the following twelve to twenty-four months, primarily in our North American operations. At December 31, 2014, we had outstanding futures and option contracts that hedged approximately 93 million bushels of forecasted corn purchases and 4 million pounds of soybean oil. We are unable to directly hedge price risk related to co-product sales; however, we occasionally enter into hedges of soybean oil (a competing product to corn oil) in order to mitigate the price risk of corn oil sales. Also at December 31, 2014, we had outstanding swap and option contracts that hedged approximately 14 million mmbtu’s of forecasted natural gas purchases. Based on our overall commodity hedge position at December 31, 2014, a hypothetical 10 percent decline in market prices 30 INGREDION INCORPORATEDapplied to the fair value of the instruments would result in a charge to other comprehensive income of approximately $28 million, net of income tax benefit. It should be noted that any change in the fair value of the contracts, real or hypothetical, would be substantially offset by an inverse change in the value of the underlying hedged item. Foreign Currencies Due to our global operations, we are exposed to fluctuations in foreign currency exchange rates. As a result, we have exposure to translational foreign exchange risk when our foreign operation results are translated to USD and to transactional foreign exchange risk when transactions not denominated in the functional currency of the operating unit are revalued. We have significant operations in Argentina. We utilize the official exchange rate published by the Argentine government for re-measurement purposes. Due to exchange controls put in place by the Argentine government, a parallel market exists for exchanging Argentine pesos to US dollars at rates less favorable than the official rate. Argentina and other emerging markets experienced increased devaluation and volatility in 2014 and we anticipate that this trend will continue in 2015. We selectively use derivative instruments such as forward contracts, currency swaps and options to manage transactional foreign exchange risk. Based on our overall foreign currency transactional exposure at December 31, 2014, we estimate that a hypothetical 10 percent decline in the value of the USD would have resulted in a transactional foreign exchange gain of less than $1 million. At December 31, 2014, our accumulated other comprehensive loss account included in the equity section of our consolidated balance sheet includes a cumulative translation loss of $701 million. The aggregate net assets of our foreign subsidiaries where the local currency is the functional currency approximated $1.6 billion at December 31, 2014. A hypothetical 10 percent decline in the value of the USD relative to foreign currencies would have resulted in a reduction to our cumulative translation loss and a credit to other comprehensive income of approximately $181 million. 31 INGREDION INCORPORATEDItem 8. Financial Statements and Supplementary Data Report of Independent Registered Public Accounting Firm The Board of Directors and Stockholders Ingredion Incorporated: We have audited the accompanying consolidated balance sheets of Ingredion Incorporated and subsidiaries (the Company) as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, equity and redeemable equity, and cash flows for each of the years in the three-year period ended December 31, 2014. We also have audited the Company’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, includ- ed in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on these consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the consolidated financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the mainte- nance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Ingredion Incorporated and subsidiaries as of December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework (1992) issued by the Committee of Sponsoring Organiza- tions of the Treadway Commission (COSO). /s/ KPMG LLP Chicago, Illinois February 20, 2015 32 INGREDION INCORPORATEDConsolidated Statements of Income (in millions, except per share amounts) Net sales before shipping and handling costs Less – shipping and handling costs Net sales Cost of sales Gross profit Selling, general and administrative expenses Other (income) – net Impairment/restructuring charges Operating income Financing costs – net Income before income taxes Provision for income taxes Net income Less – Net income attributable to non-controlling interests Net income attributable to Ingredion Weighted average common shares outstanding: Basic Diluted Earnings per common share of Ingredion: Basic Diluted See notes to the consolidated financial statements. Years Ended December 31, 2014 $5,998 330 5,668 4,553 1,115 525 (24) 33 534 581 61 520 157 363 8 $÷«355 73.6 74.9 $÷4.82 4.74 2013 $6,653 325 6,328 5,197 1,131 534 (16) – 518 613 66 547 144 403 7 $÷«396 77.0 78.3 $÷5.14 5.05 2012 $6,868 336 6,532 5,294 1,238 556 (22) 36 570 668 67 601 167 434 6 $÷«428 76.5 78.2 $÷5.59 5.47 33 INGREDION INCORPORATEDConsolidated Statements of Comprehensive Income (in millions) Years ended December 31, Net income Other comprehensive income: Gains (losses) on cash-flow hedges, net of income tax effect of $12, $29 and $25, respectively Reclassification adjustment for losses (gains) on cash-flow hedges included in net income, net of income tax effect of $23, $19 and $15, respectively Actuarial gains (losses) on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect of $5, $32 and $27, respectively Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax effect of $1, $3 and $2, respectively Unrealized gain on investment, net of income tax effect Currency translation adjustment Comprehensive income Less: Comprehensive income attributable to non-controlling interests Comprehensive income attributable to Ingredion See notes to the consolidated financial statements. 2014 $«363 (29) 50 (12) 4 – (212) $«164 8 $«156 2013 $«403 (64) 41 63 5 1 (154) $«295 7 $«288 2012 $434 43 (25) (56) 5 – (29) $372 6 $366 34 INGREDION INCORPORATEDConsolidated Balance Sheets (in millions, except share and per share amounts) As of December 31, 2014 2013 Assets Current assets Cash and cash equivalents Short-term investments Accounts receivable – net Inventories Prepaid expenses Deferred income tax assets Total current assets Property, plant and equipment, at cost Land Buildings Machinery and equipment Less: accumulated depreciation Goodwill Other intangible assets (less accumulated amortization of $62 and $49, respectively) Deferred income tax assets Investments Other assets Total assets Liabilities and equity Current liabilities Short-term borrowings Accounts payable Accrued liabilities Total current liabilities Non-current liabilities Long-term debt Deferred income taxes Share-based payments subject to redemption Ingredion stockholders’ equity Preferred stock – authorized 25,000,000 shares – $0.01 par value, none issued Common stock – authorized 200,000,000 shares – $0.01 par value, 77,810,875 and 77,672,670 issued at December 31, 2014 and 2013, respectively Additional paid-in capital Less – Treasury stock (common stock: 6,488,605 and 3,361,180 shares at December 31, 2014 and 2013, respectively) at cost Accumulated other comprehensive loss Retained earnings Total Ingredion stockholders’ equity Non-controlling interests Total equity Total liabilities and equity See notes to the consolidated financial statements. $÷÷580 34 762 699 21 48 2,144 170 695 4,021 4,886 (2,813) 2,073 478 290 4 5 97 $«5,091 $23 430 268 721 157 1,804 180 22 – 1 1,164 (481) (782) 2,275 $÷÷574 – 832 723 17 68 2,214 173 696 4,063 4,932 (2,776) 2,156 535 311 15 11 118 $«5,360 $93 458 269 820 163 1,717 207 24 – 1 1,166 (225) (583) 2,045 2,177 30 2,207 $«5,091 2,404 25 2,429 $«5,360 35 INGREDION INCORPORATEDConsolidated Statements of Equity and Redeemable Equity Common Stock $1 Additional Paid-In Capital $1,146 Treasury Stock $÷(42) Equity Accumulated Other Comprehensive Income (Loss) $(413) Retained Earnings $1,412 Non- Controlling Interests $29 Share-based Payments Subject to Redemption $15 (18) 47 7 (13) 7 (3) 11 428 (71) 43 (25) (29) (56) 5 $1 $1,148 $÷÷(6) $(475) $1,769 396 (120) (228) 6 3 8 6 (1) 5 $1 $1,166 $(225) (3) (17) 7 5 6 (301) 37 8 $1 $1,164 $(481) (64) 41 (154) 63 5 1 $(583) (29) 50 (212) (12) 4 $(782) 6 (4) (7) (2) $22 7 (4) 4 $19 5 $2,045 $25 $24 355 (125) 8 (3) (2) $2,275 $30 $22 (in millions) Balance, December 31, 2011 Net income attributable to Ingredion Net income attributable to non-controlling interests Dividends declared Gains on cash-flow hedges, net of income tax effect of $25 Amount of gains on cash-flow hedges reclassified to earnings, net of income tax effect of $15 Repurchases of common stock Issuance of common stock on exercise of stock options Stock option expense Other share-based compensation Excess tax benefit on share-based compensation Currency translation adjustment Sale of non-controlling interests Actuarial losses on pension and postretirement obligations, settlements and plan amendments, net of income tax effect of $27 Losses on pension and postretirement obligations reclassified to earnings, net of income tax effect of $2 Other Balance, December 31, 2012 Net income attributable to Ingredion Net income attributable to non-controlling interests Dividends declared Losses on cash-flow hedges, net of income tax effect of $29 Amount of losses on cash-flow hedges reclassified to earnings, net of income tax effect of $19 Repurchases of common stock Issuance of common stock on exercise of stock options Stock option expense Other share-based compensation Excess tax benefit on share-based compensation Currency translation adjustment Actuarial gains on pension and postretirement obligations, settlements and plan amendments, net of income tax effect of $32 Losses on pension and postretirement obligations reclassified to earnings, net of income tax effect of $3 Unrealized gain on investment, net of income tax effect Balance, December 31, 2013 Net income attributable to Ingredion Net income attributable to non-controlling interests Dividends declared Losses on cash-flow hedges, net of income tax effect of $12 Amount of losses on cash-flow hedges reclassified to earnings, net of income tax effect of $23 Repurchases of common stock Issuance of common stock on exercise of stock options Stock option expense Other share-based compensation Excess tax benefit on share-based compensation Currency translation adjustment Actuarial losses on pension and postretirement obligations, settlements and plan amendments, net of income tax effect of $5 Losses on pension and postretirement obligations reclassified to earnings, net of income tax effect of $1 Balance, December 31, 2014 See notes to the consolidated financial statements 36 INGREDION INCORPORATEDConsolidated Statements of Cash Flows (in millions) Years ended December 31, Cash provided by operating activities: Net income Non-cash charges (credits) to net income: Depreciation and amortization Deferred income taxes Write-off of impaired assets Other Changes in working capital: Accounts receivable and prepaid expenses Inventories Accounts payable and accrued liabilities Decrease in margin accounts Other Cash provided by operating activities Cash used for investing activities: Capital expenditures Short-term investments Proceeds from disposal of plants and properties Proceeds from sale of investment Other Cash used for investing activities Cash used for financing activities: Payments on debt Proceeds from borrowings Debt issuance costs Dividends paid (including to non-controlling interests) Repurchases of common stock Issuance of common stock Excess tax benefit on share-based compensation Cash used for financing activities Effects of foreign exchange rate changes on cash Increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period See notes to the consolidated financial statements. 2014 $«363 195 (11) 33 68 (15) (6) 66 39 (1) 731 (276) (34) 5 11 – (294) (213) 231 – (128) (304) 20 6 (388) (43) 6 574 $«580 2013 $«403 194 30 – 74 (69) 76 (78) 14 (25) 619 (298) 19 3 – 2 (274) (53) 21 – (112) (228) 14 5 (353) (27) (35) 609 $«574 2012 $«434 211 (3) 24 55 22 (69) 80 – (22) 732 (313) (18) 9 – – (322) (462) 312 (5) (69) (18) 34 11 (197) (5) 208 401 $«609 37 INGREDION INCORPORATEDNotes to the Consolidated Financial Statements Note 1. Description of the Business Ingredion Incorporated (“the Company”) was founded in 1906 and became an independent and public company as of December 31, 1997. The Company manufactures and sells starches and sweeteners derived from the wet milling and processing of corn and other starch-based materials to a wide range of industries, both domestically and internationally. Note 2. Summary of Significant Accounting Policies Basis of Presentation The consolidated financial statements consist of the accounts of the Company, including all significant subsidiaries. Intercompany accounts and transactions are eliminated in consolidation. The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the value of purchase consideration, valuation of accounts receivable, inventories, goodwill, intangible assets and other long-lived assets, legal contingencies, guarantee obligations, and assumptions used in the calculation of income taxes, and pension and other postretirement benefits, among others. These estimates and assump- tions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. Management will adjust such estimates and assumptions when facts and circumstances dictate. Foreign currency devaluations, corn price volatility, access to difficult credit markets and adverse changes in the global economic environ- ment have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates will be reflected in the financial statements in future periods. A new line item entitled “other” was established within the non-cash charges (credits) to net income portion of the operating section of the Consolidated Statements of Cash Flows. Prior year amounts have been reclassified to conform to the current year’s presentation. These reclassifications had no effect on previously reported total cash provided by operating activities. Assets and liabilities of foreign subsidiaries, other than those whose functional currency is the US dollar, are translated at current exchange rates with the related translation adjustments reported in equity as a component of accumulated other comprehensive income (loss). The US dollar is the functional currency for the Company’s Mexico subsidiary. Income statement accounts are translated at the average exchange rate during the period. For foreign subsidiaries where the US dollar is the functional currency, monetary assets and liabilities are translated at current exchange rates with the related adjustment included in net income. Non-monetary assets and liabilities are translated at historical exchange rates. Although the Company hedges the predominance of its transactional foreign exchange risk (see Note 5), the Company incurs foreign currency transaction gains/losses relating to assets and liabilities that are denominated in a currency other than the functional currency. For 2014, 2013 and 2012, the Company incurred foreign currency transaction losses of $1 million, $3 million and less than $1 million, respectively. The Company’s accumulated other comprehensive loss included in equity on the Consolidated Balance Sheets includes cumulative translation loss adjustments of $701 million and $489 million at December 31, 2014 and 2013, respectively. Cash and Cash Equivalents Cash equivalents consist of all instruments purchased with an original maturity of three months or less, and which have virtually no risk of loss in value. Inventories Inventories are stated at the lower of cost or net realizable value. Costs are determined using the weighted average method. Investments Investments in the common stock of affiliated companies over which the Company does not exercise significant influence are accounted for under the cost method. In 2014, the Company sold an investment that it had accounted for under the cost method. The Company received $11 million in cash and recorded a pre-tax gain of $5 million from the sale. The Company no longer has any investments accounted for under the cost method at December 31, 2014. The carrying value of the investment was $6 million at December 31, 2013. Investments that enable the Company to exercise significant influence, but do not represent a controlling interest, are accounted for under the equity method; such investments are carried at cost, adjusted to reflect the Company’s proportionate share of income or loss, less dividends received. The Company did not have any investments accounted for under the equity method at December 31, 2014 or 2013. The Company also has equity interests in the CME Group Inc., which it classifies as 38 INGREDION INCORPORATEDavailable for sale securities. The investment is carried at fair value with unrealized gains and losses recorded to other comprehensive income. The Company would recognize a loss on its investments when there is a loss in value of an investment that is other than temporary. Property, Plant and Equipment and Depreciation Property, plant and equipment (“PP&E”) are stated at cost less accumulated depreciation. Depreciation is generally computed on the straight-line method over the estimated useful lives of depreciable assets, which range from 10 to 50 years for buildings and from 3 to 20 years for all other assets. Where permitted by law, accelerated depreciation methods are used for tax purposes. The Company reviews the recoverability of the net book value of property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable from estimated future cash flows expected to result from its use and eventual disposition. If this review indicates that the carrying values will not be recovered, the carrying values would be reduced to fair value and an impairment loss would be recognized. As required under accounting principles generally accepted in the United States, the impairment analysis for long-lived assets occurs before the goodwill impairment assessment described below. Goodwill and Other Intangible Assets Goodwill ($478 million and $535 million at December 31, 2014 and 2013, respectively) represents the excess of the cost of an acquired entity over the fair value assigned to identifiable assets acquired and liabilities assumed. The Company also has other intangible assets aggregating $290 million and $311 mil- lion at December 31, 2014 and 2013, respectively. The carrying amount of goodwill by geographic segment at December 31, 2014 and 2013 was as follows: (in millions) Balance at December 31, 2011 Impairment charges Currency translation Balance at December 31, 2012 Currency translation Balance at December 31, 2013 Impairment charges Currency translation Balance at December 31, 2014 Goodwill before impairment charges Accumulated impairment charges Balance at December 31, 2013 Goodwill before impairment charges Accumulated impairment charges Balance at December 31, 2014 North America South America Asia Pacific EMEA Total $278 – – $278 – $278 – – $278 $279 (1) $278 $279 (1) $278 $101 – (6) $÷95 (17) $÷78 (33) (13) $÷32 $÷78 – $÷78 $÷65 (33) $÷32 $«106 (2) – $«104 (7) $÷«97 – (4) $93 $«218 (121) $97 $«214 (121) $÷«93 $77 – 3 $80 2 $82 – (7) $75 $82 – $82 $75 – $75 $«562 (2) (3) $«557 (22) $«535 (33) (24) $«478 $«657 (122) $«535 $«633 (155) $«478 The following table summarizes the Company’s other intangible assets for the periods presented: As of December 31, 2014 As of December 31, 2013 (in millions) Trademarks/tradenames Customer relationships Technology Other Total other intangible assets Gross $132 132 83 5 $352 Accumulated Amortization Weighted Average Useful Life (years) Net $÷«– (23) (35) (4) $(62) $132 109 48 1 $290 – 25 10 8 19 Gross $132 139 83 6 $360 Accumulated Amortization $÷«– (18) (27) (4) $(49) Weighted Average Useful Life (years) – 25 10 8 19 Net $132 121 56 2 $311 39 INGREDION INCORPORATEDFor definite-lived intangible assets, the Company recognizes the cost of such amortizable assets in operations over their estimated useful lives and evaluates the recoverability of the assets whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Amortization expense related to intangible assets was $14 million for each of the years ended December 31, 2014, 2013 and 2012. Based on acquisitions completed through December 31, 2014, the Company expects intangible asset amortization expense for future years to be approximately $14 million annually through 2019. The Company assesses goodwill and other indefinite-lived intangible assets for impairment annually (or more frequently if impairment indicators arise). The Company has chosen to perform this annual impairment assessment as of October 1 of each year. The Company has completed the required impairment assessments and determined that it was necessary to record an impairment charge to write-off the goodwill at its Southern Cone of South America reporting unit in the fourth quarter of 2014 (see below). In testing goodwill for impairment, the Company first assesses qualitative factors in determining whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. After assessing the qualitative factors, if the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount then the Company does not perform the two-step impairment test. If the Company concludes otherwise, then it performs the first step of the two-step impairment test as described in ASC Topic 350. In the first step, the fair value of the reporting unit is compared to its carrying value. If the fair value of the reporting unit exceeds the carrying value of its net assets, goodwill is not considered impaired and no further testing is required. If the carrying value of the net assets exceeds the fair value of the reporting unit, a second step of the impairment assessment is performed in order to determine the implied fair value of a reporting unit’s goodwill. Determining the implied fair value of goodwill requires a valuation of the reporting unit’s tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the carrying value of the reporting unit’s goodwill exceeds the implied fair value of its goodwill, goodwill is deemed impaired and is written down to the extent of the difference. The results of the Company’s impair- ment testing in the fourth quarter of 2014 indicated that the estimated fair value of the Company’s Southern Cone of South America reporting unit was less than its carrying amount primarily due to the impacts on its fair value of the elongation of unfavorable financial trends, such as the impact of higher production costs and the Company’s inability to increase selling prices to a level sufficient to recover the impacts of inflation and currency devaluation. Also, the political and economic volatility in the region and continued uncertainty in Argentina negatively impacted earnings forecasts for the reporting unit in the near term. Therefore, the Company recorded a non-cash impairment charge of $33 million to write-off the remaining balance of goodwill for this reporting unit. Additionally, based on the results of the annual assessment, the Company concluded that as of October 1, 2014, it was more likely than not that the fair value of all other reporting units was greater than their carrying value (although the $32 million of goodwill at the Brazil reporting unit continues to be closely monitored due to recent trends experienced in this reporting unit). In testing indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is impaired. After assessing the qualitative factors, if the Company determines that it is not more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount, then it would not be required to compute the fair value of the indefinite-lived intangible asset. In the event the qualitative assessment leads the Company to conclude otherwise, then it would be required to determine the fair value of the indefinite-lived intangible asset and perform the quantitative impairment test in accordance with ASC subtopic 350-30. In performing the qualitative analysis, the Company considers various factors including net sales derived from these intangibles and certain market and industry conditions. Based on the results of this qualitative assessment, the Company concluded that as of October 1, 2014, it was more likely than not that the fair value of the indefinite-lived intangible assets was greater than their carrying value. Revenue Recognition The Company recognizes operating revenues at the time title to the goods and all risks of ownership transfer to the customer. This transfer is considered complete when a sales agreement is in place, delivery has occurred, pricing is fixed or determinable and collection is reasonably assured. In the case of consigned inventories, the title passes and the transfer of ownership risk occurs when the goods are used by the customer. Taxes assessed by governmental authorities and collected from customers are accounted for on a net basis and excluded from revenues. Hedging Instruments The Company uses derivative financial instru- ments principally to offset exposure to market risks arising from changes in commodity prices, foreign currency exchange rates and interest rates. Derivative financial instruments used by the Company consist of commodity futures and option contracts, forward currency contracts and options, interest rate swap agreements and treasury lock agreements. The Company enters into futures and option contracts, which are designated as hedges of specific volumes of commodities (primarily corn and natural gas) that will be purchased in a future month. These derivative financial instruments are recognized in the Consolidated Balance Sheets at fair value. The Company has also entered into interest rate swap agreements that effectively convert the interest rate on certain fixed rate debt to a variable interest rate and, on certain variable rate debt, to a fixed interest rate. The Company 40 INGREDION INCORPORATEDperiodically enters into treasury lock agreements to lock the bench- mark rate for an anticipated fixed-rate borrowing. See also Note 5 and Note 6 of the notes to the consolidated financial statements for additional information. On the date a derivative contract is entered into, the Company designates the derivative as either a hedge of variable cash flows to be paid related to interest on variable rate debt, as a hedge of market variation in the benchmark rate for a future fixed rate debt issue, as a hedge of foreign currency cash flows associated with certain forecast- ed commercial transactions or loans, as a hedge of certain forecasted purchases of corn or natural gas used in the manufacturing process (“a cash-flow hedge”), or as a hedge of the fair value of certain debt obligations (“a fair-value hedge”). This process includes linking all derivatives that are designated as fair-value or cash-flow hedges to specific assets and liabilities on the Consolidated Balance Sheet, or to specific firm commitments or forecasted transactions. For all hedging relationships, the Company documents the hedging relationships and its risk-management objective and strategy for undertaking the hedge transactions, the hedging instrument, the hedged item, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed and a description of the method of measuring ineffectiveness. The Company also formally assesses both, at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. When it is determined that a derivative is not highly effective as a hedge or has ceased to be a highly effective hedge, the Company discontinues hedge accounting prospectively. Changes in the fair value of floating-to-fixed interest rate swaps, treasury locks or commodity futures and option contracts that are highly effective and that are designated and qualify as cash-flow hedges are recorded in other comprehensive income, net of applicable income taxes. Realized gains and losses associated with changes in the fair value of interest rate swaps and treasury locks are reclassified from accumu- lated other comprehensive income (“AOCI”) to the Consolidated Statement of Income over the life of the underlying debt. Gains and losses on hedges of foreign currency cash flows associated with certain forecasted commercial transactions or loans are reclassified from AOCI to the Consolidated Statement of Income when such transactions or obligations are settled. Gains and losses on commodity hedging contracts are reclassified from AOCI to the Consolidated Statement of Income when the finished goods produced using the hedged item are sold. The maximum term over which the Company hedges exposures to the variability of cash flows for commodity price risk is generally 24 months. Changes in the fair value of a fixed-to-floating interest rate swap agreement that is highly effective and that is designated and qualifies as a fair-value hedge, along with the loss or gain on the hedged debt obligation, are recorded in earnings. The ineffective portion of the change in fair value of a derivative instrument that qualifies as either a cash-flow hedge or a fair-value hedge is reported in earnings. The Company discontinues hedge accounting prospectively when it is determined that the derivative is no longer effective in offsetting changes in the cash flows or fair value of the hedged item, the derivative is de-designated as a hedging instrument because it is unlikely that a forecasted transaction will occur, or management determines that designation of the derivative as a hedging instrument is no longer appropriate. When hedge accounting is discontinued, the Company continues to carry the derivative on the Consolidated Balance Sheet at its fair value, and gains and losses that were included in AOCI are recognized in earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings, or in the month a hedge is determined to be ineffective. The Company uses derivative financial instruments such as foreign currency forward contracts, swaps and options to manage the transactional foreign exchange risk that is created when transactions not denominated in the functional currency of the operating unit are revalued. The changes in fair value of these derivative instruments and the offsetting changes in the value of the underlying non-functional currency denominated transactions are recorded in earnings on a monthly basis. Stock-based Compensation The Company has a stock incentive plan that provides for stock-based employee compensation, including the granting of stock options, shares of restricted stock, restricted stock units and performance shares to certain key employees. Compensation expense is recognized in the Consolidated Statements of Income for the Company’s stock-based employee compensation plan. The plan is more fully described in Note 11. Earnings per Common Share Basic earnings per common share is computed by dividing net income attributable to Ingredion by the weighted average number of shares outstanding, which totaled 73.6 million for 2014, 77.0 million for 2013 and 76.5 million for 2012. Diluted earnings per share (EPS) is computed by dividing net income attributable to Ingredion by the weighted average number of shares outstanding, including the dilutive effect of outstanding stock options and other instruments associated with long-term incentive compensa- tion plans. The weighted average number of shares outstanding for diluted EPS calculations was 74.9 million, 78.3 million and 78.2 million for 2014, 2013 and 2012, respectively. In 2014, 2013 and 2012, options to purchase approximately 0.1 million, 0.4 million and 0.9 million shares of common stock, respectively, were excluded from the calculation of the weighted average number of shares outstanding for diluted EPS because their effects were anti-dilutive. Risks and Uncertainties The Company operates domestically and internationally. In each country, the business and assets are subject to varying degrees of risk and uncertainty. The Company insures its business and assets in each country against insurable risks in a manner 41 INGREDION INCORPORATEDthat it deems appropriate. Because of this geographic dispersion, the Company believes that a loss from non-insurable events in any one country would not have a material adverse effect on the Company’s operations as a whole. Additionally, the Company believes there is no significant concentration of risk with any single customer or supplier whose failure or non-performance would materially affect the Company’s results. Recently Adopted Accounting Standards In July 2013, the Financial Accounting Standards Board issued Accounting Standards Update No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. This Update provides guidance pertaining to the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit carryforward exists, to resolve diversity in practice. The Update requires that companies present an unrecognized tax benefit as a reduction of a deferred tax asset for a tax loss or credit carryforward on the balance sheet when (a) the tax law requires the company to use the tax loss or credit carryforward to satisfy amounts payable upon disallowance of the tax position; or (b) the tax loss or credit carryforward is available to satisfy amounts payable upon disallowance of the tax position, and the company intends to use the deferred tax asset for that purpose. The guidance in this Update is effective prospectively for fiscal years beginning after December 15, 2013, and interim periods within those fiscal years. The Company adopted the guidance in this Update prospectively and the adoption did not have a material impact on the Company’s Consolidated Financial Statements. Note 3. Acquisition On October 14, 2014, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among Penford Corporation, a Washington corporation (“Penford”), Prospect Sub, Inc., a Washington corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), and the Company. The Merger Agreement and the consumma- tion of the transactions contemplated by the Merger Agreement were unanimously approved by the Company’s board of directors. The Merger Agreement provides for the merger of Merger Sub with and into Penford, on the terms and subject to the conditions set forth in the Merger Agreement (the “Merger”), with Penford continuing as the surviving corporation in the Merger. As a result of the Merger, Penford will become a wholly-owned subsidiary of the Company. Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share (a “Share”) of common stock of Penford (“Penford Common Stock”) issued and outstanding immediately prior to the Effective Time, other than (a) Shares owned by the Company or Merger Sub, or by any subsidiary of the Company or Merger Sub, immediately prior to the Effective Time and (b) Shares outstanding immediately prior to the Effective Time and held by a holder who is entitled to exercise dissenters’ rights and properly exercises dissenters’ rights under Washington law with respect to such Shares, will be converted into the right to receive $19.00 in cash per Share, without interest and subject to and reduced by the amount of any tax withholding. As of the date of the Merger Agreement, Penford had 12,735,038 outstanding Shares and 1,429,000 Shares underlying outstanding options. Outstanding borrowings under Penford’s revolving credit agreement will become due as a result of the Merger. The purchase price is estimated to be $340 million, including the assumption of debt. The Company expects to fund the acquisition of Penford with available cash and proceeds from borrowings under the Company’s revolving credit agreement. Penford, headquartered in Centennial, Colorado had net sales of $444 million for the fiscal year ended August 31, 2014. Penford employs approximately 443 people and operates six plants in the United States, all of which manufacture specialty starches. The Merger has been approved by the shareholders of Penford. The consummation of the Merger is subject to the satisfaction or waiver of specified closing conditions, including, among other things, (a) the receipt of certain required antitrust approvals and (b) other specified customary closing conditions. The Merger could close as early as March, 2015. Note 4. Impairment and Restructuring Charges The Company assesses goodwill and other indefinite-lived intangible assets for impairment annually (or more frequently if impairment indicators arise). The Company has chosen to perform this annual impairment assessment as of October 1 of each year. The results of the Company’s impairment testing in the fourth quarter of 2014 indicated that the estimated fair value of the Company’s Southern Cone of South America reporting unit was less than its carrying amount primarily due to the impacts on its fair value of the elongation of unfavorable financial trends, such as the impact of higher production costs and the Company’s inability to increase selling prices to a level sufficient to recover the impacts of inflation and currency devaluation. Also, the political and economic volatility in the region and continued uncertainty in Argentina negatively impacted earnings forecasts for the reporting unit in the near term. Therefore, the Company recorded a non-cash impairment charge of $33 million in the fourth quarter of 2014 to write-off the remaining balance of goodwill for this reporting unit. In the second quarter of 2012, the Company decided to restructure its business operations in Kenya and to close its manufacturing plant in the country. As part of that decision, the Company recorded $20 million of restructuring charges to its Statement of Income consisting of an $8 million charge to realize the cumulative translation adjustment associated with the Kenyan operations, a $6 million fixed asset impairment charge, a $2 million charge to reduce certain working capital balances to net realizable value based on the announced closure, $2 million of costs primarily consisting of severance pay 42 INGREDION INCORPORATEDrelated to the termination of the majority of its employees in Kenya and $2 million of additional charges related to this restructuring. As part of the Company’s ongoing strategic optimization, in the third quarter of 2012, the Company decided to exit its investment in Shouguang Golden Far East Modified Starch Co., Ltd (“GFEMS”), a non-wholly-owned consolidated subsidiary in China. In conjunction with that decision, the Company recorded a $4 million impairment charge to reduce the carrying value of GFEMS to its estimated net realizable value. The Company also recorded a $1 million charge for impaired assets in Colombia in 2012. The Company sold its interest in GFEMS in 2012 for $3 million in cash, which approximated the carrying value of the investment in GFEMS following the aforementioned impairment charge. Additionally, as part of a manufacturing optimization program developed in conjunction with the acquisition of National Starch to improve profitability, in the second quarter of 2011 the Company committed to a plan to optimize its production capabilities at certain of its North American facilities. The plan was completed in October 2012. As a result, the Company recorded restructuring charges to write-off certain equipment by the plan completion date. These charges totaled $11 million in 2012, of which $10 million represented accelerated depreciation on the equipment. Note 5. Financial Instruments, Derivatives and Hedging Activities The Company is exposed to market risk stemming from changes in commodity prices (corn and natural gas), foreign currency exchange rates and interest rates. In the normal course of business, the Company actively manages its exposure to these market risks by entering into various hedging transactions, authorized under established policies that place clear controls on these activities. These transactions utilize exchange-traded derivatives or over-the-counter derivatives with investment-grade counterparties. Derivative financial instruments currently used by the Company consist of commodity futures, options and swap contracts, foreign currency forward contracts, swaps and options, and interest rate swaps. Commodity Price Hedging The Company’s principal use of derivative financial instruments is to manage commodity price risk in North America relating to anticipated purchases of corn and natural gas to be used in the manufacturing process, generally over the next twelve to twenty-four months. The Company maintains a commodity-price risk management strategy that uses derivative instruments to minimize significant, unanticipated earnings fluctuations caused by commodity- price volatility. For example, the manufacturing of the Company’s products requires a significant volume of corn and natural gas. Price fluctuations in corn and natural gas cause the actual purchase price of corn and natural gas to differ from anticipated prices. To manage price risk related to corn purchases in North America, the Company uses corn futures and options contracts that trade on regulated commodity exchanges to lock in its corn costs associated with firm-priced customer sales contracts. The Company uses over-the- counter gas swaps to hedge a portion of its natural gas usage in North America. These derivative financial instruments limit the impact that volatility resulting from fluctuations in market prices will have on corn and natural gas purchases and have been designated as cash-flow hedges. Unrealized gains and losses associated with marking the commodity hedging contracts to market (fair value) are recorded as a component of other comprehensive income (“OCI”) and included in the equity section of the Consolidated Balance Sheets as part of AOCI. These amounts are subsequently reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings, or in the month a hedge is determined to be ineffective. The Company assesses the effectiveness of a commodity hedge contract based on changes in the contract’s fair value. The changes in the market value of such contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in the price of the hedged items. The amounts representing the ineffectiveness of these cash-flow hedges are not significant. At December 31, 2014 and 2013, AOCI included $13 million of losses (net of tax of $6 million) and $32 million of losses (net of tax of $15 million), respectively, pertaining to commodities-related derivative instruments designated as cash-flow hedges. Interest Rate Hedging The Company assesses its exposure to variability in interest rates by identifying and monitoring changes in interest rates that may adversely impact future cash flows and the fair value of existing debt instruments, and by evaluating hedging opportunities. The Company maintains risk management control systems to monitor interest rate risk attributable to both the Company’s outstanding and forecasted debt obligations as well as the Company’s offsetting hedge positions. The risk management control systems involve the use of analytical techniques, including sensitivity analysis, to estimate the expected impact of changes in interest rates on future cash flows and the fair value of the Company’s outstanding and forecasted debt instruments. Derivative financial instruments that have been used by the Company to manage its interest rate risk consist of Treasury Lock agreements (“T-Locks”) and interest rate swaps. The Company periodically enters into T-Locks to fix the benchmark component of the interest rate to be established for certain planned fixed-rate debt issuances. The T-Locks are designated as hedges of the variability in cash flows associated with future interest payments caused by market fluctuations in the benchmark interest rate until the fixed interest rate is established, and are accounted for as cash-flow hedges. Accordingly, changes in the fair value of the T-Locks are recorded to AOCI until the consummation of the underlying debt offering, at which time any realized gain (loss) is amortized to earnings over the life of the debt. 43 INGREDION INCORPORATEDThe net gain or loss recognized in earnings during 2014, 2013 and 2012 was not significant. The Company also, from time to time, enters into interest rate swap agreements that effectively convert the interest rate on certain fixed-rate debt to a variable rate. These swaps call for the Company to receive interest at a fixed rate and to pay interest at a variable rate, thereby creating the equivalent of variable-rate debt. The Company designates these interest rate swap agreements as hedges of the changes in fair value of the underlying debt obligation attributable to changes in interest rates and accounts for them as fair-value hedges. Changes in the fair value of interest rate swaps designated as hedging instruments that effectively offset the variability in the fair value of outstanding debt obligations are reported in earnings. These amounts offset the gain or loss (that is, the change in fair value) of the hedged debt instrument that is attributable to changes in interest rates (that is, the hedged risk) which is also recognized in earnings. The Company did not have any T-Locks outstanding at December 31, 2014 or 2013. At December 31, 2014 and 2013, AOCI included $7 million of losses (net of income taxes of $4 million) and $8 million of losses (net of income taxes of $5 million), respectively, related to settled T-Locks. These deferred losses are being amortized to financing costs over the terms of the senior notes with which they are associated. In September 2014, the Company entered into interest rate swap agreements that effectively convert the interest rates on its 6.0 percent $200 million senior notes due April 15, 2017, its 1.8 percent $300 mil- lion senior notes due September 25, 2017 and on $200 million of its $400 million 4.625 percent senior notes due November 1, 2020, to variable rates. Additionally, the Company has interest rate swap agreements that effectively convert the interest rate on its 3.2 percent $350 million senior notes due November 1, 2015 to a variable rate. These swap agreements call for the Company to receive interest at the fixed coupon rate of the respective notes and to pay interest at a variable rate based on the six-month US dollar LIBOR rate plus a spread. The Company has designated these interest rate swap agreements as hedges of the changes in fair value of the underlying debt obligations attributable to changes in interest rates and accounts for them as fair-value hedges. The fair value of these interest rate swap agreements was $13 million at both December 31, 2014 and December 31, 2013, and is reflected in the Consolidated Balance Sheets within other assets, with an offsetting amount recorded in long-term debt to adjust the carrying amount of the hedged debt obligations. Foreign Currency Hedging Due to the Company’s global operations, including many emerging markets, it is exposed to fluctuations in foreign currency exchange rates. As a result, the Company has exposure to translational foreign exchange risk when the results of its foreign operations are translated to US dollars and to transactional foreign exchange risk when transactions not denominated in the functional currency are revalued. The Company primarily uses derivative financial instruments such as foreign currency forward contracts, swaps and options to manage its transactional foreign exchange risk. At December 31, 2014, the Company had foreign currency forward sales contracts with an aggregate notional amount of $150 million and foreign currency forward purchase contracts with an aggregate notional amount of $70 million that hedged transactional exposures. At December 31, 2013, the Company had foreign currency forward sales contracts with an aggregate notional amount of $147 million and foreign currency forward purchase contracts with an aggregate notional amount of $78 million that hedged transactional exposures. The fair value of these derivative instruments were assets of $1 million at December 31, 2014 and liabilities of $5 million at December 31, 2013, respectively. The Company also has foreign currency derivative instruments that hedge certain foreign currency transactional exposures and are designated as cash-flow hedges. The amounts included in AOCI relating to these hedges at both December 31, 2014 and 2013 were not significant. By using derivative financial instruments to hedge exposures, the Company exposes itself to credit risk and market risk. Credit risk is the risk that the counterparty will fail to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is negative, the Company owes the counterparty and, therefore, it does not possess credit risk. The Company minimizes the credit risk in derivative instruments by entering into over-the-counter transactions only with investment grade counterparties or by utilizing exchange- traded derivatives. Market risk is the adverse effect on the value of a financial instrument that results from a change in commodity prices, interest rates or foreign exchange rates. The market risk associated with commodity-price, interest rate or foreign exchange contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken. The fair value and balance sheet location of the Company’s derivative instruments accounted for as cash-flow hedges are presented below: Fair Value of Derivative Instruments Fair Value Fair Value Derivatives designated as cash-flow hedging instruments: (in millions) Balance Sheet Location At Dec. 31, 2014 At Dec. 31, 2013 Balance Sheet Location At Dec. 31, 2014 At Dec. 31, 2013 Commodity and foreign currency contracts Commodity and foreign currency contracts Total Accounts receivable-net $15 $2 Other assets 1 $16 5 $7 Accounts payable and accrued liabilities Non-current liabilities $18 $27 6 $24 – $27 44 INGREDION INCORPORATEDAt December 31, 2014, the Company had outstanding futures and option contracts that hedged the forecasted purchase of approximately 93 million bushels of corn and 4 million pounds of soybean oil. The Company is unable to directly hedge price risk related to co-product sales; however, it occasionally enters into hedges of soybean oil (a competing product to corn oil) in order to mitigate the price risk of corn oil sales. Additionally at December 31, 2014, the Company had outstanding swap and option contracts that hedged the forecasted purchase of approximately 14 million mmbtu’s of natural gas. Additional information relating to the Company’s derivative instruments is presented below (in millions, pre-tax): Derivatives in Cash-Flow Hedging Relationships Commodity and foreign currency contracts Interest rate contracts Total At December 31, 2014, AOCI included approximately $13 million of losses, net of income taxes of $6 million, on commodities-related derivative instruments designated as cash-flow hedges that are expected to be reclassified into earnings during the next twelve months. Transactions and events expected to occur over the next twelve months that will necessitate reclassifying these derivative losses to earnings include the sale of finished goods inventory that includes previously hedged purchases of corn and natural gas. The (in millions) Available for sale securities Derivative assets Derivative liabilities Long-term debt Amount of Gains (Losses) Recognized in OCI on Derivatives Year Ended Dec. 31, 2014 ($41) – ($41) Year Ended Dec. 31, 2013 ($93) – ($93) Year Ended Dec. 31, 2012 Location of Gains (Losses) Reclassified from AOCI into Income Cost of Sales Financing costs, net $68 – $68 Amount of Gains (Losses) Reclassified from AOCI into Income Year Ended Dec. 31, 2014 ($70) (3) ($73) Year Ended Dec. 31, 2013 ($57) (3) ($60) Year Ended Dec. 31, 2012 $43 (3) $40 Company expects the losses to be offset by changes in the underlying commodities cost. Additionally at December 31, 2014, AOCI included $2 million of losses on settled T-Locks (net of income taxes of $1 million) and $1 million of gains related to foreign currency hedges (net of income taxes of $1 million), which are expected to be reclassi- fied into earnings during the next twelve months. Cash-flow hedges discontinued during 2014 or 2013 were not significant. Presented below are the fair values of the Company’s financial instruments and derivatives for the periods presented: As of December 31, 2014 As of December 31, 2013 Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 $÷÷÷«5 29 23 1,939 $÷5 12 6 – $÷÷÷«– 17 17 1,939 $– – – – $÷÷÷«4 20 32 1,813 $÷4 – 22 – $÷÷÷«– 20 10 1,813 $– – – – Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly for substantially the full term of the financial instrument. Level 2 inputs are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. The carrying values of cash equivalents, short-term investments, accounts receivable, accounts payable and short-term borrowings approximate fair values. Commodity futures, options and swap contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of the Company’s long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities. Presented below are the carrying amounts and the fair values of the Company’s long-term debt at December 31, 2014 and 2013. (in millions) 4.625% senior notes due November 1, 2020 3.2% senior notes due November 1, 2015 1.8% senior notes due September 25, 2017 6.625% senior notes due April 15, 2037 6.0% senior notes due April 15, 2017 5.62% senior notes due March 25, 2020 U.S. revolving credit facility due October 22, 2017 Fair value adjustment related to hedged fixed rate debt instrument Total long-term debt Carrying amount 2014 Fair value Carrying amount 2013 Fair value $÷«399 $÷«427 $÷«399 $÷«420 363 296 281 219 221 350 299 256 200 200 356 302 312 220 222 350 298 257 200 200 87 87 – – 13 13 $1,804 $1,939 $1,717 $1,813 13 13 45 INGREDION INCORPORATEDNote 6. Financing Arrangements The Company had total debt outstanding of $1.83 billion and $1.81 bil- lion at December 31, 2014 and 2013, respectively. Short-term borrowings at December 31, 2014 and 2013 consist primarily of amounts outstanding under various unsecured local country operating lines of credit. Short-term borrowings consist of the following at December 31: (in millions) 2014 2013 Short-term borrowings in various currencies (at rates ranging from 1% to 7% for 2014 and 1% to 11% for 2013) $23 $93 The Company has a senior, unsecured $1 billion revolving credit agreement (the “Revolving Credit Agreement”) that matures on October 22, 2017. Subject to certain terms and conditions, the Company may increase the amount of the revolving facility under the Revolving Credit Agreement by up to $250 million in the aggregate. All commit- ted pro rata borrowings under the revolving facility will bear interest at a variable annual rate based on the LIBOR or prime rate, at the Company’s election, subject to the terms and conditions thereof, plus, in each case, an applicable margin based on the Company’s leverage ratio (as reported in the financial statements delivered pursuant to the Revolving Credit Agreement). The Revolving Credit Agreement contains customary representations, warranties, covenants, events of default, terms and conditions, including limitations on liens, incurrence of debt, mergers and significant asset dispositions. The Company must also comply with a leverage ratio and an interest coverage ratio covenant. The occurrence of an event of default under the Revolving Credit Agreement could result in all loans and other obligations under the agreement being declared due and payable and the revolving credit facility being terminated. At December 31, 2014, there were $87 million of borrowings outstanding under the Revolving Credit Agreement. In addition to borrowing availability under its Revolving Credit Agreement, the Company has approximately $485 million of unused operating lines of credit in the various foreign countries in which it operates. Long-term debt consists of the following at December 31: (in millions) 2014 2013 4.625% senior notes due November 1, 2020, net of discount of $1 3.2% senior notes due November 1, 2015 1.8% senior notes due September 25, 2017, net of discount of $1 and $2, respectively 6.625% senior notes due April 15, 2037, including premium of $6 and $7, respectively 6.0% senior notes due April 15, 2017 5.62% senior notes due March 25, 2020 U.S. revolving credit facility due October 22, 2017 Fair value adjustment related to hedged fixed rate debt instrument Total Less: current maturities Long-term debt $÷«399 350 $÷«399 350 299 256 200 200 87 13 298 257 200 200 – 13 $1,804 – $1,804 $1,717 – $1,717 The Company’s long-term debt matures as follows: $350 million in 2015, $587 million in 2017, $600 million in 2020 and $250 million in 2037. The Company’s long-term debt at December 31, 2014 includes $350 million of 3.2 percent senior notes that mature November 1, 2015. These borrowings are included in long-term debt as the Company has the ability and intent to refinance the notes on a long-term basis prior to the maturity date. Ingredion Incorporated guarantees certain obligations of its consolidated subsidiaries. The amount of the obligations guaranteed aggregated $214 million and $225 million at December 31, 2014 and 2013, respectively. Note 7. Leases The Company leases rail cars, certain machinery and equipment, and office space under various operating leases. Rental expense under operating leases was $47 million, $47 million and $45 million in 2014, 2013 and 2012, respectively. Minimum lease payments due on non- cancellable leases existing at December 31, 2014 are shown below: (in millions) 2015 2016 2017 2018 2019 Balance thereafter Minimum Lease Payments $41 36 28 22 19 28 46 INGREDION INCORPORATEDNote 8. Income Taxes The components of income before income taxes and the provision for income taxes are shown below: (in millions) 2014 2013 2012 Income before income taxes: United States Foreign Total Provision for income taxes: Current tax expense US federal State and local Foreign Total current Deferred tax expense (benefit) US federal State and local Foreign Total deferred Total provision for income taxes $÷83 437 $520 $÷÷8 1 159 $168 $«(16) (2) 7 $«(11) $157 $138 409 $547 $5 3 106 $114 $÷11 (2) 21 $÷30 $144 $÷91 510 $601 $÷÷3 1 166 $170 $÷«(5) 2 – $÷«(3) $167 Deferred income taxes are provided for the tax effects of temporary differences between the financial reporting basis and tax basis of assets and liabilities. Significant temporary differences at December 31, 2014 and 2013 are summarized as follows: (in millions) 2014 2013 Deferred tax assets attributable to: Employee benefit accruals Pensions and postretirement plans Derivative contracts Net operating loss carryforwards Foreign tax credit carryforwards Other Gross deferred tax assets Valuation allowance Net deferred tax assets Deferred tax liabilities attributable to: Property, plant and equipment Identified intangibles Gross deferred tax liabilities Net deferred tax liabilities $÷23 30 9 11 – 30 $103 (3) $100 $194 34 $228 $128 $÷23 24 20 16 11 42 $136 (3) $133 $200 57 $257 $124 Of the $11 million of tax-effected net operating loss carryforwards at December 31, 2014, approximately $7 million are in Korea, and are scheduled to expire in 2021. The Company anticipates full utilization of the Korean carryforward. Income tax accounting requires that a valuation allowance be established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. In making this assessment, management considers the level of historical taxable income, scheduled reversal of deferred tax liabilities, tax planning strategies, tax carryovers and projected future taxable income. At December 31, 2014, the Company maintains valuation allowances of $2 million for state loss carryforwards and $1 million for foreign net operating losses that management has determined will more likely than not expire prior to realization. A reconciliation of the US federal statutory tax rate to the Company’s effective tax rate follows: Provision for tax at US statutory rate Tax rate difference on foreign income State and local taxes – net Nondeductible goodwill impairment – Southern Cone Reversal of Korea valuation allowance Other items – net Provision at effective tax rate 2014 35.00% (6.26) 0.13 2.18 – (0.86) 30.19% 2013 35.00% (5.28) 0.35 – – (3.74) 26.33% 2012 35.00% (3.86) 0.79 – (2.52) (1.63) 27.78% The Company has significant operations in Canada, Mexico and Thailand where the statutory tax rates are 25 percent, 30 percent and 20 percent, respectively. In addition, the Company’s subsidiary in Brazil has a lower effective tax rate of 26 percent including local tax incentives. The Company uses the US dollar as the functional currency for its subsidiaries in Mexico. Because of the decline in the value of the Mexican peso versus the US dollar, primarily late in 2014, the Mexican tax provision includes an unfavorable impact of approximately $7 million, or 1.3 percentage points in the effective tax rate, primarily associated with foreign currency transaction gains for local income tax purposes on net US dollar monetary assets held in Mexico for which there is no corresponding gain in pre-tax income. This impact is included in the rate reconciliation as “Other”. In the third quarter, the Company recognized an unfavorable impact of approximately $7 million, or 1.3 percentage points in the effective tax rate, for an audit result in a National Starch subsidiary related to a pre-acquisition period for which we are indemnified by Akzo Nobel N.V. (“Akzo”). This impact of $5 million of tax and $2 million of interest is also included in the rate reconciliation as “Other”. The $7 million of expense is recorded in the tax provision of the subsidiary, while the reimbursement from Akzo under the indemnity is recorded as other income. A portion of the tax is being disputed, but as the Company is fully indemnified for this pre-acquisition obligation, the impact on net income is zero in all cases. Provisions are made for estimated US and foreign income taxes, less credits that may be available, on distributions from foreign subsidiaries to the extent dividends are anticipated. No provision has been made for income taxes on approximately $2.172 billion of undistributed earnings of foreign subsidiaries at December 31, 2014, as such amounts are considered permanently reinvested. It is not practicable to estimate the additional income taxes, including applicable withholding taxes and credits that would be due upon the repatriation of these earnings. 47 INGREDION INCORPORATEDA reconciliation of the beginning and ending amount of unrecog- nized tax benefits, excluding interest and penalties, for 2014 and 2013 is as follows: tax benefits as current because they are expected to be resolved within the next twelve months. (in millions) Balance at January 1 Additions for tax positions related to prior years Reductions for tax positions related to prior years Additions based on tax positions related to the current year Reductions related to a lapse in the statute of limitations Balance at December 31 2014 $«34 6 (5) – (12) $«23 2013 $37 5 (6) 1 (3) $34 Of the $23 million at December 31, 2014, $5 million represents the amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate in future periods. The remaining $18 million would include an offset of $13 million of foreign tax credit carryforwards that would otherwise be created as part of the Canada and US audit process described below. In addition, $5 million of the unrecognized benefit would be offset by reversing a receivable recorded for indemnity claims that we would expect to collect from Akzo Nobel N.V. as part of the National Starch acquisition. The Company accounts for interest and penalties related to income tax matters in income tax expense. The Company has accrued $6 million of interest expense and $1 million of penalties related to the unrecog- nized tax benefits as of December 31, 2014. The accrued interest expense was $5 million (net of $3 million interest income) and accrued penalties were $1 million as of December 31, 2013. The Company is subject to US federal income tax as well as income tax in multiple state and non-US jurisdictions. The US federal tax returns are subject to audit for the years 2011 to 2014. In general, the Company’s foreign subsidiaries remain subject to audit for years 2008 and later. In 2008 and 2007, the Company made deposits of approximately $13 million and $17 million, respectively, to the Canadian tax authorities relating to an ongoing audit examination. The Company did not make any additional deposits relating to this ongoing audit examination. The Company settled $2 million of the claims and continues to pursue relief from double taxation under the US and Canadian tax treaty for the remaining items in the audit. As a result, the US and Canadian tax returns were subject to adjustment from 2000 and forward for the specific issues being contested. During 2014, the countries reached an agreement that settled the issues for the years 2000 through 2003, and it is possible but not assured, that a conclusion could be reached on the remaining periods within 12 months of December 31, 2014. The Company believes that it has adequately provided for the most likely outcome of the settlement process. It is also reasonably possible that the total amount of unrecognized tax benefits will increase or decrease within twelve months of Decem- ber 31, 2014. The Company has classified $12 million of the unrecognized Note 9. Benefit Plans The Company and its subsidiaries sponsor noncontributory defined benefit pension plans covering substantially all employees in the United States and Canada, and certain employees in other foreign countries. Plans for most salaried employees provide pay-related benefits based on years of service. Plans for hourly employees generally provide benefits based on flat dollar amounts and years of service. The Company’s general funding policy is to make contributions to the plans in amounts that comply with minimum funding requirements and are within the limits of deductibility under current tax regulations. Certain foreign countries allow income tax deductions without regard to contribution levels, and the Company’s policy in those countries is to make contributions required by the terms of the applicable plan. US salaried employees are covered by a defined benefit “cash balance” pension plan, which provides benefits based on service credits to the participating employees’ accounts of between 3 percent and 10 percent of base salary, bonus and overtime. Included in the Company’s pension obligation are nonqualified supplemental retirement plans for certain key employees. All benefits provided under these plans are unfunded, and payments to plan participants are made by the Company. The Company also provides healthcare and/or life insurance benefits for retired employees in the United States, Canada and Brazil. Healthcare benefits for retirees outside of the United States, Canada, and Brazil are generally covered through local government plans. In the fourth quarter of 2014, the Company amended its retiree medical plan in the US for salaried employees. This amendment required certain age and years of service requirements through December 31, 2014 in order to continue to participate in the plan. As such, the number of eligible employees was significantly reduced. For those eligible US salaried employees, they are provided with access to postretirement medical insurance through retirement healthcare spending accounts. US salaried employees accrue an account during employment, which can be used after employment to purchase postretirement medical insurance from the Company prior to age 65, Medigap or through Medicare HMO policies after age 65. The accounts are credited with a flat dollar amount and indexed for inflation annually during employment. These credits will cease after December 31, 2014. The accounts also accrue interest credits using a rate equal to a specified amount above the yield on five-year US Treasury notes. Employees can use the amounts accumulated in these accounts, including credited interest, to purchase postretirement medical insurance. Employees become eligible for benefits when they meet minimum age and service requirements. The Company recognizes the cost of these postretirement benefits by accruing a flat dollar amount on an annual basis for each US salaried employee. 48 INGREDION INCORPORATED$314 $293 $267 $250 Components of net periodic benefit cost consist of the following for Pension Obligation and Funded Status The changes in pension benefit obligations and plan assets during 2014 and 2013, as well as the funded status and the amounts recognized in the Company’s Consolidated Balance Sheets related to the Company’s pension plans at December 31, 2014 and 2013, were as follows: (in millions) Benefit obligation At January 1 Service cost Interest cost Benefits paid Actuarial (gain) loss Business combinations/transfers Curtailment/settlement/ amendments Foreign currency translation Benefit obligation at December 31 Fair value of plan assets At January 1 Actual return on plan assets Employer contributions Benefits paid Plan settlements Foreign currency translation Fair value of plan assets at December 31 Funded status 2014 $293 7 13 (17) 22 – (4) – US Plans 2013 Non-US Plans 2014 2013 $323 8 11 (14) (36) 1 – – $250 6 14 (11) 33 (2) – (23) $272 9 12 (12) (15) – (2) (14) $297 30 6 (17) (3) – $313 $÷«(1) $257 41 13 (14) – – $297 $÷÷4 $223 28 11 (11) – (19) $232 $«(35) $189 16 43 (12) – (13) $223 $«(27) Amounts recognized in the Consolidated Balance Sheets as of December 31, 2014 and 2013 were as follows: (in millions) Non-current asset Current liabilities Non-current liabilities Net asset (liability) recognized US Plans Non-US Plans 2014 $«12 (1) (12) $÷(1) 2013 $«16 (1) (11) $÷«4 2014 $«18 (1) (52) $(35) 2013 $«26 (3) (50) $(27) Amounts recognized in accumulated other comprehensive loss, excluding tax effects, that have not yet been recognized as compo- nents of net periodic benefit cost at December 31, 2014 and 2013 were as follows: (in millions) Net actuarial loss Transition obligation Prior service credit Net amount recognized US Plans 2013 $7 – – $7 2014 $19 – (2) $17 Non-US Plans 2013 $59 2 – $61 2014 $69 2 (1) $70 The increase in the net amount recognized in accumulated comprehensive loss at December 31, 2014, as compared to Decem- ber 31, 2013, is largely due to a decrease in discount rates used to measure the Company’s obligations under its pension plans slightly offset by higher than expected returns on plan assets during 2014 for most plans. The accumulated benefit obligation for all defined benefit pension plans was $527 million and $493 million at December 31, 2014 and 2013, respectively. Information about plan obligations and assets for plans with an accumulated benefit obligation in excess of plan assets is as follows: (in millions) Projected benefit obligation Accumulated benefit obligation Fair value of plan assets US Plans Non-US Plans 2014 $9 8 – 2013 $10 8 – 2014 $54 43 2 2013 $52 42 3 the years ended December 31, 2014, 2013 and 2012: US Plans Non-US Plans (in millions) 2014 2013 2012 2014 2013 2012 Service cost Interest cost Expected return on plan assets Amortization of actuarial loss Amortization of transition obligation Settlement/curtailment $÷«7 13 (21) 1 $÷«8 11 (18) 2 $÷«7 12 (16) 1 $÷«6 14 (14) 3 $÷«9 12 (12) 5 $÷«8 13 (13) 4 – – – – – – – – – – 1 1 Net periodic benefit cost $÷«– $÷«3 $÷«4 $÷«9 $«14 $«14 For the US plans, the Company estimates that net periodic benefit cost for 2015 will include approximately $1 million relating to the amortization of its accumulated actuarial loss included in accumulated other comprehensive loss at December 31, 2014. For the non-US plans, the Company estimates that net periodic benefit cost for 2015 will include approximately $4 million relating to the amortization of its accumulated actuarial loss and $0.3 million relating to the amortization of the transition obligation included in accumulated other comprehensive loss at December 31, 2014. Actuarial gains and losses in excess of 10 percent of the greater of the projected benefit obligation or the market-related value of plan assets are recognized as a component of net periodic benefit cost over the average remaining service period of a plan’s active employees for active defined benefit pension plans and over the average remaining life of a plan’s active employees for frozen defined benefit pension plans. 49 INGREDION INCORPORATEDTotal amounts recorded in other comprehensive income and net periodic benefit cost during 2014 was as follows: (in millions, pre-tax) Net actuarial loss Prior service credit Amortization of actuarial loss Foreign currency translation Total recorded in other comprehensive income Net periodic benefit cost Total recorded in other comprehensive income and net periodic benefit cost US Plans Non-US Plans $13 (2) (1) – 10 – $10 $19 – (3) (7) 9 9 $18 The following weighted average assumptions were used to determine the Company’s obligations under the pension plans: (in millions) Discount rate Rate of compensation increase US Plans Non-US Plans 2014 4.00% 4.31% 2013 4.60% 4.22% 2014 4.47% 3.76% 2013 5.60% 4.39% The following weighted average assumptions were used to determine the Company’s net periodic benefit cost for the pension plans: US Plans Non-US Plans (in millions) 2014 2013 2012 2014 2013 2012 Discount rate Expected long-term return on plan assets Rate of compensation increase 4.60% 3.60% 4.50% 5.60% 4.88% 5.68% 7.25% 4.22% 7.25% 4.19% 7.25% 4.19% 6.82% 4.39% 6.69% 4.35% 6.81% 4.51% return achieved on plan assets and the asset allocation of the plans, input from the Company’s independent actuaries and investment consultants, and historical trends in long-term inflation rates. Projected return estimates made by such consultants are based upon broad equity and bond indices. The discount rate reflects a rate of return on high-quality fixed income investments that match the duration of the expected benefit payments. The Company has typically used returns on long-term, high-quality corporate AA bonds as a benchmark in establishing this assumption. Plan Assets The Company’s investment policy for its pension plans is to balance risk and return through diversified portfolios of equity instruments, fixed income securities, and short-term investments. Maturities for fixed income securities are managed such that sufficient liquidity exists to meet near-term benefit payment obligations. For US pension plans, the weighted average target range allocation of assets was 38-72 percent in equities, 31-58 percent in fixed income and 1-3 percent in cash and other short-term investments. The asset allocation is reviewed regularly and portfolio investments are rebalanced to the targeted allocation when considered appropriate. The Company anticipates increasing its target allocation of assets in fixed income portfolios in the future due to the funded nature of the US plans. The Company’s weighted average asset allocation as of December 31, 2014 and 2013 for US and non-US pension plan assets is as follows: For 2015 and 2014, the Company has assumed an expected long-term rate of return on assets of 7.00 percent and 7.25 percent for US plans and 6.00 percent and 6.45 percent for Canadian plans, respectively. In developing the expected long-term rate of return assumption on plan assets, which consist mainly of US and Canadian equity and debt securities, management evaluated historical rates of Asset Category Equity securities Debt securities Cash and other Total US Plans Non-US Plans 2014 62% 37% 1% 100% 2013 62% 36% 2% 100% 2014 50% 40% 10% 100% 2013 51% 39% 10% 100% 50 INGREDION INCORPORATEDThe fair values of the Company’s plan assets at December 31, 2014, by asset category and level in the fair value hierarchy are as follows: Asset Category Fair Value Measurements at December 31, 2014 (in millions) US Plans: Equity index: US (a) International (b) Real estate (c) Fixed income index: Intermediate bond (d) Long bond (e) Cash (f) Total US Plans Non-US Plans: Equity index: US (a) Canada (g) International (b) Fixed income index: Intermediate bond (d) Long bond (h) Other (i) Cash (f) Total Non-US Plans Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) $158 30 5 61 54 5 $313 $÷42 36 37 1 92 22 $230 2 $2 Total $158 30 5 61 54 5 $313 $÷42 36 37 1 92 22 2 $232 (a) This category consists of a passively managed equity index fund that tracks the return of large capitalization US equities. (b) This category consists of a passively managed equity index fund that tracks an index of returns on international developed market equities. (c) This category consists of a passively managed equity index fund that tracks a US real estate equity securities index that includes equities of real estate investment trusts and real estate operating companies. (d) This category consists of a passively managed fixed income index fund that tracks the return of intermediate duration government and investment grade corporate bonds. (e) This category consists of a passively managed fixed income fund that tracks the return of long duration US government and investment grade corporate bonds. (f) This category represents cash or cash equivalents. (g) This category consists of a passively managed equity index fund that tracks the return of large and midsized capitalization equities traded on the Toronto Stock Exchange. (h) This category consists of a passively managed fixed income index fund that tracks the return of the universe of Canada government and investment grade corporate bonds. (i) This category mainly consists of investment products provided by an insurance company that offers returns that are subject to a minimum guarantee. All significant pension plan assets are held in collective trusts by the Company’s US and non-US plans. The fair values of shares of collective trusts are based upon the net asset values of the funds reported by the fund managers based on quoted market prices of the underlying securities as of the balance sheet date and are considered to be Level 2 fair value measurements. This may produce a fair value measurement that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with those of other market participants, the use of different methodologies could result in different fair value measurements at the reporting date. In 2014, the Company made cash contributions of $6 million and $11 million to its US and non-US pension plans, respectively. The Company anticipates that in 2015 it will make cash contributions of $1 million and $2 million to its US and non-US pension plans, respec- tively. Cash contributions in subsequent years will depend on a number of factors including the performance of plan assets. The following benefit payments, which reflect anticipated future service, as appropriate, are expected to be made: (in millions, pre-tax) 2015 2016 2017 2018 2019 Years 2020 – 2024 US Plans Non-US Plans $÷17 17 19 19 19 107 $10 14 11 12 13 73 The Company and certain subsidiaries also maintain defined contribution plans. The Company makes matching contributions to these plans that are subject to certain vesting requirements and are based on a percentage of employee contributions. Amounts charged to expense for defined contribution plans totaled $17 million, $15 million and $13 million in 2014, 2013 and 2012, respectively. Postretirement Benefit Plans The Company’s postretirement benefit plans currently are not funded. The information presented below includes plans in the United States, Brazil, and Canada. The changes in the benefit obligations of the plans during 2014 and 2013, and the amounts recognized in the Company’s Consolidated Balance Sheets at December 31, 2014 and 2013, are as follows: (in millions) 2014 2013 Accumulated postretirement benefit obligation At January 1 Service cost Interest cost Curtailment / settlement Plan amendment Actuarial (gain) loss Benefits paid Foreign currency translation At December 31 Fair value of plan assets Funded status $«57 3 4 – (16) 4 (3) (2) $«47 – $(47) $«74 3 4 (1) – (15) (3) (5) $«57 – $(57) 51 INGREDION INCORPORATEDAmounts recognized in the Consolidated Balance Sheet consist of: The following weighted average assumptions were used to determine (in millions) Current liabilities Non-current liabilities Net liability recognized 2014 $÷(3) (44) $(47) 2013 $÷(2) (55) $(57) Amounts recognized in accumulated other comprehensive (income) loss, excluding tax effects, that have not yet been recognized as components of net periodic benefit cost at December 31, 2014 and 2013 were as follows: (in millions) Net actuarial loss Prior service credit Net amount recognized 2014 $÷«9 (15) $÷(6) 2013 $7 – $7 Components of net periodic benefit cost consisted of the following for the years ended December 31, 2014, 2013 and 2012: Service cost Interest cost Amortization of actuarial loss Net periodic benefit cost 2014 2013 2012 $3 4 – $7 $3 4 1 $8 $2 3 1 $6 The Company estimates that postretirement benefit expense for 2015 will include approximately $0.5 million relating to the amortiza- tion of its accumulated actuarial loss and $2.2 million relating to the amortization of its prior service credit included in accumulated other comprehensive income at December 31, 2014. Total amounts recorded in other comprehensive income and net periodic benefit cost during 2014 was as follows: (in millions, pre-tax) Net actuarial loss New prior service credit Total recorded in other comprehensive income Net periodic benefit cost Total recorded in other comprehensive income and net periodic benefit cost 2014 $÷«2 (15) (13) 7 $÷(6) the Company’s obligations under the postretirement plans: Discount rate 2014 5.70% 2013 6.47% The following weighted average assumptions were used to determine the Company’s net postretirement benefit cost: Discount rate 2014 6.47% 2013 5.44% 2013 6.23% The discount rate reflects a rate of return on high-quality fixed-income investments that match the duration of expected benefit payments. The Company has typically used returns on long-term, high-quality corporate AA bonds as a benchmark in establishing this assumption. The healthcare cost trend rates used in valuing the Company’s postretirement benefit obligations are established based upon actual healthcare trends and consultation with actuaries and benefit providers. The following assumptions were used as of December 31, 2014: 2015 increase in per capita cost Ultimate trend Year ultimate trend reached US 6.70% 4.50% 2027 Canada 7.05% 4.50% 2031 Brazil 8.66% 8.66% 2014 The sensitivities of service cost and interest cost and year-end benefit obligations to changes in healthcare cost trend rates for the postretirement benefit plans as of December 31, 2014 are as follows: One-percentage point increase in trend rates: Increase in service cost and interest cost components Increase in year-end benefit obligations One-percentage point decrease in trend rates: Decrease in service cost and interest cost components Decrease in year-end benefit obligations 2014 $1 million $4 million $1 million $3 million The following benefit payments, which reflect anticipated future service, as appropriate, are expected to be made under the Company’s postretirement benefit plans: (in millions) 2015 2016 2017 2018 2019 Years 2020 – 2024 $÷3 3 3 3 3 $16 52 INGREDION INCORPORATEDMultiemployer Plans The Company participates in and contributes to one multiemployer benefit plan under the terms of a collective bargaining agreement that covers certain union-represented employ- ees and retirees in the US. The plan covers medical and dental benefits for active hourly employees and retirees represented by the United States Steel Workers Union for certain US locations. The risks of participating in this multiemployer plan are different from single-employer plans. This plan receives contributions from two or more unrelated employers pursuant to one or more collective bargaining agreements and the assets contributed by one employer may be used to fund the benefits of all employees covered within the plan. The Company is required to make contributions to this plan as determined by the terms and conditions of the collective bargaining agreements and plan terms. For the years ended December 31, 2014, 2013 and 2012, the Company made regular contributions of $12 million in each year to this multi-employer plan. The Company cannot currently estimate the amount of multiemployer plan contributions that will be required in 2015 and future years, but these contributions could increase due to healthcare cost trends. Statements of Income (in millions) Other income – net: Income tax indemnification income (a) Gain from sale of investment Gain from sale of idled plant and land Gain from change in benefit plan in North America Other Other income – net 2014 2013 2012 $÷7 5 3 – 9 $24 $÷– – – – 16 $16 $÷– – 2 5 15 $22 (a) Amount fully offset by $7 million of expense recorded in the income tax provision. (in millions) 2014 2013 2012 Financing costs – net: Interest expense, net of amounts capitalized (a) Interest income Foreign currency transaction losses Financing costs – net $«73 (13) 1 $«61 $«74 (11) 3 $«66 $«77 (10) – $«67 (a) Interest capitalized amounted to $2 million, $4 million and $6 million in 2014, 2013 and 2012, respectively. Note 10. Supplementary Information Balance Sheets Statements of Cash Flow: (in millions) 2014 2013 2012 (in millions) Accounts receivable – net: Accounts receivable – trade Accounts receivable – other Allowance for doubtful accounts Total accounts receivable – net Inventories: Finished and in process Raw materials Manufacturing supplies Total inventories Accrued liabilities: Compensation-related costs Income taxes payable Dividends payable Accrued interest Taxes payable other than income taxes Other Total accrued liabilities Non-current liabilities: Employees’ pension, indemnity and postretirement Other Total non-current liabilities 2014 2013 Other non-cash charges to net income: Mechanical stores expense (a) Share-based compensation expense Other Total other non-cash charges to net income $56 19 (7) $68 $48 17 9 $74 $42 18 (5) $55 (a) Represents spare parts used in the production process. Such spare parts are recorded in PP&E as part of machinery and equipment until they are utilized in the manufacturing process and expensed as a period cost. (in millions) Interest paid Income taxes paid 2014 $59 94 2013 $61 135 2012 $÷65 133 $655 111 (4) $762 $428 225 46 $699 $÷74 36 31 16 36 75 $268 $126 31 $157 $667 171 (6) $832 $440 235 48 $723 $÷75 14 32 16 32 100 $269 $133 30 $163 53 INGREDION INCORPORATEDNote 11. Equity Preferred Stock The Company has authorized 25 million shares of $0.01 par value preferred stock, none of which were issued or outstanding at December 31, 2014 and 2013. 2014, 2013 and 2012, respectively. All of the acquired shares are held as common stock in treasury, less shares issued to employees under the stock incentive plan. Set forth below is a reconciliation of common stock share activity for the years ended December 31, 2012, 2013 and 2014: Treasury Stock On December 12, 2014, the Board of Directors authorized a new stock repurchase program permitting the Company to purchase up to 5 million of its outstanding common shares from January 1, 2015 through December 12, 2019. The Company’s previously authorized stock repurchase program permitting the purchase of up to 4 million shares has been almost fully utilized with 176 thousand shares available to be repurchased at December 31, 2014. The parameters of the Company’s stock repurchase program are not established solely with reference to the dilutive impact of shares issued under the Company’s stock incentive plan. However, the Company expects that, over time, share repurchases will offset the dilutive impact of shares issued under the stock incentive plan. As part of the previous stock repurchase program, the Company entered into an accelerated share repurchase agreement (“ASR”) on July 30, 2014 with an investment bank under which the Company repurchased $300 million of its common stock. The Company paid the $300 million on August 1, 2014 and received an initial delivery of shares from the investment bank of 3,152,502 shares, representing approxi- mately 80 percent of the shares anticipated to be repurchased based on current market prices at that time. The ASR was initially accounted for as an initial stock purchase transaction and a forward stock purchase contract. The initial delivery of shares resulted in an immedi- ate reduction in the number of shares used to calculate the weighted average common shares outstanding for basic and diluted net earnings per share from the effective date of the ASR. On December 29, 2014, the ASR was completed and the Company received 671,823 additional shares of its common stock bringing the total amount of repurchases to 3,824,325 shares, based upon the volume-weighted average price of $78.45 per share over the term of the share repurchase agreement. The ASR was funded through a combination of cash on hand and utilization of the Revolving Credit Agreement. In 2013, the Company repurchased 3,385,000 common shares in open market transactions at a cost of approximately $227 million. In 2012, the Company repurchased 300,000 common shares in open market transactions at a cost of approximately $15 million. The Company also reacquired 8,738, 21,629 and 44,674 shares of its common stock during 2014, 2013 and 2012, respectively, by both repurchasing shares from employees under the stock incentive plan and through the cancellation of forfeited restricted stock. The Company repurchased shares from employees at average purchase prices of $61.05, $44.55 and $58.59, or fair value at the date of purchase, during (Shares of common stock, in thousands) Balance at December 31, 2011 Issuance of restricted stock units as compensation Issuance under incentive and other plans Stock options exercised Purchase/acquisition of treasury stock Balance at December 31, 2012 Issuance of restricted stock units as compensation Issuance under incentive and other plans Stock options exercised Purchase/acquisition of treasury stock Balance at December 31, 2013 Issuance of restricted stock units as compensation Issuance under incentive and other plans Stock options exercised Purchase/acquisition of treasury stock Balance at December 31, 2014 Issued 76,822 – – 320 – 77,142 6 130 395 – 77,673 89 49 – – 77,811 Held in Treasury Outstanding 939 75,883 (6) (142) (1,026) 345 110 (3) (43) (110) 3,407 3,361 (24) (63) (618) 3,833 6,489 6 142 1,346 (345) 77,032 9 173 505 (3,407) 74,312 113 112 618 (3,833) 71,322 Share-based Payments The following table summarizes the components of the Company’s share-based compensation expense for the last three years: (in millions) Stock options: 2014 2013 2012 Pre-tax compensation expense Income tax (benefit) Stock option expense, net of income taxes $÷7 (3) 4 $÷6 (2) 4 $÷7 (3) 4 RSUs and RSAs: Pre-tax compensation expense Income tax (benefit) RSU and RSA compensation expense, net of income taxes Performance shares and other share-based awards: Pre-tax compensation expense Income tax (benefit) Performance shares and other share-based compensation expense, net of income taxes Total share-based compensation: Pre-tax compensation expense Income tax (benefit) 8 (3) 5 4 (1) 3 19 (7) 7 (3) 4 4 (1) 3 17 (6) 6 (2) 4 5 (2) 3 18 (7) Total share-based compensation expense, net of income taxes $12 $11 $11 54 INGREDION INCORPORATEDThe Company has a stock incentive plan (“SIP”) administered by the compensation committee of its Board of Directors that provides for the granting of stock options, restricted stock, restricted stock units and other share-based awards to certain key employees. A maximum of 8 million shares were originally authorized for awards under the SIP. As of December 31, 2014, 6.0 million shares were available for future grants under the SIP. Shares covered by awards that expire, terminate or lapse will again be available for the grant of awards under the SIP. The Company grants nonqualified options to purchase shares of the Company’s common stock. The stock options have a ten-year life and are exercisable upon vesting, which occurs evenly over a three-year period at the anniversary dates of the date of grant. Compensation expense is recognized on a straight-line basis for awards. As of December 31, 2014, certain of these nonqualified options have been forfeited due to the termination of employees. The fair value of stock option awards was estimated at the grant dates using the Black-Scholes option-pricing model with the following assumptions: Expected life (in years) Risk-free interest rate Expected volatility Expected dividend yield 2014 5.5 1.6% 30.3% 2.8% 2013 5.8 1.1% 32.6% 1.6% 2012 5.8 1.1% 33.3% 1.2% The expected life of options represents the weighted-average period of time that options granted are expected to be outstanding giving consideration to vesting schedules and the Company’s historical exercise patterns. The risk-free interest rate is based on the US Treasury yield curve in effect at the time of the grant for periods corresponding with the expected life of the options. Expected volatility is based on historical volatilities of the Company’s common stock. Dividend yields are based on historical dividend payments. The weighted average fair value of options granted during 2014, 2013 and 2012 was estimated to be $12.99, $17.87 and $16.16, respectively. A summary of stock option transactions for the last three years follows: (shares in thousands) Outstanding at December 31, 2011 Granted Exercised Cancelled Outstanding at December 31, 2012 Granted Exercised Cancelled Outstanding at December 31, 2013 Granted Exercised Cancelled Outstanding at December 31, 2014 Stock Option Shares 4,030 460 (1,409) (49) 3,032 416 (511) (88) 2,849 715 (618) (57) 2,889 Stock Option Price Range $14.33 to 52.64 55.95 to 57.33 14.33 to 47.95 25.58 to 55.95 16.92 to 57.33 66.07 to 66.26 16.92 to 57.33 47.95 to 66.07 24.70 to 66.26 59.58 to 69.14 24.70 to 66.07 24.70 to 66.07 25.83 to 69.14 Weighted Average per Share Exercise Price for Stock Options $30.29 55.96 26.80 39.29 35.66 66.07 28.74 54.37 40.77 59.65 33.25 51.54 46.84 The intrinsic values of stock options exercised during 2014, 2013 and 2012 were approximately $26 million, $20 million and $46 million, respectively. For the years ended December 31, 2014, 2013 and 2012, cash received from the exercise of stock options was $20 million, $14 million and $34 million, respectively. The excess income tax benefit realized from share-based compensation was $6 million, $5 million and $11 million in 2014, 2013 and 2012, respectively. As of December 31, 2014, the unrecognized compensation cost related to non-vested stock options totaled $9 million, which is expected to be amortized over the weighted-average period of approximately 1.8 years. The following table summarizes information about stock options outstanding at December 31, 2014: (options in thousands) Options Outstanding Weighted Average Exercise Price per Share Average Remaining Contractual Life (Years) Options Exercisable Range of Exercise Prices $24.70 to 27.30 $27.31 to 29.90 $32.51 to 35.10 $45.51 to 53.30 $55.91 to 58.50 $58.51 to 61.10 $63.71 to 66.26 $68.91 to 71.50 334 369 472 281 369 695 364 5 2,889 $25.68 29.06 34.06 47.95 55.95 59.58 66.07 69.14 $46.84 2.89 5.07 2.79 6.11 7.11 9.10 8.10 9.34 6.17 334 369 472 281 253 – 131 – 1,840 Weighted Average Exercise Price per Share $25.68 29.06 34.07 47.95 55.95 – 66.07 – $38.95 55 INGREDION INCORPORATEDStock options outstanding at December 31, 2014 had an aggregate intrinsic value of approximately $110 million and an average remaining contractual life of 6.2 years. Stock options exercisable at December 31, 2014 had an aggregate intrinsic value of approximately $85 million and an average remaining contractual life of 4.7 years. Stock options outstanding at December 31, 2013 had an aggregate intrinsic value of approximately $79 million and an average remaining contractual life of 5.8 years. Stock options exercisable at December 31, 2013 had an aggregate intrinsic value of approximately $72 million and an average remaining contractual life of 4.8 years. In addition to stock options, the Company awards shares of restricted common stock (“restricted shares”) and restricted stock units (“restricted units”) to certain key employees. The restricted shares and restricted units issued under the plan are subject to cliff vesting, generally after three to five years provided the employee remains in the service of the Company. Expense is recognized on a straight-line basis over the vesting period taking into account an estimated forfeiture rate. The fair value of the restricted stock and restricted units is determined based upon the number of shares granted and the quoted market price of the Company’s common stock at the date of the grant. The following table summarizes restricted share and restricted unit activity for the last three years: (shares in thousands) Non-vested at December 31, 2011 Granted Vested Cancelled Non-vested at December 31, 2012 Granted Vested Cancelled Non-vested at December 31, 2013 Granted Vested Cancelled Non-vested at Number of Restricted Shares Weighted Average Fair Value per Share Number of Restricted Units Weighted Average Fair Value per Share 136 – (37) (4) 95 – (33) (14) 48 – (31) (1) $30.69 – 33.73 25.58 $29.69 – 34.02 31.25 $26.25 – 25.35 28.75 235 174 (9) (15) 385 144 (17) (43) 469 161 (168) (28) $44.24 55.69 37.57 44.95 $49.77 66.27 46.82 54.93 $54.47 61.50 48.16 53.27 December 31, 2014 16 $27.94 434 $59.61 The total fair value of restricted units that vested in 2014, 2013 and 2012 was $8 million, $1 million and $0.3 million, respectively. Restricted shares with a total fair value of $1 million vested in each of 2014, 2013 and 2012. At December 31, 2014, the total remaining unrecognized compen- sation cost related to restricted units was $11 million which will be amortized on a weighted-average basis over approximately 1.9 years. Unrecognized compensation cost related to restricted shares was insignificant at December 31, 2014. Recognized compensation cost related to unvested restricted share and restricted stock unit awards is included in share-based payments subject to redemption in the Consolidated Balance Sheets and totaled $16 million and $17 million at December 31, 2014 and 2013, respectively. Other Share-based Awards Under the SIP Under the compensation agreement with the Board of Directors at least 50 percent of a director’s compensation is awarded in shares of common stock or restricted units based on each director’s election to receive his or her compensation or a portion thereof in the form of restricted units. These restricted units vest immediately, but cannot be transferred until a date not less than six months after the director’s termination of service from the board at which time the restricted units will be settled by delivering shares of common stock. The compensation expense relating to this plan included in the Consoli- dated Statements of Income did not exceed $1 million in 2014, 2013 or 2012. At December 31, 2014, there were approximately 183,000 restricted units outstanding under this plan at a carrying value of approximately $7 million. The Company has a long-term incentive plan for officers in the form of performance shares. The ultimate payments for performance shares awarded in 2012, 2013 and 2014 to be paid in 2015, 2016 and 2017 will be based solely on the Company’s stock performance as compared to the stock performance of a peer group. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. The total compensation expense for these awards is amortized over a three-year service period. As of December 31, 2014, the unrecognized compensation cost relating to these plans was $3 million, which will be amortized over the remaining requisite service periods of 1 to 2 years. Recognized compensation cost related to these unvested awards is included in share-based payments subject to redemption in the Consolidated Balance Sheets and totaled $6 million and $7 million at December 31, 2014 and 2013, respectively. 56 INGREDION INCORPORATEDPension/ Postretirement Adjustment $÷(70) Unrealized Gain (Loss) on Investment Accumulated Other Comprehensive Loss $(2) $(413) Accumulated Other Comprehensive Loss A summary of accumulated other comprehensive income (loss) for the years ended December 31, 2012, 2013 and 2014 is presented below: (in millions) Balance, December 31, 2011 Gains on cash-flow hedges, net of income tax effect of $25 Amount of gains on cash-flow hedges reclassified to earnings, net of income tax effect of $15 Actuarial losses on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect of $27 Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax effect of $2 Currency translation adjustment Balance, December 31, 2012 Losses on cash-flow hedges, net of income tax effect of $29 Amount of losses on cash-flow hedges reclassified to earnings, net of income tax effect of $19 Actuarial gains on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect of $32 Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax of $3 Unrealized gain on investment, net of income tax effect Currency translation adjustment Balance, December 31, 2013 Losses on cash-flow hedges, net of income tax effect of $12 Amount of losses on cash-flow hedges reclassified to earnings, net of income tax effect of $23 Actuarial losses on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect of $5 Losses related to pension and other postretirement obligations reclassified to earnings, net of income tax effect of $1 Currency translation adjustment Balance, December 31, 2014 Cumulative Translation Adjustment $(306) (29) $(335) (154) $(489) (212) $(701) Deferred Gain/(Loss) on Hedging Activities $(35) 43 (25) $(17) (64) 41 $(40) (29) 50 (56) 5 $(121) $(2) 1 $(1) 63 5 $÷(53) (12) 4 $(19) $÷(61) $(1) 43 (25) (56) 5 (29) $(475) (64) 41 63 5 1 (154) $(583) (29) 50 (12) 4 (212) $(782) 57 INGREDION INCORPORATEDThe following table provides detail pertaining to reclassifications from AOCI into net income for the periods presented: (in millions) Details about AOCI Components Gains (losses) on cash-flow hedges: Commodity and foreign currency contracts Interest rate contracts Losses related to pension and other postretirement obligations Total before tax reclassifications Income tax (expense) benefit Total after-tax reclassifications Amount Reclassified from AOCI 2014 2013 2012 $(70) (3) (5) $(78) 24 $(54) $(57) (3) (8) $(68) 22 $(46) $«43 (3) (7) $«33 (13) $«20 Affected Line Item in Consolidated Statements of Income Cost of sales Financing costs, net (a) (a) This component is included in the computation of net periodic benefit cost and affects both cost of sales and SG&A expenses on the Consolidated Statements of Income. The following table provides the computation of basic and diluted earnings per common share (“EPS”) for the periods presented. (in millions, except per share amounts) Basic EPS Effect of Dilutive Securities: Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs, RSAs and other awards Diluted EPS Net Income Available to Ingredion (Numerator) $354.9 Weighted Average Shares (Denominator) 2014 Per Share Amount Net Income Available to Ingredion (Numerator) Weighted Average Shares (Denominator) 2013 Per Share Amount Net Income Available to Ingredion (Numerator) Weighted Average Shares (Denominator) 2012 Per Share Amount 73.6 $4.82 $395.7 77.0 $5.14 $427.5 76.5 $5.59 $354.9 1.3 74.9 $4.74 $395.7 1.3 78.3 $5.05 $427.5 1.7 78.2 $5.47 Note 12. Segment Information The Company is principally engaged in the production and sale of starches and sweeteners for a wide range of industries, and is managed geographically on a regional basis. The Company’s opera- tions are classified into four reportable business segments: North America, South America, Asia Pacific and Europe, Middle East and Africa (“EMEA”). Its North America segment includes businesses in the United States, Canada and Mexico. The Company’s South America segment includes businesses in Brazil, Colombia and Ecuador and the Southern Cone of South America, which includes Argentina, Chile, Peru and Uruguay. Its Asia Pacific segment includes businesses in Korea, Thailand, Malaysia, China, Japan, Indonesia, the Philippines, 58 INGREDION INCORPORATEDSingapore, India, Australia and New Zealand. The Company’s EMEA segment includes businesses in the United Kingdom, Germany, South Africa, Pakistan and Kenya. (in millions) 2014 2013 2012 Net sales to unaffiliated customers: North America South America Asia Pacific EMEA Total Operating income: North America South America Asia Pacific EMEA (a) Corporate (b) Subtotal Impairment / restructuring charges (c) Acquisition / integration costs Gain from change in benefit plans Gain from land sale Total Total assets: North America South America Asia Pacific EMEA Total Depreciation and amortization: North America South America Asia Pacific EMEA Total Capital expenditures: North America South America Asia Pacific EMEA Total $3,093 1,203 794 578 $5,668 $÷«375 108 103 95 (65) 616 (33) (2) – – $÷«581 $2,907 923 711 550 $5,091 $÷«111 38 26 20 $÷«195 $÷«130 90 30 26 $÷«276 $3,647 1,334 805 542 $6,328 $÷«401 116 97 74 (75) 613 – – – – $÷«613 $3,008 1,088 711 553 $5,360 $÷«112 41 25 16 $÷«194 $÷«141 76 28 53 $÷«298 $3,741 1,462 816 513 $6,532 $÷«408 198 95 78 (78) 701 (36) (4) 5 2 $÷«668 $3,116 1,230 730 516 $5,592 $÷«130 44 24 13 $÷«211 $÷«162 75 33 43 $÷«313 (a) For 2014, includes a $3 million gain from the sale of an idled plant in Kenya. (b) For 2014, includes $7 million of income relating to a tax indemnification agreement with an offsetting expense of $7 million recorded in the provision for income taxes (see also Note 8). (c) For 2014, includes a $33 million write-off of impaired goodwill in the Southern Cone of South America. For 2012, includes $20 million of charges for impaired assets and restructuring costs in Kenya, $11 million of charges to write-down certain equipment as part of the Company’s North American manufacturing optimization plan and $5 million of charges for impaired assets in China and Colombia. The following table presents net sales to unaffiliated customers by country of origin for the last three years: Net Sales (in millions) United States Mexico Brazil Canada Korea Argentina Others Total 2014 2013 2012 $1,681 955 591 457 295 262 1,427 $5,668 $1,970 1,130 670 547 301 305 1,405 $6,328 $2,035 1,143 731 564 306 356 1,397 $6,532 The following table presents long-lived assets (excluding intangible assets and deferred income taxes) by country at December 31: Long-lived Assets (in millions) United States Mexico Brazil Canada Germany Thailand Korea Argentina Others Total 2014 2013 2012 $÷«809 296 294 154 133 105 88 82 214 $2,175 $÷«822 296 321 181 151 112 91 92 219 $2,285 $÷«824 290 346 199 114 117 90 111 234 $2,325 Note 13. Commitments and Contingencies As previously reported, on April 22, 2011, Western Sugar and two other sugar companies filed a complaint in the U.S. District Court for the Central District of California against the Corn Refiners Association (“CRA”) and certain of its member companies, including the Company, alleging false and/or misleading statements relating to high fructose corn syrup in violation of the Lanham Act and California’s unfair competition law. The complaint seeks injunctive relief and unspecified damages. On May 23, 2011, the plaintiffs amended the complaint to add additional plaintiffs, among other reasons. On July 1, 2011, the CRA and the member companies in the case filed a motion to dismiss the first amended complaint on multiple grounds. On October 21, 2011, the U.S. District Court for the Central District of California dismissed all Federal and state claims against the Company and the other members of the CRA, with leave for the plaintiffs to amend their complaint, and also dismissed all state law claims against the CRA. 59 INGREDION INCORPORATEDThe state law claims against the CRA were dismissed pursuant to a California law known as the anti-SLAPP (Strategic Lawsuit Against Public Participation) statute, which, according to the court’s opinion, allows early dismissal of meritless first amendment cases aimed at chilling expression through costly, time-consuming litigation. The court held that the CRA’s statements were protected speech made in a public forum in connection with an issue of public interest (high fructose corn syrup). Under the anti-SLAPP statute, the CRA is entitled to recover its attorney’s fees and costs from the plaintiffs. On November 18, 2011, the plaintiffs filed a second amended complaint against certain of the CRA member companies, including the Company, seeking to reinstate the federal law claims, but not the state law claims, against certain of the CRA member companies, including us. On December 16, 2011, the CRA member companies filed a motion to dismiss the second amended complaint on multiple grounds. On July 31, 2012, the U.S. District Court for the Central District of California denied the motion to dismiss for all CRA member companies other than Roquette America, Inc. On September 4, 2012, the Company and the other CRA member companies that remain defendants in the case filed an answer to the plaintiffs’ second amended complaint that, among other things, added a counterclaim against the Sugar Association. The counterclaim alleges that the Sugar Association has made false and misleading statements that processed sugar differs from high fructose corn syrup in ways that are beneficial to consumers’ health (i.e., that consumers will be healthier if they consume foods and beverages containing processed sugar instead of high fructose corn syrup). The counterclaim, which was filed in the U.S. District Court for the Central District of California, seeks injunctive relief and unspecified damages. Although the counter- claim was initially only filed against the Sugar Association, the Company and the other CRA member companies that remain defendants in the Western Sugar case have reserved the right to add other plaintiffs to the counterclaim in the future. On October 29, 2012, the Sugar Association and the other plaintiffs filed a motion to dismiss the counterclaim and certain related portions of the defendants’ answer, each on multiple grounds. On December 10, 2012, the remaining member companies which are defendants in the case responded to the motion to dismiss the counterclaim. On January 14, 2013, the plaintiffs filed a reply to the defendants’ response to the motion to dismiss. On September 16, 2013, the U.S. District Court for the Central District of California denied the motion to dismiss the counterclaim, which entitles the Company and the other CRA member companies to continue to pursue the counterclaim against the Sugar Association and the other plaintiffs. On May 23, 2014, the defendants asked the court for leave to amend their counterclaim to add the individual sugar companies as counterclaim defendants. The motion for leave to amend was denied by the court on August 4, 2014 and this decision is in the process of being appealed by the defendants. On August 26, 2014, each of the Company and Tate & Lyle filed motions to disqualify the plaintiffs’ lead counsel, Squire Patton Boggs, due to a conflict of interest arising from Squire Sanders’ merger with Patton Boggs, a firm which represents each of the Company and Tate & Lyle. In addition, on August 26, 2014, the defendants filed two separate motions for summary judgment, one on the issue of liability and the other on the issue of damages, and the plaintiffs filed a motion for summary judgment with respect to the defendants’ counterclaim. The motion to disqualify the plaintiff’s attorneys was argued before the court on both November 13 and November 25, 2014. On February 13, 2015, the court granted the Company’s and Tate & Lyle’s motions to dismiss Squire Patton Boggs due to a conflict of interest. The schedule for arguing the summary judgment motions and the pre-trial conference have been delayed until May 5, 2015 while the plaintiffs seek replacement counsel in the case. The Company continues to believe that the second amended complaint is without merit and intends to vigorously defend this case. In addition, the Company intends to vigorously pursue its rights in connection with the counterclaim. In the ordinary course of business, the Company enters into purchase commitments principally related to power supply and raw material sourcing. Such agreements, including take or pay contracts, help to provide the Company with adequate supply of power and raw material at certain of our facilities. The Company would be subject to liquidated damages in the unlikely event that it did not fulfill such commitments. The Company is also party to a large number of labor claims relating to its Brazilian operations. The Company has reserved an aggregate of approximately $5 million as of December 31, 2014 in respect of these claims. These labor claims primarily relate to dismissals, severance, health and safety, work schedules and salary adjustments. The Company is currently subject to various other claims and suits arising in the ordinary course of business, including certain environmental proceedings and product liability claims. The Company does not believe that the results of such legal proceedings, even if unfavorable to the Company, will be material to the Company. There can be no assurance, however, that such claims or suits or those arising in the future, whether taken individually or in the aggregate, will not have a material adverse effect on the Company’s financial condition or results of operations. 60 INGREDION INCORPORATEDQuarterly Financial Data (Unaudited) Summarized quarterly financial data is as follows: (in millions, except per share amounts) 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr* 2014 Net sales before shipping and handling costs Less: shipping and handling costs Net sales Gross profit Net income attributable to Ingredion Basic earnings per common share $1,435 78 $1,357 250 73 $1,568 85 $1,483 296 103 $1,545 85 $1,460 298 119 $1,450 82 $1,368 272 61 of Ingredion $÷0.97 $÷1.37 $÷1.62 $÷0.85 Diluted earnings per common share of Ingredion 2013 Net sales before shipping and handling costs Less: shipping and handling costs Net sales Gross profit Net income attributable to Ingredion Basic earnings per common share $÷0.96 $÷1.35 $÷1.60 $÷0.83 $1,662 78 $1,584 306 111 $1,715 82 $1,633 276 95 $1,696 84 $1,612 259 86 $1,579 80 $1,499 291 104 of Ingredion $÷1.43 $÷1.22 $÷1.12 $÷1.37 Diluted earnings per common share of Ingredion $÷1.41 $÷1.20 $÷1.10 $÷1.35 * Fourth quarter 2014 includes a write-off of impaired goodwill in the Southern Cone of South America of $33 million ($0.44 per diluted common share) and $2 million of costs ($1 million after-tax, or $0.02 per diluted common share) related to the pending Penford acquisition. Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Not applicable. Item 9A. Controls and Procedures Evaluation of Disclosure Controls and Procedures Our management, including our Chief Executive Officer and our Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of December 31, 2014. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures (a) are effective in providing reasonable assurance that all material informa- tion required to be filed in this report has been recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (b) are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. There have been no changes in our internal control over financial reporting during the quarter ended December 31, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Management’s Report on Internal Control over Financial Reporting Our management is responsible for establishing and maintaining adequate internal control over financial reporting. This system of internal controls is designed to provide reasonable assurance that assets are safeguarded and transactions are properly recorded and executed in accordance with management’s authorization. Internal control over financial reporting includes those policies and procedures that: 1. Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets. 2. Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in conformity with accounting principles generally accepted in the United States, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors. 3. Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on our financial statements. Management conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework of Internal Control – Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on the evaluation, management concluded that our internal control over financial reporting was effective as of December 31, 2014. The effectiveness of our internal control over financial reporting has been audited by KPMG LLP, an independent registered public account- ing firm, as stated in their attestation report included herein. Item 9B. Other Information None. 61 INGREDION INCORPORATEDPart III Part IV Item 10. Directors, Executive Officers and Corporate Governance The information contained under the headings “Proposal 1. Election of Directors,” “The Board and Committees” and “Section 16(a) Beneficial Ownership Reporting Compliance” in the Company’s definitive proxy statement for the Company’s 2015 Annual Meeting of Stockholders (the “Proxy Statement”) is incorporated herein by reference. The informa- tion regarding executive officers called for by Item 401 of Regulation S-K is included in Part 1 of this report under the heading “Executive Officers of the Registrant.” The Company has adopted a code of ethics that applies to its principal executive officer, principal financial officer, and controller. The code of ethics is posted on the Company’s Internet website, which is found at www.ingredion.com. The Company intends to include on its website any amendments to, or waivers from, a provision of its code of ethics that applies to the Company’s principal executive officer, principal financial officer or controller that relates to any element of the code of ethics definition enumerated in Item 406(b) of Regulation S-K. Item 11. Executive Compensation The information contained under the headings “Executive Compensa- tion,” “Compensation Committee Report,” “Director Compensation” and “Compensation Committee Interlocks and Insider Participation” in the Proxy Statement is incorporated herein by reference. Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters The information contained under the headings “Equity Compensation Plan Information as of December 31, 2014” and “Security Ownership of Certain Beneficial Owners and Management” in the Proxy Statement is incorporated herein by reference. Item 13. Certain Relationships and Related Transactions, and Director Independence The information contained under the headings “Review and Approval of Transactions with Related Persons,” “Certain Relationships and Related Transactions” and “Independence of Board Members” in the Proxy Statement is incorporated herein by reference. Item 14. Principal Accountant Fees and Services The information contained under the heading “2014 and 2013 Audit Firm Fee Summary” in the Proxy Statement is incorporated herein by reference. Item 15. Exhibits and Financial Statement Schedules Item 15(a)(1) Consolidated Financial Statements Financial Statements (see Item 8 of the Table of Contents of this report). Item 15(a)(2) Financial Statement Schedules All financial statement schedules have been omitted because the information either is not required or is otherwise included in the consolidated financial statements and notes thereto. Item 15(a)(3) Exhibits The following list of exhibits includes both exhibits submitted with this Form 10-K as filed with the SEC and those incorporated by reference from other filings. Exhibit No. Description 2.1(a) 3.1(a) 3.2(a) 3.3(a) 3.4(a) 3.5(a) 4.1(a) 4.2(a) Agreement and Plan of Merger, dated as of October 14, 2014, by and among Penford Corporation, a Washington corporation, Prospect Sub, Inc., a Washington corporation and a wholly-owned subsidiary of the Company, and the Company, filed on November 3, 2014 as Exhibit 2.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, File No. 1-13397. Certain schedules referenced in the Agreement and Plan of Merger have been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the SEC upon request. Amended and Restated Certificate of Incorporation of the Company, filed as Exhibit 3.1 to the Company’s Registration Statement on Form 10, File No. 1-13397. Certificate of Elimination of Series A Junior Participating Preferred Stock of Corn Products International, Inc., filed on May 25, 2010 as Exhibit 10.5 to the Company’s Current Report on Form 8-K dated May 19, 2010, File No. 1-13397. Amendments to Amended and Restated Certificate of Incorporation filed on April 9, 2010 as Appendix A to the Company’s Proxy Statement for its 2010 Annual Meeting of Stockholders, File No. 1-13397. Certificate of Amendment of Certificate of Amended and Restated Certificate of Incorporation of the Company, filed on February 28, 2013 as Exhibit 3.4 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2012, File No. 1-13397. Amended By-Laws of the Company, filed on December 19, 2013 as Exhibit 3.1 to the Company’s Current Report on Form 8-K dated December 13, 2013, File No. 1-13397. Revolving Credit Agreement dated October 22, 2012, among Ingredion Incorporated, the lenders signatory thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, Bank of America, N.A., Citibank, N.A. and Bank of Montreal, as Co-Syndication Agents, and Mizuho Corporate Bank (USA), U.S. Bank National Association and Branch Banking and Trust Company, as Co-Documentation Agents filed on October 25, 2012 as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated October 22, 2012, File No. 1-13397. Private Shelf Agreement, dated as of March 25, 2010 by and between Corn Products International, Inc. and Prudential Investment Manage- ment, Inc., filed on May 5, 2010 as Exhibit 4.10 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended March 31, 2010. 62 INGREDION INCORPORATED4.3(a) 4.4(a) 4.5(a) 4.6(a) 4.7(a) 4.8(a) 4.9(a) 4.10(a) 4.11(a) 10.1(a)(c) 10.2(a)(c) 10.3(b)(c) Amendment No. 1 to Private Shelf Agreement, dated as of February 25, 2011 by and between Corn Products International, Inc. and Prudential Investment Management, Inc., filed on May 6, 2011 as Exhibit 4.11 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended March 31, 2011. Amendment No. 2 to Private Shelf Agreement, dated as of Decem- ber 21, 2012 by and between Ingredion Incorporated and Prudential Investment Management, Inc. , filed on February 28, 2013 as Exhibit 4.4 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2012, File No. 1-13397. Indenture Agreement dated as of August 18, 1999 between the Company and The Bank of New York, as Trustee, filed on August 27, 1999 as Exhibit 4.1 to the Company’s Current Report on Form 8-K, File No. 1-13397. Third Supplemental Indenture dated as of April 10, 2007 between Corn Products International, Inc. and The Bank of New York Trust Company, N.A., as trustee, filed on April 10, 2007 as Exhibit 4.3 to the Company’s Current Report on Form 8-K, dated April 10, 2007, File No. 1-13397. Fourth Supplemental Indenture dated as of April 10, 2007 between Corn Products International, Inc. and The Bank of New York Trust Company, N.A., as trustee, filed on April 10, 2007 as Exhibit 4.4 to the Company’s Current Report on Form 8-K dated April 10, 2007, File No. 1-13397. Fifth Supplemental Indenture, dated September 17, 2010, between Corn Products International, Inc. and The Bank of New York Mellon Trust Company, N.A. (as successor trustee to The Bank of New York), as trustee, filed on September 20, 2010 as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated September 14, 2010, File No. 1-13397. Sixth Supplemental Indenture, dated September 17, 2010, between Corn Products International, Inc. and The Bank of New York Mellon Trust Company, N.A. (as successor trustee to The Bank of New York), as trustee, filed on September 20, 2010 as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated September 14, 2010, File No. 1-13397. Seventh Supplemental Indenture, dated September 17, 2010, between Corn Products International, Inc. and The Bank of New York Mellon Trust Company, N.A. (as successor trustee to The Bank of New York), as trustee, filed on September 20, 2010 as Exhibit 4.3 to the Company’s Current Report on Form 8-K dated September 14, 2010, File No. 1-13397. Eighth Supplemental Indenture, dated September 20, 2012, between Ingredion Incorporated and The Bank of New York Mellon Trust Compa- ny, N.A. (as successor trustee to The Bank of New York), as trustee, filed on September 21, 2012 as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated September 20, 2012, File No. 1-13397. Stock Incentive Plan as effective May 21, 2014, filed on April 8, 2014 as Appendix B to the Company’s Proxy Statement for its 2014 Annual Meeting of Stockholders, File No. 1-13397. Form of Executive Severance Agreement entered into by Ilene S. Gordon, Cheryl K. Beebe, Jack C. Fortnum and John F. Saucier, filed on May 6, 2008 as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended March 31, 2008, File No. 1-13397. Form of Indemnification Agreement entered into by each of the members of the Company’s Board of Directors and the Company’s executive officers. 10.4(a)(c) Deferred Compensation Plan for Outside Directors of the Company (Amended and Restated as of September 19, 2001), filed as Exhibit 4(d) to the Company’s Registration Statement on Form S-8, File No. 333-75844, as amended by Amendment No. 1 dated December 1, 2004, filed as Exhibit 10.6 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2004, File No. 1-13397. 10.5(a)(c) Supplemental Executive Retirement Plan as effective July 18, 2012, filed on November 2, 2012as Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended September 30, 2012, File No. 1-13397. Executive Life Insurance Plan. 10.6(b)(c) 10.7(a)(c) Deferred Compensation Plan, as amended by Amendment No. 1 filed as Exhibit 10.21 to the Company’s Annual Report on Form 10-K/A for the Year ended December 31, 2001, File No. 1-13397. 10.8(a)(c) Annual Incentive Plan as effective July 18, 2012 filed, on November 2, 10.9(a)(c) 2012 as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended September 30, 2012, File No. 1-13397. Executive Life Insurance Plan, Compensation Committee Summary, filed as Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2004, File No. 1-13397. 10.10(a)(c) Form of Executive Life Insurance Plan Participation Agreement and Collateral Assignment entered into by Cheryl K. Beebe and Jack C. Fortnum, filed as Exhibit 10.15 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2004, File No. 1-13397. 10.11(a)(c) Form of Notice of Restricted Stock Award Agreement for use in connection with awards under the Stock Incentive Plan, filed on February 27, 2009 as Exhibit 10.11 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2008, File No. 1-13397. 10.12(a)(c) Form of Performance Share Award Agreement for use in connection with awards under the Stock Incentive Plan, filed on February 9, 2015 as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated February 3, 2015, File No. 1-13397. 10.13(a)(c) Form of Stock Option Award Agreement for use in connection with awards under the Stock Incentive Plan, filed on February 9, 2015 as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated February 3, 2015, File No. 1-13397. 10.14(a)(c) Form of Restricted Stock Units Award Agreement for use in connection with awards under the Stock Incentive Plan, filed on February 9, 2015 as Exhibit 10.3 to the Company’s Current Report on Form 8-K dated February 3, 2015, File No. 1-13397. 10.15(a) Natural Gas Purchase and Sale Agreement between Corn Products Brasil-Ingredientes Industrias Ltda. and Companhia de Ga de Sao Paulo-Comgas, filed as Exhibit 10.17 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2005, File No. 1-13397. 10.16(a)(c) Letter of Agreement dated as of April 2, 2009 between the Company and Ilene S. Gordon, filed on August 6, 2009 as Exhibit 10.21 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended June 30, 2009, file No. 1-13397. 10.17(a)(c) Letter of Agreement dated as of April 2, 2010 between the Company and Diane Frisch, filed on August 6, 2010 as Exhibit 10.24 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended June 30, 2010, File No. 1-13397. 10.18(a)(c) Executive Severance Agreement dated as of May 1, 2010 between the Company and Diane Frisch, filed on August 6, 2010 as Exhibit 10.25 to the Company’s Quarterly Report on Form 10-Q, for the quarter ended June 30, 2010, File No. 1-13397. 10.19(a)(c) Letter of Agreement dated as of September 28, 2010 between the Company and James Zallie, filed as Exhibit 10.30 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2010, File No. 1-13397. 10.20(a)(c) Form of Executive Severance Agreement entered into by James Zallie, Christine M. Castellano, Anthony P. DeLio and Robert F. Stefansic, filed on February 24, 2014 as Exhibit 10.27 to the Company’s Annual Report on Form 10-K for the Year ended December 31, 2013, File No. 1-13397. 63 INGREDION INCORPORATEDSignatures Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 20th day of February, 2015. Ingredion Incorporated By: /s/ Ilene S. Gordon Ilene S. Gordon Chairman, President and Chief Executive Officer Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant, in the capacities indicated and on the 20th day of February, 2015. Signature Title Chairman, President, Chief Executive Officer and Director Chief Financial Officer Controller Director Director Director Director Director Director Director Director Director /s/ Ilene S. Gordon Ilene S. Gordon /s/ Jack C. Fortnum Jack C. Fortnum /s/ Matthew R. Galvanoni Matthew R. Galvanoni *Luis Aranguren-Trellez Luis Aranguren-Trellez *David B. Fischer David B. Fischer *Paul Hanrahan Paul Hanrahan *Wayne M. Hewett Wayne M. Hewett *Rhonda L. Jordan Rhonda L. Jordan *Gregory B. Kenny Gregory B. Kenny *Barbara A. Klein Barbara A. Klein *Victoria J. Reich Victoria J. Reich *Dwayne A. Wilson Dwayne A. Wilson *By: /s/ Christine M. Castellano Christine M. Castellano Attorney-in-fact (Being the principal executive officer, the principal financial officer, the controller and a majority of the directors of Ingredion Incorporated) 10.21(a)(c) Form of Executive Severance Agreement entered into by Ricardo de Abreu Souza and Jorgen Kokke, filed as Exhibit 10.39 to the Company’s Quarterly Report on Form 10-Q for the Quarter ended March 31, 2014, File No. 1-13397. 10.22(a)(c) Confidentiality and Non-Compete Agreement, dated March 7, 2014, by and between the Company and Cheryl K. Beebe, filed on May 2, 2014 as Exhibit 10.40 to the Company’s Quarterly Report on Form 10-Q for the Quarter ended March 31, 2014, File No. 1-13397. 10.23(a)(c) Confidential Separation Agreement and General Release, dated as of March 29, 2013, by and between the Company and Kimberly A. Hunter, filed on August 2, 2013 as Exhibit 10.35 to the Company’s Quarterly Report on Form 10-Q for the Quarter ended June 30, 2013, File No. 1-13397. 10.24(a)(c) Consulting Agreement, dated as of September 3, 2013, by and between the Company and Julio dos Reis, filed on November 1, 2013 as Exhibit 10.36 to the Company’s Quarterly Report on Form 10-Q for the Quarter ended September 30, 2013, File No. 1-13397. 10.25(a)(c) Mutual Separation Agreement, dated as of September 3, 2013, by and between Ingredion Argentina S.A. and Julio dos Reis, filed on Novem- ber 1, 2013 as Exhibit 10.37 to the Company’s Quarterly Report on Form 10-Q for the Quarter ended September 30, 2013, File No. 1-13397. 31.2 12.1 21.1 23.1 24.1 31.1 10.38(a)(c) Letter of Agreement dated as of September 2, 2013 between the Company and Ricardo de Abreu Souza and Addendum dated as of February 19, 2014, filed February 24, 2014 as Exhibit 10.38 to the Company’s Annual Report on Form 10-K for the Year ended Decem- ber 31, 2013, File No. 1-13397. Computation of Ratio of Earnings to Fixed Charges Subsidiaries of the Registrant Consent of Independent Registered Public Accounting Firm Power of Attorney CEO Section 302 Certification Pursuant to the Sarbanes-Oxley Act of 2002 CFO Section 302 Certification Pursuant to the Sarbanes-Oxley Act of 2002 CEO Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code as created by the Sarbanes-Oxley Act of 2002 CFO Certification Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code as created by the Sarbanes-Oxley Act of 2002 The following financial information from the Ingredion Incorporated Annual Report on Form 10-K for the year ended December 31, 2014 formatted in Extensible Business Reporting Language (XBRL):  (i) the Consolidated Statements of Income; (ii) the Consolidated Statements of Comprehensive Income; (iii) the Consolidated Balance Sheets; (iv) the Consolidated Statements of Equity and Redeemable Equity; (v) the Consolidated Statements of Cash Flows; and (vi) the Notes to the Consolidated Financial Statements 32.2 32.1 101 (a) (b) Incorporated herein by reference as indicated in the exhibit description. Incorporated herein by reference to the exhibits filed with the Company’s Annual Report on Form 10-K for the year ended December 31, 1997. (c) Management contract or compensatory plan or arrangement required to be filed as an exhibit to this form pursuant to Item 15(b) of this report. 64 INGREDION INCORPORATEDExhibit 12.1 Computation of Ratios of Earnings to Fixed Charges (in millions, except ratios) 2014 2013 2012 2011 2010 Income before income taxes and earnings of non-controlling interests Fixed charges Capitalized interest Total Ratio of Earnings to Fixed Charges Fixed Charges: Interest expense on debt Amortization of discount on debt Interest portion of rental expense on operating leases Total $520.1 76.3 (2.1) $594.3 $546.8 79.9 (4.3) $622.4 $600.6 84.3 (5.6) $679.3 $593.4 88.5 (5.2) $676.7 $275.5 72.4 (2.6) $345.3 7.79 7.79 8.06 7.65 4.77 $÷71.3 $÷74.6 $÷79.4 $÷83.4 $÷69.4 3.4 3.4 3.2 3.0 1.6 1.6 $÷76.3 1.9 $÷79.9 1.7 $÷84.3 2.1 $÷88.5 1.4 $÷72.4 Exhibit 21.1 Subsidiaries of the Registrant The Registrant’s subsidiaries as of December 31, 2014, are listed below showing the percentage of voting securities directly or indirectly owned by the Registrant. All other subsidiaries, if considered in the aggregate as a single subsidiary, would not constitute a significant subsidiary. Percentage of voting securities directly or indirectly owned by the Registrant(1) State or Country of incorporation or organization Arrendadora Gefemesa, S.A. de C.V. Bebidas y Algo Mas S.A. de C.V. Bedford Construction Company Brunob II B.V. Brunob IV B.V. Cali Investment Corp. Casco Holding LLC Colombia Millers Ltd. Corn Products Americas Holdings S.à r.l. Corn Products Development, Inc. Corn Products Espana Holding LLC Corn Products Germany GmbH Corn Products Global Holding S.à r.l. Corn Products Inc. & Co. KG Corn Products Kenya Limited Corn Products Mauritius (Pty) Ltd. Corn Products Netherlands Holding S.à r.l. Corn Products Puerto Rico Inc. 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 Mexico Mexico New Jersey The Netherlands The Netherlands Delaware Delaware Delaware Luxembourg Delaware Delaware Germany Luxembourg Germany Kenya Mauritius Luxembourg Delaware Corn Products Sales Corporation Corn Products Southern Cone S.A. Corn Products (Thailand) Co., Ltd. Corn Products UK Finance LP Corn Products Venezuela, C.A. CPIngredients, LLC d/b/a GTC Nutrition Crystal Car Line, Inc. Feed Products Limited Globe Ingredients Nigeria Limited Hispano-American Company, Inc. ICI Mauritius (Holdings) Limited ICI Servicios Mexico, S.A. de C.V. IMASA Brasil Ingredion ANZ Pty Ltd. Ingredion Argentina S.A. Ingredion Brasil Ingredientes Industriais Ltda. Ingredion Canada Incorporated Ingredion Chile S.A. Ingredion China Limited Ingredion Colombia S.A. Ingredion Ecuador S.A. Ingredion Employee Services S.à r.l. Ingredion Espana, S.L.U. Ingredion Germany GmbH Ingredion Holding LLC Ingredion India Private Limited Ingredion Integra, S.A. de C.V. Ingredion Japan K.K. Ingredion Korea Holding LLC Ingredion Korea Incorporated Ingredion Malaysia Sdn. Bhd. Ingredion Mexico, S.A. de C.V. Ingredion Peru S.A. Ingredion Philippines, Inc. Ingredion Singapore Pte. Ltd. Ingredion South Africa (Proprietary) Ltd. Ingredion (Thailand) Ltd. Ingredion UK Limited Ingredion Uruguay S.A. Inversiones Latinoamericanas S.A. Laing-National Limited National Starch & Chemical (Thailand) Ltd National Starch Servicios, S.A. de C.V. Prospect Sub, Inc. PT Ingredion Indonesia Rafhan Maize Products Co. Ltd. Raymond & White River LLC The Chicago, Peoria and Western Railway Company 100 Delaware 100 Argentina Thailand 100 100 England and Wales Venezuela 100 Colorado 100 Illinois 100 New Jersey 100 Nigeria 100 Delaware 100 Mauritius 100 Mexico 100 Brazil 100 Australia 100 Argentina 100 Brazil 100 Canada 100 Chile 100 China 100 Colombia 100 Ecuador 100 Luxembourg 100 Spain 100 Germany 100 Delaware 100 India 100 Mexico 100 Japan 100 Nevada 100 Korea 100 Malaysia 100 Mexico 100 Peru 100 Philippines 100 Singapore 100 South Africa 100 100 Thailand 100 England and Wales 100 Uruguay Delaware 100 100 England and Wales Thailand 100 Mexico 100 Washington 100 Indonesia 100 Pakistan 70.3 Indiana 100 Illinois 100 (1) With respect to certain companies, shares in the names of nominees and qualifying shares in the names of directors are included in the above percentages. 65 INGREDION INCORPORATEDExhibit 23.1 Consent of Independent Registered Public Accounting Firm The Board of Directors Ingredion Incorporated: We consent to the incorporation by reference in the registration statements on Form S-8 (Nos. 33343525, 333-71573, 333-75844, 333-33100, 333-105660, 333-113746, 333-129498, 333-143516, 333-160612 and 333-171310) of Ingredion Incorporated of our report dated February 20, 2015, with respect to the consolidated balance sheets of Ingredion Incorporated and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehen- sive income, equity and redeemable equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and the effectiveness of internal control over financial reporting as of December 31, 2014, which report appears in this December 31, 2014 annual report on Form 10K of Ingredion Incorporated. Exhibit 24.1 Ingredion Incorporated Power of Attorney Form 10-K for the Fiscal Year Ended December 31, 2014 KNOW ALL MEN BY THESE PRESENTS, that I, as a director of Ingredion Incorporated, a Delaware corporation (the “Company”), do hereby constitute and appoint Christine M. Castellano as my true and lawful attorney-in-fact and agent, for me and in my name, place and stead, to sign the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2014, and any and all amendments thereto, and to file the same and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorney-in- fact full power and authority to do and perform each and every act and thing requisite and necessary to be done in the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorney-in-fact may lawfully do or cause to be done by virtue thereof. /s/ KPMG LLP Chicago, Illinois February 20, 2015 IN WITNESS WHEREOF, I have executed this instrument this 20th day of February, 2015. /s/ Luis Aranguren-Trellez Luis Aranguren-Trellez /s/ David B. Fischer David B. Fischer /s/ Ilene S. Gordon Ilene S. Gordon /s/ Paul Hanrahan Paul Hanrahan /s/ Wayne M. Hewett Wayne M. Hewett /s/ Rhonda L. Jordan Rhonda L. Jordan /s/ Gregory B. Kenny Gregory B. Kenny /s/ Barbara A. Klein Barbara A. Klein /s/ Victoria J. Reich Victoria J. Reich /s/ Dwayne A. Wilson Dwayne A. Wilson 66 INGREDION INCORPORATEDExhibit 31.1 Certification of Chief Executive Officer I, Ilene S. Gordon, certify that: 1. I have reviewed this annual report on Form 10-K of Ingredion Incorporated; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circum- stances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the prepara- tion of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the regis- trant’s internal control over financial reporting; and 5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the regis- trant’s internal control over financial reporting. Date: February 20, 2015 /s/ Ilene S. Gordon Ilene S. Gordon Chairman, President and Chief Executive Officer Exhibit 31.2 Certification of Chief Financial Officer I, Jack C. Fortnum, certify that: 1. I have reviewed this annual report on Form 10-K of Ingredion Incorporated; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 67 INGREDION INCORPORATEDExhibit 32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 I, Ilene S. Gordon, the Chief Executive Officer of Ingredion Incorporated, certify that to my knowledge (i) the report on Form 10-K for the fiscal year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ingredion Incorporated. /s/ Ilene S. Gordon Ilene S. Gordon Chairman, President and Chief Executive Officer February 20, 2015 A signed original of this written statement required by Section 906 has been provided to Ingredion Incorporated and will be retained by Ingredion Incorporated and furnished to the Securities and Exchange Commission or its staff upon request. Exhibit 32.2 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 I, Jack C. Fortnum, the Chief Financial Officer of Ingredion Incorporated, certify that to my knowledge (i) the report on Form 10-K for the fiscal year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Ingredion Incorporated. /s/ Jack C. Fortnum Jack C. Fortnum Chief Financial Officer February 20, 2015 A signed original of this written statement required by Section 906 has been provided to Ingredion Incorporated and will be retained by Ingredion Incorporated and furnished to the Securities and Exchange Commission or its staff upon request. 4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15(f)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the prepara- tion of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and proce- dures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves manage- ment or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: February 20, 2015 /s/ Jack C. Fortnum Jack C. Fortnum Executive Vice President and Chief Financial Officer 68 INGREDION INCORPORATEDShareholder Cumulative Total Return The performance graph below shows the cumulative total return to shareholders (stock price appreciation or depreciation plus reinvested dividends) during the 5-year period from December 31, 2009 to December 31, 2014, for our common stock compared to the cumulative total return during the same period for the Russell 1000 Index and a peer group index. The Russell 1000 Index is a comprehensive common stock price index representing equity investments in the 1,000 larger companies measured by market capitalization of the 3,000 companies in the Russell 3000 Index. The Russell 1000 Index is value weighted and includes only publicly traded common stocks belonging to corporations domiciled in the U.S. and its territories. Our peer group index includes the following 19 companies in four identified sectors which, based on their standard industrial classification codes, are similar to us: Agricultural Processing Archer-Daniels-Midland Company Bunge Limited Gruma, S.A. de C.V. MGP Ingredients, Inc. Penford Corporation Tate & Lyle PLC Agricultural Production/ Farm Production Alico, Inc. Alliance One International, Inc. Charles River Laboratories International Inc. Universal Corporation Agricultural Chemicals Agrium, Inc. Monsanto Company Potash Corporation of Saskatchewan Inc. Syngenta AG Terra Nitrogen Company, L.P. Paper / Timber Deltic Timber Corporation MeadWestvaco Corporation Potlatch Corporation Wausau Paper Corp. ING R EDION RUS SEL L 10 00 INDEX PE E R GROUP INDEX $300 $250 $200 $150 $100 $50 $0 Ingredion Incorporated Russell 1000 Index Peer Group $100.00 $100.00 $100.00 $159.82 $116.10 $109.58 $185.19 $117.84 $103.34 $230.48 $137.19 $128.04 $250.56 $182.62 $144.05 $317.47 $206.79 $150.65 Dec. 31, 2009 Dec. 31, 2010 Dec. 31, 2011 Dec. 31, 2012 Dec. 31, 2013 Dec. 31, 2014 Comparison of Cumulative Total Return among our Company, the Russell 1000 Index and our Peer Group Index (For the period from December 31, 2009 to December 31, 2014. Source: S&P Capital IQ) The graph assumes that: • as of the market close on December 31, 2009, you made one-time $100 investments in our common stock and in market capital base-weighted amounts which were apportioned among all the companies whose equity securities constitute each of the other two named indices, and • all dividends were automatically reinvested in additional shares of the same class of equity securities constituting such investments at the frequency with which dividends were paid on such securities during the applicable time frame. Reconciliation of Non-GAAP Adjusted Diluted Earnings Per Share (Unaudited) Diluted earnings per common share of Ingredion Add back: Impairment/restructuring charges, net of income tax benefit Acquisition/integration costs, net of income tax benefit Reversal of Korean deferred tax asset valuation allowance Gain from change in benefit plan, net of income tax Gain from sale of land, net of income tax NAFTA award Charge for fair value mark-up of acquired inventory, net of income tax benefit Bridge loan fees, net of income tax benefit Other acquisition-related financing costs, net of income tax benefit Non-GAAP adjusted diluted earnings per common share of Ingredion Year Ended Dec. 31, 2014 Year Ended Dec. 31, 2013 Year Ended Dec. 31, 2012 Year Ended Dec. 31, 2011 Year Ended Dec. 31, 2010 $4.74 0.44 0.02 – – – – – – – $5.20 $5.05 – – – – – – – – – $5.05 $5.47 $5.32 0.29 0.03 (0.16) (0.04) (0.02) – – – – $5.57 0.08 0.26 – (0.23) – (0.75) – – – $4.68 $2.20 0.29 0.34 – – – – 0.23 0.16 0.02 $3.24 69 INGREDION INCORPORATED Financial Performance Metrics Return on Capital Employed (dollars in millions) Total Equity* Add: Cumulative translation adjustment* Share-based payments subject to redemption* Redeemable common stock* Total debt* Less: Cash and cash equivalents* Capital employed* (a) Operating income Adjusted for: Impairment/restructuring charges Acquisition/integration costs Gain from change in benefit plans Gain from sale of land NAFTA award Charge for fair value mark-up of acquired inventory 2014 $2,429 489 24 – 1,810 (574) $4,178 $÷«581 33 2 – – – – 2013 $2,459 335 19 – 1,800 (609) $4,004 $÷«613 – – – – – – 2012 $2,133 306 15 – 1,949 (401) $4,002 $÷«668 36 4 (5) (2) – – 2011 $2,001 180 9 – 1,769 (302) $3,657 $÷«671 10 31 (30) – (58) – 2010 $1,704 228 8 14 544 (175) $2,323 $÷«339 25 35 – – – 27 Adjusted operating income Income taxes (at effective tax rates of 28.3%, 26.3%, 30.4%, 31.9% and 33.1% in 2014, 2013, 2012, 2011 and 2010, respectively)** Adjusted operating income, net of tax (b) Return on Capital Employed (b/a) $÷«616 $÷«613 $÷«701 $÷«624 $÷«426 (174) $÷«442 10.6% (161) $÷«452 11.3% (213) $÷«488 12.2% (199) $÷«425 11.6% (141) $÷«285 12.3% * Balance sheet amounts used in computing capital employed represent beginning of period balances. ** Listed below is a schedule that reconciles the Company’s effective income tax rate under US GAAP to the adjusted Non-GAAP effective income tax rate. Non-GAAP Effective Tax Rate Income before Income Taxes (a) Provision for Income Taxes (b) Effective Income Tax Rate (b/a) (dollars in millions) 2014 2013 2012 2011 2010 2014 2013 2012 2011 $520 $547 $601 $593 $275 $157 $144 $167 $170 33 2 – – 36 4 10 31 25 35 – – – – 13 2 4 10 2014 2013 2012 2011 2010 30.2% 26.3% 27.8% 28.7% 36.1% 2010 $99 3 9 – – $555 – – $547 – – $641 – (58) $576 – – $335 – – $157 – – $144 13 – $195 – – $184 – – $111 28.3% 26.3% 30.4% 31.9% 33.1% As reported Add back (deduct): Impairment/restructuring charges Acquisition/integration costs Reversal of Korea deferred tax asset valuation allowance NAFTA award Adjusted Non-GAAP 70 INGREDION INCORPORATEDNet Debt to Adjusted EBITDA Ratio (dollars in millions) Short-term debt Long-term debt Less: Cash and cash equivalents Short-term investments Total net debt (a) Net income attributable to Ingredion Add back: Impairment/restructuring charges Acquisition/integration costs Gain from change in benefit plans Gain from sale of land Net income attributable to non-controlling interests Provision for income taxes Financing costs, net of interest income Depreciation and amortization Adjusted EBITDA (b) Net Debt to Adjusted EBITDA ratio (a/b) Net Debt to Capitalization Percentage (dollars in millions) Short-term debt Long-term debt Less: Cash and cash equivalents Short-term investments Total net debt (a) Deferred income tax liabilities Share-based payments subject to redemption Total equity Total capital Total net debt and capital (b) Net Debt to Capitalization percentage (a/b) 2014 $÷÷«23 1,804 (580) (34) $1,213 $÷«355 33 2 – – 8 157 61 195 $÷«811 1.5 2014 $÷÷«23 1,804 (580) (34) $1,213 $÷«180 22 2,207 $2,409 $3,622 33.5% 2013 $÷÷«93 1,717 (574) – $1,236 $÷«396 – – – – 7 144 66 194 $÷«807 1.5 2013 $÷÷«93 1,717 (574) – $1,236 $÷«207 24 2,429 $2,660 $3,896 31.7% 2012 $÷÷«76 1,724 (609) (19) $1,172 $÷«428 25 4 (5) (2) 6 167 67 211 $÷«901 1.3 2012 $÷÷«76 1,724 (609) (19) $1,172 $÷«160 19 2,459 $2,638 $3,810 30.8% 71 INGREDION INCORPORATEDDirectors and Officers As of April 7, 2015 Board of Directors Luis Aranguren-Trellez 3 Executive President Arancia, S.A. de C.V. Age 53; Director since 2003 David B. Fischer 2 President and Chief Executive Officer Greif, Inc. Age 52; Director since 2013 Ilene S. Gordon Chairman, President and Chief Executive Officer Ingredion Incorporated Age 61; Director since 2009 Paul Hanrahan * 3 Chief Executive Officer American Capital Energy & Infrastructure Management, LLC Age 57; Director since 2006 Wayne M. Hewett 1 President Platform Specialty Products Corporation Age 50; Director since 2010 Rhonda L. Jordan 2 Former President, Global Health & Wellness, and Sustainability Kraft Foods Inc. Age 57; Director since 2013 Gregory B. Kenny 3 President and Chief Executive Officer General Cable Corporation Age 62; Director since 2005 Barbara A. Klein 1 Former Senior Vice President and Chief Financial Officer CDW Corporation Age 60; Director since 2004 Victoria J. Reich 1 Former Senior Vice President and Chief Financial Officer United Stationers Inc. Age 57; Director since 2013 Dwayne A. Wilson 2 Senior Vice President Fluor Corporation Age 56; Director since 2010 * Lead Director Committees of the Board 1 Audit Committee, Ms. Klein is Chairman. 2 Compensation Committee, Mr. Wilson is Chairman. 3 Corporate Governance and Nominating Committee, Mr. Kenny is Chairman. Corporate Officers Ilene S. Gordon Chairman, President and Chief Executive Officer Age 61; joined Company in 2009 Christine M. Castellano Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer Age 49; joined Company in 1996 Ricardo de Abreu Souza Senior Vice President and President, South America Ingredient Solutions Age 64; joined Company in 1977 Anthony P. DeLio Senior Vice President and Chief Innovation Officer Age 59; joined Company in 2010 Jack C. Fortnum Executive Vice President and Chief Financial Officer Age 58; joined Company in 1984 Diane J. Frisch Senior Vice President, Human Resources Age 60; joined Company in 2010 Matthew R. Galvanoni Vice President and Corporate Controller Age 42; joined Company in 2012 Jorgen Kokke Senior Vice President and President, Asia-Pacific Age 46; joined Company in 2010 Richard O’Shanna Vice President, Tax Age 57; joined Company in 2009 John F. Saucier Senior Vice President, Corporate Strategy and Global Business Development Age 61; joined Company in 2006 Robert J. Stefansic Senior Vice President, Operational Excellence, Sustainability and Chief Supply Chain Officer Age 53; joined Company in 2010 C. Kevin Wilson Vice President and Corporate Treasurer, Age 53; joined Company in 2014 James P. Zallie Executive Vice President, Global Specialties and President, North America and EMEA Age 53; joined Company in 2010 72 INGREDION INCORPORATEDShareholder Information CORPORATE HEADQUARTERS 5 Westbrook Corporate Center Westchester, IL 60154 708.551.2600 708.551.2700 fax www.ingredion.com STOCK EXCHANGE The common shares of Ingredion Incorporated trade on the New York Stock Exchange under the ticker symbol INGR. Our Company is a member of the Russell 1000 Index and the S&P MidCap 400 Index. STOCK PRICES AND DIVIDENDS Common stock market price 2014 Q4 Q3 Q2 Q1 2013 Q4 Q3 Q2 Q1 High Low $87.20 $80.54 $77.92 $70.00 $70.48 $72.19 $74.31 $72.58 $69.94 $73.10 $65.25 $58.28 $63.49 $60.62 $62.65 $62.44 Cash Dividends Declared per Share $0.42 $0.42 $0.42 $0.42 $0.42 $0.38 $0.38 $0.38 SHAREHOLDERS As of January 31, 2015, there were 5,078 shareholders of record. TRANSFER AGENT, DIVIDEND DISBURSING AGENT AND REGISTRAR Computershare 866.517.4574 or 201.680.6685 (outside the U.S.) or 888.269.5221 (hearing impaired – TTY phone) SHAREHOLDER ASSISTANCE Ingredion Incorporated c/o Computershare P.O. Box 30170 College Station, TX 77842-3170 Send overnight correspondence to: Ingredion Incorporated c/o Computershare 211 Quality Circle, Suite 210 College Station, TX 77845 Shareholder website: www.computershare.com/investor INVESTOR AND SHAREHOLDER CONTACT Investor Relations Department 708.551.2592 Investor.relations@ingredion.com COMPANY INFORMATION Copies of the Annual Report, the Annual Report on Form 10-K and quarterly reports on Form 10-Q may be obtained, without charge, by writing to Investor Relations at the corporate headquarters address, by calling 708.551.2603, by emailing investor.relations@ingredion.com or by visiting our website at www.ingredion.com. ANNUAL MEETING OF SHAREHOLDERS The 2015 Annual Meeting of Shareholders will be held on Wednesday, May 20, 2015, at 9:00 a.m. local time at the Westbrook Corporate Center Meeting Facility, 5 Westbrook Corporate Center, in Westchester, IL 60154. A formal notice of that meeting, proxy statement and proxy voting card are being made available to shareholders in accordance with U.S. Securities and Exchange Commission regulations. INDEPENDENT AUDITORS KPMG LLP 200 East Randolph Drive Chicago, IL 60601 312.665.1000 BOARD COMMUNICATION Interested parties may communicate directly with any member of our Board of Directors, including the Lead Director, or the non-management directors or the independent directors, as a group, by writing in care of Corporate Secretary, Ingredion Incorporated, 5 Westbrook Corporate Center, Westchester, IL 60154. SAFE HARBOR Certain statements in this Annual Report that are neither reported financial results nor other historical information are forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results and Company plans and objectives to differ materially from those expressed in the forward-looking statements. This report was printed with soy-based inks on Green Seal certified, acid-free, recycled paper containing 10% post-consumer waste. Classic is dedicated to the preservation of the environment and ensures all printing plates, waste paper and unused inks are properly recycled, further reducing our carbon footprint. Shareholder online inquiries: https://www-us.computershare.com/investor/contact Copyright © 2015 Ingredion Incorporated. All Rights Reserved. Ingredion Incorporated 5 Westbrook Corporate Center Westchester, IL 60154 708.551.2600 www.ingredion.com 

Continue reading text version or see original annual report in PDF format above